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Candida biofilms are a substantial clinical and human health burden which are still 
underappreciated. Benefits afforded by morphogenic switching from planktonic to 
biofilm communities include resistance to antimicrobials in the host’s immune system, 
and resilience to mechanical disruption, all of which complicate the treatment and 
management of infections. Biofilm formation in Candida spp. is influenced by 
numerous factors, including response to the host, pH, bacteria, and many other 
environmental factors. This is further complicated by inherent heterogeneity within 
candidal populations in respect to biofilm forming capabilities and its response to 
external stimuli. Biofilms are heterogeneous by their nature, formed of populations of 
yeast and hyphal cells in a consortium of morphological states. Many variables exist 
to influence biofilm heterogeneity in Candida spp. and can influence the clinical 
outcomes and observations. The overarching aim of this thesis was to explore factors 
that influences C. albicans biofilm formation using omics-based approaches. 
 
We performed analysis on the microbiome derived from three distinct oral niches in 
denture stomatitis patients. Alpha and beta diversity measures were extrapolated and 
compared to identify perturbations in the microbiome that were related to either the 
oral hygiene or the Candida burden of the individuals. Correlation analysis between 
phyla, oral hygiene and fungal load were performed to identify significant 
relationships.  
 
Secondly, we selected clinical isolates, from our Scottish candidaemia study cohort, 
which were deemed high and low biofilm isolates as determined by biomass assays.  
We assessed the biofilm forming capabilities in media supplemented with and without 
serum. These assays consisted of crystal violet biomass assay and measurements of 
hyphal length. We also utilised SEM to visualise the phenotypes of the high and low 
isolates with and without serum. HBF and LBF isolates were then grown at 90min, 4h 
and 24h in the presence and absence of serum before being submitted to RNA-
Sequencing by Illumina. Differential expression analysis was performed using DESeq2 
before over representation and gene set enrichment analysis. Cell wall proteomics on 
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high and low isolates was also performed to identify computational changes in the cell 
wall. 
 
Thirdly, we performed metabolomic analysis both targeted and untargeted on the 
supernatants of HBF and LBF grown in the presence or absence of serum for 4 and 
24h. Features were identified from the LC-MS peaks by PiMP and analysis of 
differentially abundant analytes between our isolates and growth conditions were 
performed. Functional analysis of the annotated analytes was then performed by 
pathway activity profiling.  
 
Finally, utilising our identified differentially expressed features from metabolomic and 
transcriptomic analysis we submitted both datasets to integrative analysis. Using a 
combination of conceptual, joint pathway analysis by MetaboAnalyst and multivariate 
analysis using the MixOmics data integration package.  
 
From our microbiome analysis we observed that the oral hygiene measures had no 
significant effect on the diversity or composition of the oral microbiome. Candida 
similarly had no impact on the alpha diversity of the oral microbiome. However, we 
did observe some relationship in the beta diversity which correlated with Candida 
load. Further investigation identified correlations of genus including Lactobacillus with 
the Candida load. From our high and low Candida candidaemia isolates we observed 
phenotypic switching of LBF in the presence of serum. We also found functional 
differences related to this phenotypic switching. The low biofilm response to serum 
included enrichment in fatty acid and aycl-coA metabolic pathways. Metabolomic 
analysis revealed changes in arachidonic acid metabolism in serum grown isolates and 
changes in the amino acid metabolism between LBF and HBF isolates. Integrating 
these data, we were able to observe overlaps in the metabolic reprogramming of C. 
albicans isolates in serum with joint pathway analysis confirming changes in the fatty 
acid metabolic response in both transcriptomic and metabolomic data. Multivariate 
analysis by sPLS-DA identified several highly covariate discriminatory features with 
and without the presence of serum. These included many genes of currently unknown 
function and a downregulation of specific genes in serum including zinc transport.  
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Through the application of transcriptomics and metabolomics we have demonstrated 
that these holistic methodologies are invaluable to biofilm research. We identified 
molecular processes and metabolomic reprogramming of C. albicans in response to 
the biofilm inducing stimulus of serum. We also highlight the current and potential 
benefits that integration of multiple omics data sets provides. Integration is not 
without its challenges, however, and we identify some key methodologies that could 
improve interpretability of omics datasets derived from microbial communities. As 
Candida spp. do not exist within a vacuum, and infectious disease aetiology is 
dependent on the interactions between fungal and bacterial species, understanding 
the mechanisms that govern these biofilm models will help us to identify important 
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1 Candida biofilms, their clinical 
significance and role in interkingdom 
interactions 
  






Within this thesis introduction we will discuss our current knowledge of Candida 
biofilms. We discuss their clinical implications, factors that drive heterogeneity and 
differences in phenotype and how they interact with bacteria in the oral cavity. We 
also discuss the advances in omics and how they are applied to interrogating microbial 
communities and biofilms. We also discuss our current understanding of oral health, 
the oral microbiome, and its relationship with Candida.   
 
This chapter is also contributed to from work previously published: 
Kean R, Delaney C, Rajendran R, Sherry L, Metcalfe R, Thomas R, McLean W, 
Williams C, Ramage G. Gaining Insights from Candida Biofilm Heterogeneity: One 
Size Does Not Fit All. J Fungi (Basel). 2018 Jan 15;4(1):12. doi: 
10.3390/jof4010012. PMID: 29371505; PMCID: PMC5872315. 
 
Delaney C, Kean R, Short B, Tumelty M, McLean W, Nile CJ, et al. Fungi at the 
Scene of the Crime: Innocent Bystanders or Accomplices in Oral Infections? 
Current Clinical Microbiology Reports. 2018; 5:190-200,doi: 10.1007/s40588-
018-0100-3 
 
Despite their clinical significance and substantial human health burden, Candida 
infections remain relatively under-studied and under-appreciated. The widespread 
overuse of antibiotics and the increasing requirement for indwelling medical devices 
provides an opportunistic potential for the overgrowth and colonization of pathogenic 
Candida species on both biological and inert surfaces. In fact, it is now widely 
appreciated that these are a highly important part of their virulence repertoire. 
Candida albicans is regarded as the primary fungal biofilm forming species and is 
known for its role in interkingdom biofilm interactions with numerous different 
bacteria. C. albicans biofilms are heterogeneous structures by definition, existing as 
three-dimensional populations of yeast, pseudo-hyphae and hyphae, embedded 
within a self-produced extracellular matrix (ECM) (López-Ribot, 2005). Classical 
molecular approaches driven by extensive studies of laboratory strains and mutants 
have enhanced our knowledge and understanding of how these complex communities 
develop, thrive, and induce host mediated damage. Yet clinical observations tell an 
alternative story, with differential patient responses likely to be a result of inherent 




biological heterogeneity from specific clinical isolates associated with their infections. 
Moreover, the complexity of these infections is increased due to its interaction with 
host and environmental factors in addition to co-existence with many other bacterial 
species as interkingdom biofilms.  
 
1.2 Candida biofilms 
 
Candida spp. are eukaryotic fungal species of the division Ascomycota that are 
ubiquitous and exist within the normal flora on mucosal membranes, skin and gut. 
Candida spp. are present in up to ~70% of healthy humans but an overgrowth of 
Candida leads to dysbiosis such as in the case of immunocompromised patients 
(Perlroth et al., 2007). Candida spp., as pathogens, primarily cause candidiasis at the 
mucosa of the mouth, gut and vagina (Moyes and Naglik, 2011). In 
immunocompromised patients Candida causes invasive candidiasis or candidemia of 
the bloodstream which is a leading cause of bloodstream infections (BSI) (Rajendran 
et al., 2016d). Candida spp. typically associated with disease include C. albicans, C. 
glabrata, C. tropicalis and C. krusei. C. albicans is typically considered the most 
prevalent fungal species and most dominant fungal species associated with disease in 
humans (Nobile and Johnson, 2015). Although many Candida species cause infections 
of the mucosa, C. albicans is the most commonly recovered in clinical cohorts and this 
is attributed to its increased pathogenic factors (Nobile and Johnson, 2015). Key to 
this is its ability to phenotypically switch from yeast to hyphal and pseudo-hyphal 
forms. Enhanced filamentation compared to other Candida species which are only 
capable of yeast or pseudo-hyphae is thought to explain the higher prevalence of C. 
albicans in mucosal and BSI infections (Rajendran et al., 2016d, Sherry et al., 2014). 
Hyphal formation provides increased tissue invasion, host evasion and biofilm 
formation. Throughout this introduction we will discuss the process and implications 
of hyphal and biofilm formation and how this influences disease and its interaction 
with the host and other microorganisms. 
 
Microbes rarely exist planktonically as a single entity, instead the majority of 
organisms are found as complex heterogeneous sessile communities on abiotic and 




biotic surfaces defined as polymicrobial biofilms (Peters et al., 2012). It has been 
suggested that up to 80 percent of bacteria favour a co-operative existence (Ramage 
et al., 2014). It is estimated that two thirds of all infections are due to the presence of 
a microbial biofilm (Potera, 1999, Sintim and Gursoy, 2016). Biofilms are considered 
as surface attached or aggregates of microbial cells (bacteria, fungi, and protozoa) that 
are encased in some form of polymeric substrate. These tenacious and sticky 
structures are classically recalcitrant to antimicrobial therapies, difficult to remove, 
and drive pro-inflammatory chronic immune responses that can damage host tissues 
and materials. C. albicans is considered the paradigm for fungal biofilms and 
significant strides have been made in elucidating how it forms and the mechanistic 
control of this. C. albicans is a normal commensal of human mucosal surfaces and 
opportunistic pathogen in immunocompromised patients. This dimorphic yeast exists 
in budding-yeast and hyphal forms, and these morphologies lend themselves to 
creating a structurally complex biofilm. A simplified model of this begins with yeast 
cells attaching to a relevant surface via defined adhesins. A microcolony is formed and 
yeast cells undergo morphological switching to pseudo- and true hyphae, rapidly 
forming an intertwined meshwork of hyphae interspersed with budding yeast cells. A 
glucan rich polymeric matrix then encloses the biofilms as it matures, providing 
protection from host defences and antimicrobial agents. The hypoxic stressful 
environment within the mature biofilm leads to further filamentation, but also release 
of yeast daughter cells can then disperse from the site of biofilm formation under 
physical force, such as flow, and attach to a new substrate and biofilm development 
starts again. Figure 1.1 illustrates this development cycle and the morphological 
transitioning. Microscopic analysis has demonstrated that C. albicans biofilm 
formation could be separated into three distinct developmental phases: Early (0 to 11 
hours); Intermediate (12 to 30 hours); and Maturation (31 to 72 hours). Confocal laser 
scanning microscopy (CLSM) has shown mature C. albicans biofilms to be complex 3-
D structures that can range from anything between 50 to 350 µm thick, depending on 
the model utilised (Chandra et al., 2001).  





Figure 1.1 Simplified developmental cycle of C. albicans biofilm (Ramage and Williams, 2012). 
 
1.2.1 Adhesion and virulence 
Adhesion of yeast cells is mediated by the agglutinin like sequence proteins ALS1/ALS3 
and the GPI anchored cell wall protein Eap1p (Zhao et al., 2006, Li et al., 2007). Once 
microcolonies are formed, morphological transitioning is governed under the 
regulatory control of Efg1p (Ramage et al., 2002a). This regulator leads to the 
colonisation of pseudo- and true hyphae mixed biofilms, additionally hyphal wall 
protein Hwp2 and putative glycosylphosphatidylinositol (GPI) lipid anchored protein 
Pga1, Ihd1 and Hyr1 have also been implicated in initial adhesion. Following adhesion 
the yeast wall protein Ypw1 S. cerevisiae homolog is believed to maintain adhesion 
during early biofilm development (McCall et al., 2019).  
 
Key to successful colonisation and host damage to a mucosal niche is the secretion of 
various hydrolytic enzymes. These secreted proteins are a primary attribute within the 
virulence armamentarium of the organism allowing it to invade host tissue, and 
include proteinases, haemolysin and phospholipase. Of these enzymes, the secreted 
aspartyl proteinases (Saps) are the most studied, comprising a family of ten genes 




(SAP1-10). The secretion of these enzymes has been attributed with increased 
virulence, with high levels of expression observed from a variety of diseases including 
infections of the oral cavity, bloodstream, vagina and patients with diabetes mellitus 
(Naglik et al., 2008, Joo et al., 2013, Ramage et al., 2012a). Given the diversity of the 
Sap family, then differential expression of independent genes has been associated 
with varying anatomical location (Naglik et al., 2003, Joo et al., 2013). During biofilm 
formation, SAP5 is up-regulated, significantly correlating with biomass (Sherry et al., 
2014). Indeed, an integrated global substrate and proteomics approach identified 
SAP5 and SAP6 as the major biofilm related proteases utilised by C. albicans. 
Manipulation of both genes resulted in decreased adhesion and impaired biofilm 
development both in vitro and in vivo, highlighting their role as potential biofilm 
biomarkers (Winter et al., 2016). Recent studies have identified a novel fungal toxin 
termed Candidalysin, a hyphae-specific peptide critical for epithelial damage (Moyes 
et al., 2016) and expression of the gene coding this toxin (ECE1) was shown to be highly 
up-regulated in C. albicans isolates capable of forming biofilms (Rajendran et al., 
2016b). 
 
1.2.2 Biofilm matrix 
Through experimental advancement and use of more sophisticated technologies, 
Candida biofilm ECM has been extensively analysed (Zarnowski et al., 2014, Nett et 
al., 2010a, Nett et al., 2010b, Mitchell et al., 2016). Compositionally, the ECM is 
comprised of four main macromolecular constituents: proteins, carbohydrates, lipids 
and nucleic acid. However, through use of a multi-omics approach, Zarnowksi et al 
(2014) identified an abundance of novel components within these subclasses, 
generating a distinguished compendium of its constituents. This demonstrated its 
clinical relevance of providing biofilm stability, sequestration of drugs and protection 
from the surrounding environmental stressors as well as subsequently facilitating 
biofilm dispersal (Zarnowski et al., 2014). While the majority of ECM-mediated 
research has focused on the role of polysaccharides, another notable component is 
extracellular DNA (eDNA) (Martins et al., 2010). Despite only contributing to 5% of the 
ECM, eDNA plays a substantial role in maintaining structural homeostasis within the 
matrix. It is thought to act as molecular glue, facilitating cohesion between the other 




matrix constituents. Exogenous addition and enzymatic depletion of eDNA have been 
shown to have both positively and negatively influence biofilm formation respectively 
(Martins et al., 2010). Furthermore, the addition of DNase to amphotericin B and 
caspofungin enhances their activity against sessile communities, however no positive 
interaction is observed with azoles (Martins et al., 2012). 
 
1.2.3 Molecular basis and transcriptional regulation 
Given the complexity of the biofilm formation process it is unsurprising that it is 
determined by a variety of transcriptional regulations. Central to this is the master 
regulatory transcriptional network as defined by Nobile and colleagues (2012) (Nobile 
et al., 2012). Originally, a hub of six regulatory genes (TEC1, NDT80, ROB1, BRG1, BCR1, 
EFG1) was identified that regulate both themselves and approximately 1000 genes 
involved in biofilm formation processes such as hyphal morphogenesis, ECM 
production and drug resistance (Nobile et al., 2012). Furthermore, this same group 
identified an additional three regulatory genes responding to temporal changes in 
biofilm formation. Using deletion strains, they identified FLO8 as a regulator 
throughout all stages of development from initial adherence to fully mature biofilms, 
whereas RFX2 and GAL4 are required only in the later stages of maturation (Fox et al., 
2015). While these approaches provide invaluable insights into the transcriptional 
mechanisms underpinning biofilm development, their limitations lie within only 
considering laboratory reference strains. Indeed, when the transcriptional profile of a 
group of C. albicans LBF and HBF were compared, no transcriptional differences of two 
of the master biofilm regulators (BCR1 and EFG1) was shown, despite the phenotypic 
and biological differences between the strain subsets (Sherry et al., 2014). Figure 1.2 
illustrates our current understanding of the molecular basis of C. albicans biofilm 
development.





Figure 1.2 Molecular basis of C. albicans biofilm formation (Finkel and Mitchell, 2011, Nobile 
et al., 2012). 
 
1.2.4 Metabolism 
As well as a defined transcriptional network governing biofilm formation, various 
metabolic circuits control the transition from planktonic cells to biofilm maturity. 
Using a metabolomics approach, Zhu and colleagues (2013), performed a time-course 
analysis of the metabolome of C. albicans biofilm development (Zhu et al., 2013). They 
identified 31 metabolites that were differently expressed between planktonic and 
biofilm cells that were involved in various processes including the TCA cycle, amino 
acid biosynthesis and oxidative stress. Interestingly, they showed that trehalose was 
highly up regulated after 6 hours of maturation. Using a TPS1 knockout, they 
demonstrated an impaired biofilm phenotype, as well as increased sensitivity to 
amphotericin B and miconazole, thus highlighting the importance of the trehalose 
biosynthesis pathway for biofilm maturation (Zhu et al., 2013). Metabolomics has 
been used in numerous studies to investigate Candida biofilms under different 
environmental conditions. Such as those that illicit a modified biofilm response. 
Metabolic reprogramming is an important consideration in many biofilm studies, and 
we discuss this in further detail in section 1.6.6. 
 




1.3 Biofilm heterogeneity 
 
As highlighted in the previous sections, classical molecular microbiological approaches 
have shown that deletion or over expression of particular genes enables us to 
definitively deduce their function in C. albicans biofilms. Reinforced by structural 
biology studies, these tactics have enabled us to deduce the structure/function of 
specific proteins within the context of biofilm development. Nevertheless, this 
assumes that molecular manipulations do not have any pleiotropic effects, nor does 
this take into account inherent biological heterogeneity that bears itself amongst a 
range of clinical isolates. This begs the question whether using laboratory strains is the 
optimal way to develop our understanding of microbial pathogenesis (Fux et al., 2005), 
or instead, whether taking a combinatory approach through evaluating both 
phenotypic and genotypic characteristics of clinical isolates would enhance our 
understanding. This section focuses on C. albicans biofilm heterogeneity and attempts 
to examine the literature with respect to what insights can be garnered from working 
with clinical isolates and observing the inherent heterogeneity that exists. Biofilm 
heterogeneity for any micro-organism is the difference observed in biofilm formation 
from a few patchy cells to thick multi layered masses (Wimpenny et al., 2000). Further 
to this, biofilm heterogeneity in Candida biofilms involves cells at different stages of 
morphology, fluctuating levels of ECM and differences in thickness.  
 
1.3.1 Is heterogeneity clinically important? 
Since the earliest descriptions of Candida biofilms great strides have been made to 
unequivocally demonstrate their clinical significance, despite perceived contention in 
the field. Throughout the human host, Candida biofilms colonize a wide variety of 
anatomical locations, as shown in Figure 1.3. The oral and vaginal epithelium provide 
a mucosal niche for biofilm formation, whilst indwelling medical devices such as 
prosthetic heart valves and central venous catheters provide an inert, abiotic 
substrate for subsequent biofilm adherence and proliferation (Kojic and Darouiche, 
2004, Ganguly and Mitchell, 2011). Irrespective of isolation site, biofilm heterogeneity 
has been reported within the oral cavity, bloodstream, and urinary tract (O'Donnell et 
al., 2017, Rajendran et al., 2016d, Sherry et al., 2017, Jain et al., 2007, Bitar et al., 2014, 




Alnuaimi et al., 2013). Within a clinical setting, intravascular catheters provide an 
optimal environment for Candida spp., allowing for the development and maturation 
of biofilms to which cells can disperse and subsequently cause candidemia. Dispersed 
biofilm cells have been shown to be more pathogenic than their planktonic 
counterparts, exhibiting greater cytotoxicity and virulence in vivo (Uppuluri et al., 
2010). Therefore, the role of the biofilm phenotype has potentially profound 
implications within the clinical environment. An initial study from Tumbarello and 
colleagues (2007) aimed to identify the top risk factors associated with mortality rates 
in candidaemia patients. Using multivariate analysis, they were able to distinguish 
inadequate antifungal therapy (OR 2.36, p=0.03), APACHE III (OR 1.03, p<0.001) and 
overall biofilm-forming Candida species (OR 2.33, p<0.007) as significant variables 
associated with mortality (Tumbarello et al., 2007). When scrutinized at the Candida 
species level, only C. albicans (OR 3.97, p<0.001) and C. parapsilosis (OR 4.16, p=0.03) 
were shown to significantly correlate with biofilm-based mortality. A follow up study 
subsequently identified central venous and urinary catheters, use of total parenteral 
nutrition, and diabetes mellitus as independent factors that were associated with BSI 
caused by high biofilm forming isolates (Tumbarello et al., 2012). Furthermore, they 
demonstrated the potential economic burden of these isolates resulting from 
increased lengths of hospital stays and use of antifungals and ultimately resulted in an 
increased possibility of mortality (Tumbarello et al., 2012). A more recent, prospective 
analysis subsequently identified line removal (p=0.032) as a significant risk factor 
associated with mortality rates from a candidaemia patient cohort, with the removal 
of an indwelling line correlating with a more positive patient outcome (Rajendran et 
al., 2016d). Interestingly, when this was subsequently assessed at Candida species 
level, survival analysis demonstrated significantly higher survival rates for patients 
with C. albicans associated line removal compared to no removal, with no differences 
observed in non-Candida albicans species (NCAS) (Rajendran et al., 2016c). Published 
guidelines have suggested that catheter-related bloodstream infections should result 
in the direct removal of such devices, if possible (Cornely et al., 2012, Koehler et al., 
2014, Mermel et al., 2009). Furthermore, a meta-analysis of seven clinical trials 
revealed that the removal of central venous catheters significantly correlated with 
reduced mortality rates (OR 0.50, p<0.001) (Andes et al., 2012). 






Figure 1.3 Mucosal and medical devices associated Candida biofilm infections (Peleg et al., 
2010). 
 
1.3.2 How does heterogeneity impact antifungal treatment? 
Antifungal tolerance is a complex, multifactorial process which can either be induced 
in response to a compound or manifest as an irreversible genetic alteration as a result 
of prolonged drug exposure. While resistant planktonic cells predominantly arise from 
inherited traits to maintain a tolerant phenotype, biofilm resistance rises through 
mechanisms such as over-expression of target molecules, efflux pump activity and 
through the protective barrier of the extracellular matrix (ECM) allowing limited 
diffusion. Undoubtedly the most defining characteristic of biofilms is this intrinsic and 
adaptive recalcitrance to many antimicrobial therapies. Compared to their free-
floating planktonic equivalents, up to 1000-fold higher concentrations of antifungal 
agents can be required to effectively kill Candida biofilms in vitro, with the same 
decreased sensitivities also observed in vivo (Ramage et al., 2001b, Kucharikova et al., 
2010). Figure 1.4 illustrates the factors associated with antifungal tolerance in 
biofilms.  
 





Figure 1.4 Schematic representation of factors driving biofilm-associated antifungal 
tolerance (Ramage et al., 2012b). 
 
Several clinical observations have associated the ability to form biofilms with 
mortality, but also with azole and inadequate antifungal use. Many studies have sub-
categorised C. albicans isolates as low biofilm formers (LBF) and high biofilm formers 
(HBF) (Marcos-Zambrano et al., 2016, Muadcheingka and Tantivitayakul, 2015, 
Rajendran et al., 2016d). Phenotypically, biofilms formed by these isolates are distinct, 
with LBF existing predominantly as sparse populations of yeast cells and pseudo-
hyphae, whereas HBF have a dense, tenacious hyphal based morphology. In vivo there 
is also biological differences, with increased mortality rates observed in HBF compared 
to LBF (Hasan et al., 2009, Sherry et al., 2014). Additionally, it was shown in vitro that 
isolates categorised as LBF and HBF were differentially sensitive to azoles and 
echinocandins at both low and high dosage, with the later less susceptible to these 
concentrations (Rajendran et al., 2016d).  
 
1.3.3 What drives biofilm heterogeneity?  
Interestingly, eDNA is a factor that contributes to the biofilm forming heterogeneity 
observed between LBF and HBF. Significantly increased quantities of eDNA were 




released from both early and mature biofilms of HBF strains compared to LBF strains 
(Rajendran et al., 2014). Given that HBF are more resistant to amphotericin B (AMB) 
than LBF (Sherry et al., 2014), the combination therapy with AMB and DNase, that 
sensitises HBF up to 8-fold compared to AMB alone, is very much a matrix-mediated 
resistance (Rajendran et al., 2014). The role of the other ECM components within 
biofilm heterogeneity observed in clinical isolates remains unknown, yet given the 
differences observed between azole and echinocandin susceptibility of these isolates 
(Rajendran et al., 2016d) it is highly likely that key components are involved and 
worthy of further scrutiny to determine if strain specific ECM motifs are present.  
 
To better our understanding of the molecular mechanisms facilitating biofilm 
heterogeneity between C. albicans clinical isolates, Rajendran and colleagues (2016) 
undertook a transcriptional profiling approach (Rajendran et al., 2016b). As expected, 
well-known biofilm related genes such as HWP1 and ALS3 were up regulated in HBF. 
A non-biased computational approach was further utilized, and in doing so the 
metabolic circuitry which defined biofilm phenotypes was established (Figure 1.5). 
 
Using KEGG pathway analysis, it was shown that the amino acid pathways arginine and 
proline metabolism, pyruvate metabolism, and also fatty acid metabolism, were highly 
upregulated in HBF. Within the subnetwork of these pathways, the gene encoding 
aspartate aminotransferase (AAT1) was shown to be a regulatory hub of these 
networks. Pharmacological inhibition of this enzyme was shown to perturb biofilm 
formation, highlighting its potential as a target for biofilm-based infections. 






The adaptation of its metabolism is fundamental to the pathogenicity and survival of 
C. albicans within the host (Brown et al., 2014a). The immune response to Candida 
biofilms is diminished compared to planktonic cells (Nett, 2016), with further evidence 
suggesting the potential to stimulate biofilm production, resulting in an altered 
inflammatory output (Chandra et al., 2007). The presence of additional environmental 
stressors such as pH, thermal and oxidative stress, and also the availability of nutrients 
results in the metabolic adaptation of the biofilm to acclimatise to its surroundings. 
Figure 1.6 illustrates an emerging concept, central to this thesis, how different clinical 
isolates differentially respond to external stimuli. This, combined with inter-
relationships with other yeasts and bacteria, creates multiple permutations of strain 
specific biofilms, all exhibiting their distinct and unique fingerprints.  
 
 
Figure 1.5 Maximum scoring metabolic subnetwork in the LBF-HBF network. Differential 
transcriptional expression between LBF and HBF. Red gene names indicate upregulation in 
HBF, with blue indicating LBF (Rajendran et al., 2016a). 





Figure 1.6 Factors influencing biofilm formation. There are multiple stimuli that can induce 
biofilm formation including the immune response, antifungal stress, and bacterial derived 
metabolites. Environmental stressors can also stimulate biofilm formation, and these include 
the availability of nutrients, temperature and pH (Kean et al., 2018a). 
 
1.4 Polymicrobiality in the oral cavity 
 
Polymicrobial oral biofilms consist of many bacterial and fungal species. 
Approximately 700 bacterial species or phylotypes (Aas et al., 2005) and more than 
100 fungal species have been identified in the oral cavity (Peters et al., 2017). It is 
estimated that overall species numbers may well exceed 1000, although many of 
these are uncultivatable (Jenkinson, 2011). There is significant diversity in the oral 
microbiome, varying greatly from individual to individual. For example, only 100-200 
species are thought to be found in the oral cavity of any given individual (Paster et al., 
2006). Despite this diversity, the concept of microbial “complexes” of microorganisms 
has emerged, that demonstrates a shift in biofilm colonisation from health to disease, 
such as in the development of periodontal disease (PD) (Socransky et al., 1998, 
Haffajee et al., 2008). Our understanding of how dental plaque composition relates to 
oral health and disease has also changed over time. For example, hypotheses such as 




the “non-specific plaque hypothesis” (Theilade, 1986), “specific plaque hypothesis” 
(Loesche, 1976), “ecological plaque hypothesis” (Marsh, 1994) and “keystone 
pathogen hypothesis” (Hajishengallis et al., 2012) were all developed over the past 50 
years. Over time, these hypotheses have set the foundations of future oral 
microbiological research, ultimately contributing to our current understanding of the 
complex nature behind microbial disease onset and progression in the oral cavity. 
Recently, multi-omics approaches (e.g., genomics, transcriptomics, proteomics, and 
metabolomics) have enhanced our understanding of microbial interactions in the oral 
cavity. Theoretically, it is now possible to identify all microbial species that colonise 
our mouths (Jenkinson, 2011, Dewhirst et al., 2010). The omics platforms provide the 
power to investigate complex systems in unprecedented detail, and these have been 
used to examine biofilms in human diseases and in animal models of disease.  
 
1.4.1 Candida and the oral cavity 
The oral ecosystem is a critical element in oral health, with dysbiosis perceived as the 
primary driver of disease phenotypes (Marsh and Zaura, 2017). Recent studies have 
shown that ecological heterogeneity of the salivary ecosystem, its functionality, and 
its interaction with host-related biochemical salivary parameters are also important 
considerations in understanding disease processes in the oral cavity (Zaura et al., 
2017). However, a notable omission from many of these studies is the importance of 
pathogenic fungi expressed in terms of the mycobiome, and how these eukaryotes 
impact the progression of various oral diseases. Indeed, fungi are often neglected in 
oral microbiology due to their relatively low quantitative contribution within diseased 
sites of the oral cavity. Nevertheless, consideration of their size may lead to a rethink, 
as conservative estimates for a yeast cell bio-volume is approximately 70μm3 whereas 
a bacterium is 0.5μm3 (Janus et al., 2016). This almost 150-fold difference in the 
occupancy of available space upon orally relevant surfaces for fungi suggests that it is 
at least a bystander, but whether a major contributor to pathogenicity or not remains 
to be determined.  
 
The oral cavity contains numerous different micro-environments, ranging from 
enamel, mucosa, periodontal pockets, acrylic and metal substrates, and dentine, that 




are inhabited by tens to hundreds of bacterial species (Xu et al., 2015). Polymicrobial 
communities can form biofilms upon this vast variety of substrates (Shibli et al., 2008, 
Diaz et al., 2012, Vieira Colombo et al., 2016). It is now generally well understood that 
dental plaque biofilms contain many resident species that modulate one another, 
their environment, and the host response (Millhouse et al., 2014, Hirschfeld et al., 
2017, Ramage et al., 2017). Despite the widely acknowledged presence of yeasts 
within the oral cavity, their active role and participation in oral diseases is generally 
perceived to be restricted to mucosal-related diseases. Yet, more than 100 fungal 
species have been reported to colonise the oral cavity and co-exist within complex 
biofilm populations within aggregates alongside resident bacterial microbiomes 
(Peters et al., 2017). The emergence of these datasets has been the catalyst for several 
studies investigating the importance of fungi within oral biofilm infections. This has 
fuelled the concept of interkingdom communities, which continues to grow above and 
beyond our traditional viewpoint of bacterial-bacterial interactions (Mukherjee et al., 
2017, Bamford et al., 2009, Boisvert and Duncan, 2008). Indeed, the advancement in 
sequencing technologies has facilitated the characterization of the fungal oral 
microbiome (Ghannoum et al., 2010, Persoon et al., 2017b, Peters et al., 2017). 
 
1.4.2 Periodontal disease 
Periodontitis is a disease, or group of diseases, characterised by a complex host 
inflammatory response that is stimulated by microbial interactions from complex 
polymicrobial biofilm plaque. This subsequently leads to damage to the surrounding 
gingival tissues and supporting structures of the tooth. It varies in severity from 
reversible gingivitis to severe irreversible periodontitis, where the periodontal 
ligaments and alveolar bone are destroyed (Page et al., 1978). Despite our ability to 
easily prevent this disease with oral hygiene measures, it remains one of the most 
prevalent diseases in the world, with nearly half of adults in the USA developing 
periodontitis (Eke et al., 2015). Periodontal disease has a well understood bacterial 
aetiology, with Porphyromonas gingivalis considered the keystone pathogen within 
periodontitis (Hajishengallis et al., 2012). Several other bacteria have also been 
implicated, including but not limited to, Tannerella forsythia, Aggregatibacter 
actinomycetemcomitans, and Fusobacterium nucleatum (Megson et al., 2015, Settem 




et al., 2012). Given the diversity and numbers of other bacteria in and around the 
periodontal neighbourhood, then it is difficult to say with absolute certainty that 
particular periodontal pathogens are the sole cause of periodontitis. Indeed, the 
concept of oral ecotypes and pathotypes suggests that the sum of different varieties 
of periodontal pathogens and their functional capacity within the periodontal 
environment, despite functionally redundant metabolic processes, are more likely to 
drive synergised virulence leading to clinical disease (Zaura et al., 2017). 
 
Several fungal species have been isolated from the periodontal pockets of patients 
with periodontitis, with C. albicans generally being the most prevalent (Canabarro et 
al., 2013, Al Mubarak et al., 2013). Notably, the presence of C. albicans has also 
correlated with the severity of periodontitis (Canabarro et al., 2013). Whether it is 
simply innocently colonizing this environment and playing no active pathogenic role is 
unknown, yet mounting evidence suggests that it has the capacity to interact with 
periodontal pathogens and influence their behaviours. Specific bacteria frequently co-
isolated with C. albicans in periodontal pockets include the anaerobes F. nucleatum 
and P. gingivalis. Remarkably, it has been shown that fungi are able to rapidly deplete 
oxygen within mixed species environments, which may explain why obligate 
anaerobes and yeasts are observed together (Lambooij et al., 2017). For instance, P. 
gingivalis modulates and enhances the germ tube formation of C. albicans (Nair et al., 
2001), whereas F. nucleatum has been demonstrated to inhibit C. albicans hyphal 
morphogenesis (Bor et al., 2016). Other P. gingivalis-related studies however noted 
an antagonistic effect on the yeast-hyphal transition in C. albicans, with P. gingivalis 
notably down-regulating hyphal related genes ALS3, HWP1 and SAP4 (Cavalcanti et 
al., 2016b, Thein et al., 2006). Most recently, it has been demonstrated that the 
attachment of P. gingivalis to C. albicans is facilitated by the virulence factor InlJ from 
the internalin protein family, which interacts with the C. albicans adhesin ALS3 
(Sztukowska et al., 2018a). Additionally, co-adhesion specific interactions were 
observed, where adhesive interactions between these pathogens appears to induce 
the type 9 secretion system of P. gingivalis, a system characterised as having an 
increased community pathogenicity (Hajishengallis and Lamont, 2016).  
 




Further studies have shown that enhanced invasion of a gingival epithelial cell line and 
gingival fibroblasts by P. gingivalis is enhanced by pre-incubation with heat-killed cells 
and the mannoprotein-β-glucan complex from C. albicans (Tamai et al., 2011). The 
mechanism by which C. albicans facilitates this invasion is unclear, though the authors 
hypothesise that the recruitment of C. albicans cell wall components increase the 
recruitment of clathrin in epithelial cells. This is a mechanism by which P. gingivalis 
has been shown to invade host cells (Boisvert and Duncan, 2008). Further physical 
interactions have been investigated with F. nucleatum. This contact-dependent 
interaction is mediated by the FLO9 C. albicans cell wall protein and the RadD F. 
nucleatum membrane protein, which prohibits the morphological switching from 
yeast to hyphae (Bor et al., 2016). Only recently has this interaction of FLO9 and RadD 
have been shown to be necessary for co-aggregation of F. nucleatum and C. albicans 
under both planktonic and biofilm conditions (Wu et al., 2015). It has additionally been 
shown that this co-aggregation with F. nucleatum has a modulatory effect on the 
innate immune response. MCP-1 and TNF-α production are reduced during co-
aggregation, which Bor et al (2016) conclude has the potential to provide a mutualistic 
protection from macrophage killing and recruitment of monocytes resulting in an 
increased persistence (Bor et al., 2016).  
 
Finally, A. actinomycetemcomitans has been associated with severe periodontitis 
(Brusca et al., 2010). In vitro, A. actinomycetemcomitans adheres to hyphae, although 
interactions with C. albicans show decreased fungal biofilm formation which is 
mediated by the luxS synthesized autoinducer-2 (AI-2) dependent mechanism. This 
was also mirrored using the 4,5-dihydroxy-2,3-pentanedione (DPD) synthetic 
molecule (Bachtiar et al., 2014). In Streptococcus gordonii, a ubiquitous oral 
commensal, it was shown that C. albicans hyphal formation was induced in a luxS 
dependent manner, and that the addition of DPD had no effect on hyphal formation 
(Bamford et al., 2009). It is evident, as the authors concede, that more studies are 
necessary to elucidate the interactions between C. albicans and A. 
actinomycetemcomitans. 
 




There is still much that is unknown and there is conflicting evidence within the 
literature regarding the importance of interkingdom relationships and their 
involvement in the progression of periodontitis. The literature does highlight some 
potentially important synergistic relationships between fungal and bacterial species. 
However, as is true for many aspects of fungal-bacterial interactions further clinical 
studies are required to demonstrate functional dependency.  A starting point would 
be to show in vivo presence of hyphae within periodontal pockets of patients and 
associated bacteria. 
 
1.4.3 Denture stomatitis  
As the elderly population expands to a predicted two billion by 2050, the number of 
denture wearers are coincidently rising. Currently, around 20% of the UK population 
wear removable dentures of some form, with 70% of UK adults older than 75 years 
old wearing dentures (Hannah et al., 2017), with many of these individuals suffering 
from denture stomatitis (DS), an inflammation of the palate (Gendreau and Loewy, 
2011). Poor oral hygiene is frequently observed within this patient group and several 
factors can impact the onset of DS such as salivary flow, denture cleanliness, age of 
denture, smoking and diet (Martori et al., 2014). Soft tissue inflammation below or 
above the denture, as a result of persistent exposure to microorganisms, is 
characteristic of DS (O’Donnell et al., 2017). Microbes frequently adhere to the 
denture surface and a biofilm quickly develops which can contain numerous species 
of bacteria and fungi. This is aided by the varied topographical landscape that 
promotes microbial retention within cracks and crevices of acrylic substrates (Hannah 
et al., 2017). Denture plaque microbiome studies by our group have identified a 
variety of oral pathogens, including cariogenic bacteria, such as the Lactobacillus 
species that were positively correlated with high levels of Candida spp. (O’Donnell et 
al., 2015).  
 
Discovery of C. albicans and Lactobacillus species in denture plaques was unexpected, 
as these bacteria have previously displayed antagonism with C. albicans at other 
mucosal sites (Parolin et al., 2015). The interactions and mechanisms employed by C. 
albicans and Lactobacilli remain somewhat enigmatic. Lactobacilli species have 




demonstrated the ability to inhibit C. albicans growth via the release of hydrogen 
peroxide and fatty acids (Li et al., 2012). Previous to this, in an ex vivo experiment, L. 
rhamnosus and L. reuteri altered host responses by eliciting an increased 
inflammatory cytokine response in a C. albicans co-infection model (Martinez et al., 
2009). Hypothetically, a pro-inflammatory response could exacerbate the 
inflammation of DS whilst ultimately assisting in the clearance of C. albicans. 
Lactobacilli supernatants have been shown to considerably reduce the ability of C. 
albicans to form biofilms (Matsubara et al., 2016). However, the supernatants were 
unable to significantly reduce the viability of mature biofilms compared to bacterial 
cell suspensions. It is likely that production of excreted metabolites such as hydrogen 
peroxide and short chain fatty acids may interfere with initial adhesion, but direct 
bacterial-fungal interactions occur to disperse mature C. albicans biofilms. Patients 
with more severe DS are colonised with greater numbers of C. albicans and 
Lactobacilli, indicating the possibility that these organisms can detect changes in their 
environment and alter their behaviours appropriately to effectively colonise the oral 
cavity (Bilhan et al., 2008). 
 
Although Lactobacillus species are the most commonly isolated bacteria from DS 
biofilms, other Candida species, namely C. glabrata, have also been detected (Coco et 
al., 2008a). Co-infection with C. glabrata results in upregulation of key virulence genes 
(ALS3 and HWP1) in C. albicans (Alves et al., 2014). This increased virulence, in return, 
complements the ability of C. glabrata to invade epithelial tissue (Silva et al., 2011). 
Authors hypothesised that during penetration of tissues by C. albicans, C. glabrata is 
transported into host cells via forming aggregates on the hyphae, as has been shown 
with various bacteria.  
 
As studies get closer to understanding the mechanisms of interactions within dual-
species biofilms, this will pave the way to elucidate how interactions within 
multispecies denture plaque contribute to disease processes. Indeed, it has been 
shown in vitro that multi-species interkingdom interactions synergise one another, 
with hyphae induced by Streptococcus oralis, and the overall biovolume of denture 
biofilms further enhanced with accompanying Actinomyces oris (Cavalcanti et al., 




2016a). Understanding the behaviours of multi-species biofilms in vivo will prove more 
useful in the management of DS, where rough surface topography plays an additional 
physical role in supporting detrimental interactions. Though, this can be mitigated by 
physically altering denture surfaces to prevent Candida adhesion (Alalwan et al., 
2018). 
 
These sections have highlighted how some Candida is a key human pathogen with high 
variability in its ability to form biofilms, additionally through different interactions it is 
able to modulate its morphology and virulence. We have discussed how C. albicans, 
as in other host sites such as the vagina and bloodstream, forms a critical role in oral 
diseases. It undoubtedly plays an important accessory role to a variety of bacterial 
pathogens. Within the myriad of different microbial interactions that occur within the 
oral microbiome, there are synergisms and antagonisms, with the most dominant 
manifesting themselves in disease outcomes. C. albicans can physically, metabolically 
and through the release of soluble molecules, play an important participatory role in 
the oral diseases outlined above. 
 
1.5 Methodological approaches to understanding Candida and mixed-
species biofilms 
 
1.5.1 The conventional and established approaches 
When screening large collections of clinical isolates from different patient cohorts, 
several experimental strategies have been utilized, predominantly quantifying 
biomass using dry weight, stains such as crystal violet, and the metabolic dye XTT 
(Azeredo et al., 2017). Each technique has their own benefits and caveats, but caution 
must be taken when interpreting the data achieved from each assay, particularly when 
correlating it to clinical outcomes. Due to the heterogeneity found between strains 
and the varying laboratory models and techniques, standardization becomes 
problematic. One of the most used bioassays is the sodium salt XTT [2,3-bis(2-
methoxy-4-nitro-5-sulfo-phenyl)-2Htetrazolium-5-carboxanilide] (Hawser, 1996, 
Hawser et al., 1998). This biofilm assay is highly reproducible and allows for a high 
throughput of multiple microtiter plates without compromising accuracy. Its 




usefulness comes with susceptibility testing, allowing for the direct comparison of 
antifungal treated samples compared to an untreated control (Ramage et al., 2001a). 
Given the metabolic variation observed between both different strains and species 
then caution must be taken when interpreting the assay, as a measurement for biofilm 
development may simply reflect high cell numbers (Kuhn et al., 2003, Taff et al., 2012). 
For example, scant biofilms of non-albicans yeasts may show a high XTT value, yet 
minimal biomass is present. Therefore, the output achieved from XTT is only cellular 
viability and it does not take into account other biofilm components such as the ECM, 
which are arguably the most important when it comes to biofilms (Nett et al., 2007).  
 
Another commonly used assay for biofilm formation is crystal violet staining. This 
method provides the total quantification of the biofilm biomass (cells and ECM) and 
allows for rapid high throughput processing of multiple samples. However, variability 
of the washing step can result in both over- and under-estimation of biomass, with 
the assay also unable to differentiate subtle differences between samples (Azeredo et 
al., 2017). An interesting example of this was described in a recent study, where these 
techniques were used to stratify the ability of Candida bloodstream isolates to form 
biofilms (Pongracz et al., 2016). There was no clear standard for their stratification to 
denote strains as biofilm or non-biofilm formers, with crystal violet values of OD570 
>0.09 simply denoted as a biofilm former. By doing so, it was concluded that NCAS 
form greater biofilms than C. albicans, and that biofilm formation does not correlate 
to clinical outcomes. This is in contrary to a wealth of previous literature, whereby the 
ability of Candida isolates to form a biofilm does associate with mortality (Rajendran 
et al., 2016d, Soldini et al., 2017, Tumbarello et al., 2012, Tumbarello et al., 2007).  
 
Discrepancies between these findings illustrates the necessity for standardised testing 
to elucidate biofilm-related risk factors. The Ramage group have taken a ‘belt and 
braces’ approach, using a combinational approach of crystal violet, XTT and SYTO9 
fluorescence quantitative biofilm assays. Here, significant correlations were observed 
in C. albicans biofilm formation, which was subsequently used to stratify biofilm-
forming ability (Rajendran et al., 2016d). Irrespective of the quantitative approach, 
wide-spread biofilm heterogeneity is observed within different clinical panels of 




isolates (Kumar and Menon, 2006, Pongracz et al., 2016, Rajendran et al., 2016d, 
Sherry et al., 2014). Collectively, these data suggest that different Candida strains 
function differently, and that consideration should be given to the individual isolates 
as we try and understand their clinical importance with respect to antifungal 
resistance and pathogenic potential. 
 
Conventional culturing by process of nutrient plates is still a highly effective and 
efficient way of determining Candida characteristics. First stage identification via 
CHROMagar is a fast and effective way to distinguish between Candida spp. It is 
routinely used in first pass screening of clinical isolates from which improved 
identification can be performed (Ozcan et al., 2010). Matrix assisted laser desorption 
ionization time-of-flight mass spectrometry (MALDI-TOF) has become an integral tool 
in the microbiologist’s toolkit for the fast and accurate identification of clinical yeasts. 
This technique offers an improved method of identification with a higher resolution, 
capable of identifying more Candida spp. than previous techniques (Alizadeh et al., 
2017, Yaman et al., 2012). 
 
Microscopy, both light and fluorescence, have remained consistently used in Candida 
biofilm research. Useful in distinguishing between both yeast and hyphal forms and 
additionally visualising interactions with host and bacterial organisms. One of many 
examples of the utilisation of light and fluorescent microscopy has been to identify 
the level of C. albicans filamentation, and additionally the ability of C. albicans survival 
strategies in response to macrophages (Uwamahoro et al., 2014). Moreover, 
microscopy is useful in determining the level of interaction with synergistic and 
antagonistic bacteria. Methodologies that profile both Streptococcus and 
Porphyromonas spp. have been developed, aided by light microscopy to quantify the 
level of adherence between yeast and hyphal cells of C. albicans. Using bacterial and 
fungal specific probes C. albicans cells can be classified as adhered or non-adhered to 
bacteria allowing for quantification through high levels of repeated fluorescent images 
(Bamford et al., 2009, Sztukowska et al., 2018b). Additionally, confocal and scanning 
electron microscopy (SEM) are routinely utilised to identify structural and 
architectural changes in Candida biofilms. Confocal Scanning Laser Microscopy 




(CSLM), as discussed previously, allows for the identification of overall structure and 
features such as the thickness of biofilms. It is also useful in biofilm models for 
determining changes in thickness and architecture of the biofilm in the presence of 
treatments or changes induced through genetic knockouts (Nobile and Mitchell, 
2005). Similarly, those biofilm changes that are elicited by the presence of bacteria 
can also be visualised using CSLM (Fox et al., 2014). 
 
1.5.2 The new and innovative approaches 
Over the past 20 years, the use of high throughput technologies has started to become 
routine to support biological discoveries and drive hypotheses. Omics approaches are 
a collection of technologies and bioinformatics approaches that allow for increasingly 
broad and in-depth analysis of the microbiome, transcriptome, metabolome, 
proteome, and genome. They can give a holistic view of the genes, mRNA expression, 
metabolites, and proteins of cell (Horgan and Kenny, 2011, Zhang et al., 2010). Such 
techniques are now increasingly being used to answer questions regarding 
interactions and functional properties of microbial communities. The literature shows 
that there are several clinically relevant sites in which poly-microbial communities are 
known to exist, comprising of numerous fungi and bacterial species (Harriott and 
Noverr, 2011, Peters et al., 2012, Sherry et al., 2016b, Thein et al., 2006). Relevant 
sites include diabetic foot wounds, sinus infections, oral cavity and respiratory tract 
infections, as well as medical device related infections (Peters et al., 2012). At these 
sites, fungal-bacterial biofilms, particularly Candida species biofilms, are responsible 
for the occurrence of disease driven by synergistic microbial interactions (Harriott and 
Noverr, 2011). Omics allow for new avenues of research in understanding these 
polymicrobial biofilm communities.  
 
1.5.3 Microbiome 
The “microbiome” is a term that has been used to mean both all the microorganisms 
and all the genetic material of microbes in a community. For the purposes of the work 
in this thesis we are commonly referring to the genomes of all the microbes (Kho and 
Lal, 2018). Over the last 10-15 years several NGS platforms have emerged including 
Roche 454, Ion torrent, Nanopore and Illumina based platforms. Due to the cost 




effectiveness and the high-quality  reads provided by the Illumina platform it has 
become the primary platform for microbiome sequencing (Bharti and Grimm, 2019). 
The Illumina platforms sequence one base at a time through fluorescence signals in a 
process named sequencing by synthesis. Fragments of DNA are hybridised to a micro 
fluid flow cell with use of ligated adapters. Following cluster formation through bridge 
amplification nucleotides are then introduced to the flow cell each with their own 
fluorescent marker. Sequential images of the flow cell are taken at the incorporation 
of the nucleotide into the growing strand and the images are analysed with the colour 
of each base being recorded. Illumina has been improving their machines generation 
upon generation, each time providing larger throughput and improved error reduction 
with the Illumina Miseq/Hiseq becoming the most popular amplicon sequencing 
platforms. Work within this thesis was carried out using the Illumina MiSeq platform 
using short reads, however new sequencing platforms such as the MinION by Oxford 
Nanopore in the future may allow for faster identification of microbiomes on the lab 
bench. The ultra-long reads allow for the entire amplification of the 16s RNA region 
(Nygaard et al., 2020). Promising results from these studies which offer a potentially 
higher resolution and a faster and convenient method for microbiome sequencing. 
 
16S ribosomal RNA (rRNA) gene, the amplicon most used in identifying different 
bacterial species, is a group of nine regions (V1-9) that are “hypervariable” and 
present within all bacteria (Chakravorty et al. 2007). Each hypervariable region shows 
differing levels of consistency in identifying specific groups of bacterial species; it is 
thought that identification on one region alone can be biased due to “PCR bias and 
low taxonomic precision” (Guo et al. 2013). The sequences that are produced from 
the 16S rRNA sequencing are grouped into OTU’s based upon their similarity. 
Commonly a threshold of 97% is used, which assumes that bacterial strains have this 
similarity within the 16S rRNA gene and all sequences clustered to this OTU are 
identified as the same genus or species (Konstantinidis and Tiedje 2005). The accuracy 
of the 97% similarity threshold however is still under debate. To date one of the 
biggest limitations in 16S RNA sequencing is the ability to predict taxonomic profiles 
at the species level (Gao et al. 2017). OTUs are identified against comprehensive 




taxonomic databases which include the ribosomal database Project (RDP), SILVA and 
Greengenes (Cole et al., 2014, Pruesse et al., 2007, DeSantis et al., 2006). 
 
In place of the commonly used OUT, similarity filtering based upon a fixed similarity 
amplicon sequence variant (ASV) is being advocated. ASV methods include the DADA2, 
Deblur and UNOISE (Callahan et al., 2016, Amir et al., 2017, Edgar, 2016). These 
methods aim to denoise the data identifying true biological sequence from noise 
within the data. With biological sequence variants being considered more likely to be 
repeatedly observed than errors (Callahan et al., 2017). 
 
Due to the cost, ease of analysis and speed of targeted gene or amplicon sequencing 
has led to its relatively popularity. Alternatively, entire metagenomic screening by 
shotgun sequencing is an alternative method of microbiome profiling. Metagenomics 
is comprehensive identification of the entire genetic composition of an environment 
(Bharti and Grimm, 2019). Metagenomics, despite its cost and increased difficulty, 
overcomes many of the limitations of 16S amplicon sequencing. Biases are introduced 
by regions and there are difficulties discerning different species from the 16S alone. 
Additionally, this method offers improved identification of novel species and also 
inference of the functional profile of the microbiome (Baker et al., 2019, Al-Hebshi et 
al., 2019). Functional properties as we have described such as regarding ecotypes have 
become interesting focuses within bacterial ecology. Tools such as Phylogenetic 
Investigation of Communities by Reconstruction of Unobserved States PICRUST which 
infer KEGG functionality from the amplicon target attempt to overcome this limitation 
(Zhang et al., 2019, Langille et al., 2013). However, functional predictions from the 
total genetic composition are obviously more desirable.  
 
The oral cavity contains one of the most diverse microbiomes of the human body, 
second only to that of the gastrointestinal tract (Human Microbiome Project, 2012). 
Around 280 bacterial species from the oral cavity have been cultured and classified 
(Dewhirst et al., 2010). However, this is less than half of the 700 species predicted 
using the Human Oral Microbiome Database (HOMD) and additionally 100 fungal 
species (Ghannoum et al., 2010, Chen and Dewhirst, 2013). In 2001 the term 




microbiome was coined by Joshua Lederberg “to signify the ecological community of 
commensal, symbiotic, and pathogenic microorganisms that literally share our body 
space” (Lederberg and McCray, 2001). The term has since been adopted by 
investigators of the poly-microbial communities in oral health and disease. 
Investigation of the microbiome has become an important area of study. This is due 
to our understanding that oral diseases such as caries, periodontitis and denture 
stomatitis are related to dysregulation in a wide range of organisms as opposed to 
only one pathogen (Struzycka, 2014, Abusleme et al., 2013, O'Donnell et al., 2015b).  
 
Microbiome studies in oral disease have demonstrated the existence of distinct 
microbial communities compared to health. In periodontitis microbiome studies, in 
contrast to other clinical host sites (e.g., gastrointestinal tract), an increased bacterial 
diversity and richness in disease has been reported compared to health (Abusleme et 
al., 2013, Sousa et al., 2017). Additionally, these studies have elucidated previously 
unappreciated species. Next generation sequencing (NGS) technologies have revealed 
a greater complexity within the periodontal disease microbiome, well beyond the 
traditional “red complex” that is comprised of Tannerella forsythia, Porphyromonas 
gingivalis and Treponema denticola (Rocas et al., 2001). Microbiome studies have 
shifted this dogma, showing the prevalence of many disease associated genera and 
species, including but not limited to, Spirochetes, Filifactor and Fusobacterium, 
highlighting a more diverse disease community than previously considered (Griffen et 
al., 2012, Chen et al., 2018). 
 
Dysbiosis and the progression from a healthy to disease state is generally considered 
to be due to a decrease in the diversity of the microbiome (de Paiva et al., 2016, 
Giloteaux et al., 2016). However, within the oral cavity this assumption is not so 
straight forward. Within the oral cavity it has been shown that lower levels of diversity 
and microbial richness is associated with health in relation to periodontal disease, 
according to the Shannon alpha diversity measure (Griffen et al., 2012, Abusleme et 
al., 2013). Conversely, using multiple alpha diversity it was demonstrated that there 
was no marked difference in the species richness between periodontal disease and 
healthy microbiomes (Galimanas et al., 2014). The 2014 study highlights that 




differences in the findings can be explained by sampling location and methodologies 
in DNA extraction. Indeed, within the oral microbiome there are diverse ecological 
niches, within which the microbial composition can vary greatly (Xu et al., 2015). This 
variation is in part due to the numerous surfaces within the oral cavity which include 
but is not limited to the hard and soft tissues of the teeth, and between teeth and the 
soft and hard palate (Aas et al., 2005). The heterogeneity of the oral microbiome 
increases the challenges of studying it, this is added to by the number of distinct 
microbiome niches within the oral cavity (Avila et al., 2009). 
 
1.5.4  The mycobiome 
In addition to bacterial species, fungal species also play pivotal roles in the oral 
microbiota of healthy and diseased individuals (Ghannoum et al., 2010). There are 
approximately 2 million fungal species and of these, 600 are thought to be able to 
cause infections in humans (Roilides, 2016). Analogously with the identification of the 
prokaryote microbiome the eukaryotic mycobiome has been defined primarily using 
amplicon sequencing (Cui et al., 2013). The amplicon utilities is an internal transcribed 
spacer region (ITS) which encompasses the locus of the 18S, 5.8S and 28S ribosomal 
subunits genes (Dollive et al., 2012). The eukaryotic component has been termed 
either the fungal microbiome or the mycobiome (Ghannoum et al., 2010). 
 
Comparatively very few studies have been carried out on the fungal microbiome 
compared to the bacterial microbiome. However the importance of studying the 
fungal component and its relationship with the bacterial microbiome has been noted 
not just in relation to oral health but in regards to skin, lung and GI tract microbiomes 
(Huffnagle and Noverr, 2013). Oral mycobiome studies to date have sought to validate 
the protocols and build a baseline of the healthy community within the oral cavity 
(Dupuy et al., 2014, Ghannoum et al., 2010).  
 
Within the gut of Crohn’s disease patients, a form of Inflammatory Bowel Disease 
(IBD), there are shifts in both the fungal and bacterial microbiome with some bacterial 
and fungal species being correlated. For example, Saccharomyces species are 
negatively associated with most bacteria whilst C. tropicalis is positively associated 




with pathogenic bacteria (Hoarau et al., 2016). Another study regarding IBD showed 
changes in fungal biodiversity, with significant changes in eukaryotic species such as 
S. cerevisiae being associated with disease. Saccharomyces and Malassezia in this 
study were shown to be positively associated with numerous bacterial species (Sokol 
et al., 2017). These studies are indicative of inter- and intra-kingdom interactions that 
can occur in the transition from a healthy to disease state.  
 
In 2010, a study led the way in characterising the fungal component of the oral 
microbiota via amplification of the internal transcribed spacer (ITS). Unlike 16S 
sequences with fixed length amplicons, ITS sequences can produce variable sequence 
lengths, which makes bioinformatic processing more challenging. The authors 
observed that the most common genera of fungi were Cladosporium, Aureobasidium 
and Saccharomycetales (Ghannoum et al., 2010), many of which were subsequently 
confirmed by Dupuy and colleagues (Dupuy et al., 2014). Interestingly, amongst the 
observed operational taxonomic units (OTUs) were several genera that were not in 
consensus with the initial study, including Saccharomyces and taxa including the 
Saccharomycetales order that were not found in as high frequency as reported initially 
(Ghannoum et al., 2010).  
 
In more recent studies, comparisons between oral health and disease have been 
made. For instance, a study comparing the mycobiome of periodontal disease and 
healthy individuals reported similar levels of fungal species (over 100) compared to 
the first report (Ghannoum et al., 2010). However, in their cohort it was observed that 
Candida and Aspergillus were the most frequent genera, being present in 100% of 
samples. Interestingly, there was no significant difference in the overall diversity of 
fungal taxa between periodontal disease and the healthy cohort, or the overall 
composition. An increase in abundance the Candida genus in periodontal disease 
compared to health was observed, although this was not found to be statistically 
significant (Peters et al., 2017). Notably, this was a pilot study and was perhaps 
hampered by its limited cohort size. Future mycobiome studies with larger cohorts 
and more stringent classification of disease state and other metadata would provide 
a more comprehensive interpretation of the mycobiome in oral health. 




With 16S now being well established, and ITS amplicon sequencing becoming more 
readily available, there is now the ability to perform co-occurrence studies (Mukherjee 
et al., 2017, Persoon et al., 2017a). Dual bacteriome and mycobiome analysis of sites 
within oral cavity (endodontic) infections has been demonstrated by Persoon and 
colleagues (2017). This group demonstrated a co-occurrence of acidogenic bacteria in 
the presence of fungal species, and an overall positive correlation of C. albicans with 
bacterial species. Negative correlations of bacterial species were observed with 
increased C. dubliniensis. These authors highlight the current limitations of these 
approaches, including increased difficulty in DNA extraction, PCR amplification due to 
length variation of ITS, and inconsistent fungal nomenclature. The oral mucosal 
mycobiome and microbiome were assessed regarding oral lichen planus in 2019. They 
were able to discern correlations between fungal and bacterial species in both 
diseased and healthy cohorts. This study found higher levels of the genera Candida 
and Aspergillus in patients with oral lichen planus compared to healthy. Correlating 
with the increase abundance of Candida in disease was the increased abundance of 
pathogenic aerobes. The authors additionally note how the mycobiome is often 
overlooked in studies of this type and studies such as this highlight the potential 
benefits of profiling both the mycobiome and bacteriome (Li et al., 2019). Despite 
these issues, as these types of studies grow and analytical pipelines become more 
developed, then the possibilities for understanding complex interkingdom 
interactions will become more fully realised.  
 
1.5.5 Transcriptome  
RNA-Seq or whole transcriptome shotgun sequencing and related processes allow for 
the whole of the gene expression data to be analysed at a given point in a time. RNA 
is isolated from the micro-organisms of interest and the mRNA is selected and then 
synthesised to cDNA, amplified and sequenced (Tan et al., 2015). Sequencing is 
typically through Illumina sequencing as previously described. Sequenced data 
undergoes computational processes or a pipeline of analysis which typically involves 
quality control and clean-up of the reads, alignment, mapping to the genome, 
quantification, and differential expression analysis of the genes (Conesa et al., 2016a). 
In contrast to genomic studies, this actual expression compared to potential 




expression can lead to more accurate functional understanding of micro-organisms in 
various conditions (Horgan and Kenny, 2011). In microbiology, and specifically biofilm 
research, transcriptomics has allowed for the regulation of pathways to be shown such 
as fat metabolism, regulation of DNA repair genes and difference in regulation at 
different dynamic states (Nakamura et al., 2016). Within oral samples analysis of the 
transcriptome has been utilised to identify signatures of dysbiosis. Using databases of 
known and predicted functions, functional inferences can be made of the expression 
data. Libraries such as the KEGG and GO, which are compilations of what is currently 
known about a gene including its associated processes, importance in resistance, 
metabolism processes, signalling pathways and other key processes can be identified 
(Nakamura et al., 2016, Li et al., 2015). Metatranscriptomics is able to build upon 
metagenome/microbiome studies allowing for further inference of the functional 
activity of dysbiotic biofilms. For example in 2018 an oral study correlated the 
fluctuations in community composition with the functional changes in malate and 
lactate dehydrogenase and novel pathways in response to decreasing pH (Edlund et 
al., 2018). 
 
Previously, Rajendran and colleagues (2016) used profiling of the transcriptome to 
define C. albicans biofilm heterogeneity, demonstrating key metabolic pathways 
driving the biofilm phenotype (Rajendran et al., 2016b). A study which is a precursor 
for the work outlined within this thesis. The authors demonstrated the effectiveness 
of profiling gene expression to discern differences in low and high biofilm forming C. 
albicans. Transcriptomics has been utilised in interrogating in vitro biofilm models and 
for monitoring biofilm development from initial to mature stage in the biofilm cycle. 
Important information can be gleaned in biofilm models of many organisms including 
C. albicans. These include changes in lifestyle, biofilm-host, microbe-microbe 
interactions, and biofilm resistance. Biofilm profiling through transcriptomics has 
been previously shown in bacterial species Porphyromonas, Streptococcus, 
Psuedomonas, Enterococcus and Candida species (Romero-Lastra et al., 2019, Wu et 
al., 2019, Partoazar et al., 2019, Cheng et al., 2019, Kean et al., 2018b). Commonly 
transcriptomics by RNA-Seq has been used to compare planktonic to biofilm 
counterparts and biofilm dynamics in response to antimicrobial treatments. 




Identification of biofilm related drug transporters, which were linked to drug 
resistance, in the multi-drug resistant emerging pathogen were discerned using 
transcriptomics. Transcriptome assembly and profiling of C. auris was instrumental in 
identifying key resistance features in this clinically important pathogen. Highlighting 
differences in efflux pump expression related to resistance (Kean et al., 2018b). 
Transcriptome analysis of mixed species biofilms has also emerged as a useful way of 
profiling bacterial-bacterial and fungal-bacterial interactions. Interkingdom 
interactions from both fungi and bacteria are possible to discern through a more 
complex method of ribosomal RNA depletion. Read alignment also requires reads first 
being aligned to the fungal species before then remaining unaligned reads being 
aligned to the bacterial species. This methodology has been successfully applied in C. 
albicans-Streptococcus and C. albicans-P. gingivalis interactions (Dutton et al., 2016, 
Sztukowska et al., 2018b, Ellepola et al., 2019).  
 
1.5.6 Metabolome  
Metabolomics provides a snapshot view of the whole metabolite profile of a cell at a 
given moment under specific conditions. Quantification of the metabolome is 
performed either by mass spectrometry (MS) or nuclear magnetic resonance (NMR) 
(Schauer et al., 2005, Villas-Boas et al., 2005, Markley et al., 2016). The use of 
metabolomics in microbiology and specifically biofilm research allows for the 
identification of pathways within target organisms. This pathway analysis informs the 
overall aetiology of single or polymicrobial communities (Washio et al., 2010). The use 
of novel mass spectrometry techniques has been demonstrated to be a powerful tool 
in the investigations of fungi-bacterial interactions in a biofilm model (Weidt et al., 
2016). A study in which the associations between Candida and S. aureus were inferred 
through the detection of intra and extra-cellular metabolites. 
 
In contrast to more typical biological methods, untargeted metabolomics allows for a 
whole and unbiased view of the chemical processes (Weckwerth, 2010). Metabolites 
can be indicators of pathogenicity and upstream pathways or directly responsible for 
the pathogenicity of an organism (Bien et al., 2011, Stipetic et al., 2016). Using 
metabolites as a method of discerning a state of illness or biological system is an old 




concept in medical biology (Tang, 2011). The progress of MS and NMR technologies 
allow for this concept to be integrated with other omics and has become an important 
component of systems biology. Complementary to untargeted metabolomics targeted 
metabolomics which aims to quantify with greater sensitivity a select number of 
metabolites. These metabolites are discerned by standards, usually a pre-defined 
group of high-quality core compounds (Weidt et al., 2016). Either targeted or 
untargeted metabolic fingerprinting is the process of determining the intracellular 
metabolic activity and metabolic footprinting infers the metabolic profile from the 
supernatants (Aggio et al., 2010). Both footprinting and fingerprinting are commonly 
performed on microbiological cultures using the analytical method of mass 
spectrometry. This process is often preceded by chromatography, such as liquid 
chromatography; the process of passing metabolites through liquid within a column. 
An example is the pHILIC columns, used for separation of the analytes as they interact 
with liquid phase. The time to pass through the column and reach the detector then 
determines the retention time (RT) for the analytes (Xiang et al., 2003). Due to the 
vast number of metabolites in microbial cultures, analytes must first be separated 
before MS detection by machinery such as the Orbitrap Fourier transform analyser 
(Hu et al., 2005). The Orbitrap traps ions in orbit around a spindle via quadrupole and 
converts the image of the trapped ions in a mass spectrum m/z by fourier transform. 
LC-MS by this and similar methods can then be applied to identify the majority of 
biological metabolites. The RT and mass can then either be used in global untargeted 
fashion to identify metabolites against databases containing known masses or 
compared to pure standards for accurate RT and mass analysis resulting in a more 
targeted analysis. 
 
Targeted/untargeted metabolomics allows for a complementary analysis method 
leading to the identification of expected compounds and additionally more 
exploratory analysis. For example, in discerning the differences in mixed C. albicans-S. 
aureus biofilms which was demonstrated using targeted/untargeted metabolomics 
(Weidt et al., 2016). From spent media they were able to determine sugars, amino 
acids and organic acids that were differentially spent or excreted in the metabolic 
footprint of C. albicans single or C. albicans-S. aureus dual species biofilms. This 




metabolomic footprinting allowed for inferences to be made about the modulation of 
the pentose phosphate pathway in dual species biofilms compared to single species.  
Untargeted fingerprinting analysis of C. albicans biofilms was also capable of 
discerning metabolomic reprogramming of amino acid, ergosterol, lipid and sugar 
metabolism in response to hypoxia.  The authors utilised ultrahigh-performance liquid 
chromatography–tandem mass spectrometry on Candida lab strains grown at 10 to 
180 minute timepoints in the presence and absence of hypoxic conditions. Hypoxia 
was induced in biofilms grown in media by reducing the atmospheric conditions to 5% 
oxygen. This study highlights the global metabolomic shifts that are associated with 
shifts in biofilm formation under different environments which could only by 
elucidated through high throughput methods (Burgain et al., 2020). Within this study 
there is complex rerouting of metabolic pathways such as carbon metabolism, 
pentose phosphate pathway and amino acid metabolism, that is undertaken by 
polymorphic fungi in response to stress and environment. They additionally were able 
to correlate their analysis to the transcriptome of the same samples. Similarly, gas 
chromatography-mass spectrometry has been utilised to identify changes in 
metabolism caused by gene knockouts in C. albicans. Metabolomic fingerprinting was 
able to identify metabolites that differed in their intracellular metabolic ratio in 
glutamate dehydrogenase mutants compared to wildtype in hyphae inducing 
conditions (Han et al., 2019b). They propose that under environmental stress C. 
albicans will globally downregulate central carbon metabolism. They also proposed 
that under stress C. albicans was unable to assimilate nitrogen sources from the 
proline rich media filamentation due to the lack of glutamate dehydrogenase. They 
therefore propose nitrogen metabolic pathways as targets for therapeutic potential 
in inhibiting hyphal morphogenesis. 
 
In addition to mass spectrometry, a fragment spectrum of metabolites can be utilised 
to distinguish between analytes with same m/z value for improved resolution of 
untargeted metabolomics. Fragmentation patterns of peaks can be compared to 
known spectrums to infer which analyte is present with the sample. This has also been 
used to infer greater detail from untargeted metabolomics in biofilm and in particular 
Candida biofilm hypoxia studies previously mentioned (Burgain et al., 2020). 




Global metabolomics studies provide snapshots at a given point in time, they do not 
give much information of directionality through metabolic pathways or rates. 
Metabolic flux analysis aims to overcome these limitations using radioisotopes. 
Metabolic flux of these isotopes can be monitored and tracked as they are utilised and 
shuttled through metabolic pathways within the target cells, also highlighting changes 
in metabolic turnover rather than concentration alone. This has been demonstrated 
in a number of biofilm models in P. aeruginosa comparing fluctuations in pathways 
between planktonic and biofilm models (Wan et al., 2018). Similarly, in C. albicans, 
isotopes were utilised to identify changes in metabolomics of the glutamate 
dehydrogenase gdh2 and gdh3 mutants mentioned previously. These mutants 
effected morphogenesis and isotope labelling demonstrated changes in proline 
catabolism in the mutant strain failing to use both arginine and proline as carbon and 
nitrogen sources (Han et al., 2019a). Fragment spectrums of metabolites can be 
utilised to distinguish between analytes with same m/z value for improved resolution 
of untargeted metabolomics. Fragmentation patterns of peaks can be compared to 
known spectrums to determine which analyte is present with the sample. This has also 
been used to infer greater detail from untargeted metabolomics in biofilm and in 
particular Candida biofilm research (Burgain et al., 2020).  
 
1.5.7 Proteome 
In a similar fashion to metabolomics, shotgun proteomics has progressed to become 
a popular and effective method of identifying and characterising microbial 
populations. Proteomics like other omic technologies aims to provide a holistic and 
compete data set of proteins within a biological system at a given point in time. LC-
MS has been employed for example within C. albicans biofilms to identify many 
proteins in a high throughput manner (Shibasaki et al., 2018). In LC-MS the proteins 
undergo enzymatic cleavage, such as that performed by trypsin, into smaller peptides. 
These peptides are then ionised and mass spectrometry is performed by one of the 
MS platforms such as the Q-Exactive Plus (Thermo Fisher Scientific) before data 
acquisition of peptides by software such as the MASCOT searching engine (Karpievitch 
et al., 2010). These digested peptides are then used to infer the presence and quantity 
of proteins present in the biological sample. 




Proteomics by LC-MS has been effective at characterising Candida dynamics in 
response to several conditions. Specifically, proteomics has been employed to 
decipher the physiological changes in C. albicans in the presence of serum over time 
(Shibasaki et al., 2018). Based upon an earlier study this analysis was performed within 
a type of strain to further elucidate the serum enhanced hyphal morphogenesis. They 
discerned that up to 50 serum induced protein changes were observed related to 
detoxification of oxidative species, glucose transport, TCA cycle and iron uptake (Aoki 
et al., 2013). Within the study mentioned here they considered proteomics an 
effective tool for identifying antigens for vaccines and therapeutic targets for drugs. 
In addition, proteomics by LC-MS has been performed to identify comparative 
differences between Candida species such as C. glabrata and albicans, host evasion 
mechanisms by C. albicans and C. albicans response to stress (Taff et al., 2012, Arita 
et al., 2019, Jacobsen et al., 2018). Shotgun proteomics has advanced Candida 
proteome research, as it has done for many biological systems, where previously we 
used lower throughput systems such 2D-PAGE (Shibasaki et al., 2018).  
 
The fungal cell wall plays a pivotal role in biofilm development, hyphal elongation, 
adhesion, and host invasion. Due to this the composition and the changing dynamics 
of the cell wall are of particular interest. As discussed earlier, many cell wall bound 
adhesions and enzymes are present that both aid in biofilm formation and virulence 
(de Groot et al., 2004). For fungal cell wall proteomics homogenisation of the cell wall 
must first be performed, followed by centrifugation and multiple washes in NaCl. Then 
crude cell walls are then extracted with SDS-mercaptoethanol buffer. Digestion and 
mass spectrometry can then be performed in the same fashion as mentioned early 
without cytoplasmic and none cell wall bound contaminants (Dutton et al., 2014). In a 
2014 study involving O-mannosylation deficient Candida mutants, a process of adding 
mannose to glycan chains, were investigated using cell wall proteomics. This process 
was previously determined to be important in hyphal formation and fungal  
interaction with bacterial species. Through cell wall proteomics they were able to 
determine perturbations in cell wall protein composition due knocking out the 
mannosyltransferase genes Mnt1 and Mnt2. Many adhesion and virulence related cell 
wall proteins such as the ALS adhesin family of proteins and the Sap candidapepsin-9 




precursor were reduced due to inhibition of mannose transfer (Dutton et al., 2014). In 
a more recent study performed in Aberdeen, the influence of the antifungal agent 
caspofungin was performed. They investigated the specific fungal cell wall proteome 
changes that were influenced across several Candida spp. including C. albicans in 
response to the echinocandin caspofungin, identifying changes such as the conserved 
expression of the glycosidase Utr2 involved in crosslinking chitin and surface glucans.  
Echinocandins inhibit the correct synthesis of β-glucan in the fungal cell wall. 
Overexpression of the Urt2 was assumed to be a compensatory mechanism due to the 
inhibitory effect of caspofungin on glucan production (Walker and Munro, 2020). 
 
1.5.8 Integrative Analysis 
The systems biology approach to microbiology involves integration of the sum of 
microbiome, transcriptome, proteome, and metabolome data sets. This potentially 
allows for a more comprehensive view of the system of interest than just one 
individual technology would allow for. Integration of multiple omics data sets has been 
demonstrated to be a useful tool (Zhang et al., 2010). With the increase in data 
analysis tools and increase in computational power, methods for multiple level 
integration of datasets are now possible. 
 
In metabolomics and transcriptomic integration for example correlation analysis, 
following both data sets being processed allows for the identification of relevant 
metabolites and genes (Cavill et al., 2016). Network and pathway analysis have also 
become popular methods for integrating and interpreting different omics data sets 
(Liu et al., 2017, Fukushima et al., 2014). Numerous software packages have been 
created from online interfaces (Cottret et al., 2010) to packages developed for the R 
programming language (Luo et al., 2017). These packages allow for identification of 
overlapping enriched pathways in the transcriptome and metabolome data. 
 
Conceptual integration through separate analysis of two or more omics datasets are 
perhaps the simplest to implement and the first stage in data integration. Through our 
subjective observations of the outcomes of separate analysis of two data sets it is 
possible to identify changes that are consistent or complimentary across two parallel 




datasets (Cavill et al., 2015, Fox et al., 2014). Pathway analysis is becoming a more 
robust method for interrogating omics data due to the increase in a priori knowledge 
that is continually being curated for an increasing number of species. This has led to 
the development of network and pathway integration tools such as MetExplore and 
PaintOmics which are able to accept data from multiple omics datasets (Cottret et al., 
2010, Hernández-de-Diego et al., 2018). They can overlay and map linked pathways 
between two datasets to identify features represented by both transcripts and 
metabolites. Enrichment methodologies additionally allow for significance to be 
determined based upon the representation of features from different omics 
(Gloaguen et al., 2017, Chong et al., 2018a). 
 
Multivariate and dimensionality reduction techniques have also been shown to make 
significant advancements in data integration. Both supervised and unsupervised 
methods have been developed. Unsupervised methods cluster the data into different 
groups based upon variability within the data without any external guidance 
(Bouhaddani et al., 2018). Supervised analysis in contrast through regression analysis 
such as in the case of partial least squares (PLS) based techniques allow for the 
identification of important and key features or variables which distinguish between 
categorized data (Rohart et al., 2017, González et al., 2012). Examples include 
identification of important features in metabolomics and transcriptomic data sets that 
are related to chemical exposure in liver cells (Mesnage et al., 2018). Discriminatory 
covariate features in the microbiome and metabolome are also possible to infer 
through a discriminatory version of PLS discriminatory analysis (PLS-DA). For example 
in faecal samples, by integrating metabolomics and the microbiome data the authors 
were able to identify bacteria that were correlated with metabolic alterations in the 
gut of Crohns’ disease sufferers (Metwaly et al., 2020). 
 
1.6 Concluding Remarks and Aims 
 
Biofilms as the mediators of disease are commonplace, with interkingdom interactions 
posing a difficult relationship to be fully understood. There are fluctuations in 
pathogenicity which are due to the varying relationships of different organisms, 




environmental factors, pH of the host and genetic predisposition. Candida species live 
in complex biofilm communities, in particular C. albicans is of special note, being 
present at many clinically relevant sites. The species-species, kingdom-kingdom and 
even microbe-host relationships are extremely complex. It is due to this complexity 
that there is a need for a move towards holistic high throughput methodologies, RNA-
Seq and metabolomics. These approaches offer an unbiased, large scale view which 
can lead to the discovery of medically important biomarkers, functional pathway 
identification in disease and potential intervention points. An understanding of the 
factors which change a microbial system from an inert system to that of a disease 
forming one is a necessity and will ultimately allow for prophylactic methods and 
therapeutic targets to be discerned.  
 
Throughout the work within this thesis, we aim to utilise omics and combinations of 
omics platforms to interrogate heterogenous C. albicans biofilms. Previously, it has 
been discussed the complexities, the clinical relevance and the advancements that 
have motivated and enabled the work within this thesis. We hypothesise that we can 
improve our understanding of biofilm formation through these microbiome, 
transcriptome and metabolomic techniques. We also wish to validate these methods 
and similarly identify future biofilm models on which they can be utilised. We aim to 
comprehensively identify future complex-biofilm models and methods of holistic 
omics methodologies to which to apply to these models. Specifically, the work 
contained within this thesis aims to: 
 
1. Identify interactions with Candida in microbiome data from a recent denture 
stomatitis clinical study. We endeavour to reanalyse this clinically relevant 
denture microbiome study with a close focus on the impact of Candida 
albicans on the oral microbiome. We also aim to identify the impact of oral 
hygiene on both Candida and the bacterial microbiome through interrogation 








2. Utilise omic technologies to identify:  
A. Differentially expressed genes using RNA-Seq to profile the transcriptome 
of phenotypically distinct isolates. Additionally, how their profile changes 
in response to biofilm inducing stimulus.  
B. The changes in the composition of the cell wall proteome between 
phenotypically distinct isolates. Additionally, how the composition of the 
cell wall proteome is impacted in response to biofilm inducing stimulus 
C. The metabolic footprint from phenotypically distinct isolates in the 
presence and absence of biofilm inducing stimulus to determine changes 
in metabolic function.  
The commonly used foetal calf serum will serve as our biofilm inducing media 
throughout these experiments.  
 
3. Identify methods and analysis techniques that are available in the literature 
which can integrate omics data to assess the applicability of these 
methodologies at integrating metabolomic and transcriptomic datasets. 
Finally, we aim to determine the usefulness and interpretability of integrated 















2 The impact of Candida and its 
























Denture stomatitis (DS) and denture related illness have historically been associated 
with and C. albicans and other members of the Candida genus. Indeed, it is common 
within microbiology for individual species to become heavily implicated in specific 
diseases. This is true of Candida spp. in the case of DS where clinical studies have 
demonstrated correlations with the quantities of Candida and the severity of the 
disease through the Newton’s classification of disease severity (Coco et al., 2008b, 
Bastiaan, 1976). It has been further reported that the individual strain of C. albicans 
and its relative capacity to form biofilms plays a role in disease outcome in denture-
related disease (O'Donnell et al., 2017); a characteristic trait that has also been shown 
to be true in other systemic diseases (Kean et al., 2018a, Rajendran et al., 2016d, 
Sherry et al., 2017). Moreover, it has been shown that strain specificity also has a 
bearing on denture cleansing capacity, with those individuals harbouring more prolific 
biofilm forming strains negatively responding to treatment (O'Donnell et al., 2017). 
Taken together, these studies support the dogma of a simple mono-species oral 
infection. This has led to the disproportionate focus on Candida spp., particularly 
related to assessing denture oral hygiene strategies in vitro and in vivo (Nunes et al., 
2016, Ramage et al., 2012c).  
 
Dentures are generally bathed in the salivary microbiome, a microbial soup interacting 
on the surface of the denture acrylic. Denture plaque biofilms are complex and are 
often represented by dense, mixed interkingdom communities (Delaney et al., 2018). 
The quantities of yeast and bacteria found residing upon the pores and varied denture 
topography are vast yet are relatively poorly explored (O'Donnell et al., 2015b, Shi et 
al., 2016). The first molecular-based microbial denture studies revealed a complex 
bacterial microbiota with potentially cariogenic, periodontopathic and malodourous 
capacities (Mantzourani et al., 2010, Sachdeo et al., 2008, Yitzhaki et al., 2017). 
Moreover, in mixed dentition where there is the presence of natural teeth within a 
partially edentulous patient, differential ecology is observed that may also have a 
bearing in the progression of oral disease (Teles et al., 2012). Despite these studies 
providing greater insights into the complexity of oral bacterial biofilm ecology, they 




fail to account for the involvement of Candida spp. within the community. We know 
these yeasts are prone to contribute to a less diverse biofilm (Cho et al., 2014, 
O'Donnell et al., 2015b), which can also play a leading role in driving denture-related 
stomatitis.  
 
With this in mind and based on our greater understanding of the importance of 
bacteria and yeasts within the denture biofilm, investigating both the bacterial and 
yeast role during the development and testing of oral hygiene products is important. 
The Ramage laboratory were the first in 2017 to undertake a randomised double 
blinded control trial to assess the importance of frequency of denture cleaning 
(Ramage et al., 2019), where both bacteria and yeasts were quantified as primary 
outcome measures. This study statistically demonstrated the benefit of frequent 
(daily) cleansing regimens compared to intermittent regimens. Nevertheless, a key 
limitation of the study was the failure to employ next generation sequencing 
techniques to fully assess the microbial composition of patients under different 
cleaning regimens. Given the importance of both bacteria and yeasts within the 
denture environment, in addition to the impact of oral hygiene on DS, this study is the 
first seeking to understand how the oral microbiome is impacted by self-reported oral 
hygiene behaviours. 
 
2.2 Hypothesis and aims 
 
This component of the thesis hypothesised that denture cleansing hygiene practices 
influenced the presence of yeasts. The following chapter therefore examines the 
contribution of oral hygiene measures and the relevance of Candida spp. to the 
denture microbiomes of edentulous patients, with the overarching aim of improving 
denture antimicrobial strategies.  
Specifically, the study aims to identify: 
- Perturbations in the oral microbiome, within the dental plaque, mucosa, and 
denture plaque, which are due to differences in the oral hygiene of the wearer 




- Perturbations in the oral microbiome within the dental plaque, mucosa, and 
denture plaque, which are due to the different sleeping habits within our 
patient cohort. 
- Changes in the oral microbial communities that are influenced by the presence 
or prevalence of Candida spp. within the dental plaque, mucosal and denture 
plaque communities.  
- Specific genera that are related or in higher abundance between our different 
patient demographics. 
 
Overall, any variances in the overall community, and any specific changes, that are 
influenced by the hygiene of the denture wearer or the proportion of yeasts, will be 
explored and interrogated in detail within this chapter 
 
This chapter has been published in the Elsevier journal Biofilm under the title 
“Interkingdom interactions on the denture surface: Implications for oral hygiene”- 
https://doi.org/10.1016/j.bioflm.2019.100002. Additionally, data from this chapter 





2.3.1 In vitro denture cleansing study 
A denture plaque cleansing study and quantitative analysis of remaining viable cells 
was performed according to an established methodology devised within the 
laboratory (Sherry et al., 2016a). It was the sub-aim to investigate the impact of a 
frequent denture cleansing regimens on bacterial and yeast retention on denture 
acrylic, with an aim to understand how complex interkingdom biofilms respond to oral 
hygiene measures. Specifically, this was a combined chemical and mechanical 
brushing cleansing technique, employed sequentially over a 7-day treatment period.  
 




Briefly, laboratory strains were used to create a polymicrobial denture plaque biofilm 
model based on the most dominant genera/species identified from our recent denture 
microbiome study (O'Donnell et al., 2015b, Ramage et al., 2019). 
Polymethylmethacrylate (PMMA) discs were manufactured by Dr Hasanain Alalwan 
(PhD student), as previously described (Alalwan et al., 2018), which provided the 
physical substrates on which biofilms were formed. The biofilms included the 
following composition of bacteria and yeasts: Streptococcus mitis NCTC 12261, 
Streptococcus intermedius ATCC 27335, Streptococcus oralis ATCC 35037, C. albicans 
3153A, Actinomyces naeslundii ATCC 19039, Veillonella dispar ATCC 27335, Rothia 
dentocariosa DSMZ 43762, Lactobacillus casei DSMZ 20011 and Lactobacillus zeae 
DSMZ 20178. Maintenance conditions on agar and overnight culture conditions for 
each of the organisms are outlined in Table 2.1. 
 
Table 2.1 Maintenance and culture conditions for oral denture species 
 
 
Initially, S. mitis, S. intermedius, S. oralis and C. albicans were grown and standardised 
in artificial saliva (AS) to 1 x 107 cells/mL. These were added to each well of a 24 well 
plate (Corning Inc, New York, USA) containing 13 mm2 PMMA discs (Chaperlin and 
Jacobs Ltd, Southend-On-Sea, UK) and incubated aerobically at 37oC for 24 h. Next, 
standardised (1 x 107 cells/mL) A. naeslundii, V. dispar, R. dentocariosa, L. casei and L. 
zeae were added to the preformed 24-h biofilm and incubated at 37oC in 5% CO2 
conditions for a further 4 days. Spent supernatants were removed and replaced with 
fresh AS daily. AS was comprised of porcine stomach mucins (0.25% w/v), sodium 
chloride (0.35% w/v), potassium chloride (0.02 w/v), calcium chloride dihydrate 
(0.02% w/v), yeast extract (0.2% w/v), lab lemco powder (0.1% w/v), proteose 
Oral Species Agar Broth Growth Condition Temperature
Streptococcus mitis  NCTC 12261 Columbia Blood Agar (CBA) Tryptic Soy Broth (TSB) CO2 37°C
Streptococcus intermedius  ATCC 27335 Columbia Blood Agar (CBA) Tryptic Soy Broth (TSB) CO2 37°C
Streptococcus oralis ATCC 35037 Columbia Blood Agar (CBA) Tryptic Soy Broth (TSB) CO2 37°C
C. albicans 3153A Sabouraud’s Dextrose Agar Yeast Peptone Dextrose (YPD) O2 30°C
Actinomyces naeslundii ATCC 19039 Fastidious Anaerobic Agar (FAA) Brain Heart Infusion (BHI) AnO2 37°C
Veillonella dispar  ATCC 27335 Fastidious Anaerobic Agar (FAA) Brain Heart Infusion (BHI) AnO2 37°C
Rothia dentocariosa  DSMZ 43762 Columbia Blood Agar (CBA) Brain Heart Infusion (BHI) O2 37°C
Lactobacillus casei  DSMZ 20011 MRS Agar MRS Broth CO2 37°C
Lactobacillus casei  DSMZ 20011 MRS Agar MRS Broth CO2 37°C
Lactobacillus zeae DSMZ 20178 MRS Agar MRS Broth CO2 37°C




peptone (0.5% w/v) in ddH2O (Sigma-Aldrich). Urea was then added independently to 
a final concentration of 0.05% (v/v). 
 
The treatment regimen was a daily treatment (days 1-7) of a 3min soaking with a 
denture cleanser (Polident® 3-minute denture cleanser; GSK Consumer Healthcare, 
Weybridge, UK) followed by brushing with hard water. For analyses, sample biofilms 
were assessed pre- and post-treatment. Following each treatment, PMMA discs were 
incubated in Dey-Engley neutralising broth (Sigma-Aldrich, Gillingham, UK) for 15min. 
PMMA discs were then sonicated in phosphate buffered saline (PBS [Sigma-Aldrich, 
Gillingham, UK]) at 35 kHz for 10min to remove the biomass, as previously described 
(Ramage et al., 2012c). The treatment regimen is visualised in Figure 2.1. 
Figure 2.1 Treatment regimen for invitro assessment of denture cleansing on bacterial and 
fungal loads. The denture plaque biofilm model was prepared on PMMA discs. PMMA discs 
were prepared so that each day a pre and post treatment as well as an untreated PMMA disc 
could be taken. PMMA discs for subsequent days were also chemically and mechanically 
treated. PMMA discs control, pre and post treatment were prepared every day for the 7 days 
and sonicated before quantification of colony forming equivalents before qPCR. 
 
For quantitative analysis, quantitative live/dead PCR were performed, as described 
previously (Sherry et al., 2016a), and detailed below. Live/dead PCR was performed 




using 16S and 18S bacterial and fungal specific primers, and quantified using 
appropriate bacterial and yeast standard curves (O'Donnell et al., 2015c). 
 
2.3.2 In vivo denture hygiene study 
The clinical study specimen collection was initially performed by Dr Lindsay O’Donnell. 
I can confirm that my role in this study was to undertake detailed microbiome analysis 
pipelines to interrogate and integrate the relevant meta-data. Study collection 
through to analysis is illustrated in Figure 2.2. 
 
Figure 2.2 Sample collection and Analysis Workflow. From 131 denture wearers a denture 
swab, mucosal swab and dental plaque scraping were taken. Swabs were sonicated and all 
samples were stored in RNA-Later. All samples from 131 patients underwent DNA extraction 
for sequencing due to failures in extraction and library prep 108 denture samples, 87 mucosal 
samples and 63 dental samples remained for sequencing. After sequencing samples reads 
were processed for analysis. Microbiome data was obtained from previously published study 
and full experimental details are published there. The original work was carried out by Lindsay 
O’Donnell at the Glasgow Dental Hospital and School (O'Donnell et al., 2015b). 
 




2.3.3 Study participants  
131 denture wearing patients attending the University of Glasgow Dental Hospital and 
School were enrolled in the study, as described previously (O'Donnell et al., 2015b). 
Written informed consent was obtained from all participants. Ethical approval for the 
study was granted by the West of Scotland Research Ethics Service (12/WS/0121). 
Clinical assessments were carried out by six experienced dentists working in the 
prosthodontic department of the University of Glasgow Dental Hospital and 
School. All prosthodontists received personal training from Dr Douglas Robertson 
(Senior Clinical Lecturer in Restorative Dentistry and study Principal Investigator) to 
standardise the assessment of the clinical disease (inflammation), denture retention, 
stability, occlusion and cleanliness. 
 
Oral hygiene was graded after training and discussion as good (with little or no signs 
of denture or dental plaque visibly present), and poor (generalised or gross denture 
or denture plaque evident). All examiners were trained but no formal calibration 
calculations were carried out. The patient demographic and clinical examination data 
was recorded on a standardised data collection sheet. There were no age-related 
exclusion criteria for this study.  
 
There were several exclusion criteria included in this study which included the 
exclusion of pregnant women, those that had undergone radiotherapy for head and 
neck related malignancies, those with periodontitis and those using any prescribed 
antimicrobial therapies, prescription mouthwashes or immunosuppressants within six 
months of the study.  
 
2.3.4 Clinical sample collection 
Ethylene oxide sterilised swabs (Fisher Scientific, Loughborough, UK) were used to 
take samples from the denture surfaces in contact with the palatal mucosa and the 
palatal mucosal surface covered by the dentures. Samples were collected and 
processed as previously described (O'Donnell et al., 2015b). In total, samples from 131 
patients were collected, which included 131 denture swabs and 131 mucosal swabs. 
However, during DNA extraction process not all samples had sufficient DNA, and 




therefore only DNA from 108 denture samples, 87 mucosal samples and 63 dental 
samples remained for sequencing, collectively all these samples originated from 123 
patients.  
 
In parallel, dentures removed from the patients’ mouths were placed in sterile bags 
(Fisher Scientific) containing 50 ml PBS (Sigma-Aldrich, Dorset, UK). Adherent denture 
plaque was then removed by sonication (Ultrawave, Cardiff, UK) for 5min, as 
previously described (O'Donnell et al., 2015b). Bacterial and fungal loads were 
quantified by qPCR using 16S and ITS primers, as described previously (Kraneveld et 
al., 2012, O'Donnell et al., 2015b). 
 
2.3.5 DNA Isolation 
All samples were prepared for DNA isolation as previously described (O'Donnell et al., 
2015b), using a combination of chemical and mechanical lysis. DNA was isolated from 
clinical samples by first either centrifugation at 13000g for 15min for dental plaque 
samples before resuspension in 150ul of TE buffer, or sonication for swab samples 
before the same treatment. All samples were then lysed within a plate containing 
0.24ml of lysis buffer 0.25 ml of lysis buffer (AGOWA mag Mini DNA Isolation Kit, 
AGOWA, Berlin, Germany), 0.3g zirconium beads (diameter, 0.1mm; Biospec Products, 
Bartlesville, OK, USA) and 0.2 ml phenol. The samples within the plate were then 
homogenised using the Mini-beadbeater (Biospec Products) for 2min (O'Donnell et al., 
2015b). Bacterial and fungal loads were quantified by qPCR using 16S and ITS primers, 
as described previously (Kraneveld et al., 2012, O'Donnell et al., 2015b). Primers and 
a probe for the 16S rRNA gene were used and primers for the Candida ITS genes 
utilised to determine Candida colony forming equivalents (CFEs) are shown in Table 
2.2.  
 
Table 2.2 Primers for qPCR and Illumina Sequencing. 
 




A total reaction volume of 20 ul was used containing 3ul of DNA. Reactions contained 
2x PCR Probe Master Mix (Roche) for 16S or 2 X SYBR Green PCR Master Mix (Roche) 
in the case of ITS primers. The conditions of the qPCR were activation for 10min at 
95°C followed by 50 cycles of denaturation for 30secs at 95°, annealing for 40secs at 
60°C and extension for 30secs at 75°C. qPCR was carried out in the LC480-II light cycler 
(Roche) before bacterial 16S rDNA concentrations (CFE) were determined from 
standard curves of E. coli K12 cultures and fungal ITS concentrations were 
extrapolated using Candida dubliniensis.  
 
2.3.6 Illumina Sequencing 
For each individual sample amplicon libraries of the V4 hypervariable region of the 16S 
rRNA gene were generated. The amplification mixes and PCR conditions used were as 
previously described (O'Donnell et al., 2015b). Briefly, amplicons from the V4 
hypervariable region were prepared, and these primers also included Illumina 
adapters and unique 8nt long barcode sequences. The libraries were amplified using 
2 units of Phusion HotStart II High fidelity polymerase (Thermo Scientific), 1-unit 
Buffer Phusion HS II [5x], including 1.5 mM MgCl2 (Thermo Scientific), 0.2 mM dNTP 
(Thermo Scientific, Germany) and 1 μM of each primer. After denaturation (98°C; 
30sec), 35 cycles of denaturation (98°C; 10sec), annealing (55°C; 30sec), and extension 
(72°C; 30sec) were performed. DNA libraries were pooled in equal amounts before the 
being purified using the IllustraTM GFXTM PCR DNA and Gel Band Purification Kit (GE 
Healthcare, Eindhoven, the Netherlands). The amplicon was sequenced in paired end 
mode on a MiSeq sequencing system (Illumina, Eindhoven, the Netherlands) with the 
v2 kit (Illumina) (Caporaso et al., 2012, Kozich et al., 2013). 
 
2.3.7 Sequencing data analysis 
Reads were first quality filtered using Trimmomatic v0.32, (Bolger et al., 2014). Next, 
the reads were merged using fastq-join implemented in QIIME v.1.8.0 (Bolger et al., 
2014). Sequences were clustered into operational taxonomic units (OTUs) using 
USEARCH v7.01090 (Edgar, 2013), after quality filtered with usearch (maxee 0.5).The 
representative sequence of each cluster was assigned a taxonomy using the RDP 
classifier (Cole et al., 2009). The Ribosomal Database Project: improved alignments 




and new tools for rRNA analysis. Nucl Acids Res 37: D141–145. doi: 
10.1093/nar/gkn879) (QIIME v.1.8.0) (Greengenes v13.8 97_otus set) with a minimum 
confidence of 0.8. 
 
2.3.8 Study design and statistical analysis 
The study was designed as a pilot study and was initially only powered to detect a 
biologically meaningful association between diseased or healthy mouths and 
microbiome composition, and therefore was not originally powered to detect 
differences between additional variables including, denture hygiene, cleaning 
frequency and sleeping habits.  
 
The data set was randomly sub-sampled to 770 reads per sample (minimum number 
of reads per sample was 776), the use of a rarefaction curve based on our data deemed 
that 770 reads per sample was sufficient to avoid minimal loss in diversity which 
allowed for inclusion of the maximum number of samples for analysis. Statistical 
analysis was performed within R on the OTU, and taxonomic tables created, as 
described above. Additionally, meta table data from clinical parameters and other in 
vitro analysis including CFEs from qPCR were used for analysis within this chapter. 
Community analysis was performed using the both the Simpson and Shannon alpha 
diversity indexes within the phyloseq package (McMurdie and Holmes, 2013). 
Diversity indexes aim to apply a numerical quantification to the level of species sample 
within a community. Simpson’s index gives a measure of dominance in which the value 
increases the level of dominance increases and therefore diversity is said to decrease. 
The Shannon index increases as both the richness and evenness of the community 
increases. 
 
Nonmetric Distance Scaling (NMDS) plots of community data were performed using 
Bray-Curtis distances on community data represented as OTUs. Additionally, the 
distance measure based upon Weighted UniFrac was implemented using the phyloseq 
package. UniFrac is a β-diversity measure which unlike other distance metrics such as 
bray Curtis incorporates phylogenetic information to discern whether communities 
differ in composition. Weighted version of UniFrac incorporates the abundance of 




each feature so branches of the tree are weighted by the proportional abundance of 
each feature or taxa. This weighting removes the issue of low abundance taxa with 
long phylogenetic branches having unproportionate effect on the total distance 
calculated within the community. Non-metric multidimensional scaling (NMDS) 
ordination plots were constructed using one of the above distance metrics.  
 
To measure OTUs that significantly differed between conditions, we used the R 
package DESeq2 (Love et al., 2014), with an adjust p-value of <0.05 and log2 fold-
change cut off >1.5. DESeq2 was originally developed for identifying differential 
expressed transcripts/genes in RNA-Seq transcriptome studies. The same principles 
can be applied to identify features, in this case taxa, that are in higher abundance in 
one condition compared to another. Additionally, correlation analysis and analysis of 
variance (ANOVA) were performed using function within base R. ANOVA was utilised 
to compare differences in diversity measures, Shannon, or Simpson, between our 
different communities. When measuring significance with ANOVA a p-values of <0.05 
was used unless stated otherwise. 
 
When analysing the experimental treatment data distribution, graph production and 
statistical analysis were performed using GraphPad Prism (version 5; La Jolla, CA, USA). 
After assessing whether data conformed to a normal distribution, One-way Analysis 
of Variance (ANOVA) and t tests were used to investigate significant differences 
between independent groups of data that approximated to a Gaussian distribution. A 
Bonferroni correction was applied to the p value to account for multiple comparisons 




2.4.1 Influence of denture hygiene on in vitro biofilms 
In vitro denture biofilms were exposed to a combination of chemical and mechanical 
denture cleansing sequentially over a 7-day period. Live cell analysis was carried out 
by qPCR using the 16S and 18S rDNA primers. A control arm with no intervention was 
included for comparison. Figure 3.3 shows that denture cleansing was able to 




significantly reduce the viable bacterial colony forming equivalents (CFEs) by at least 
1 log10 when comparing pre-treatment to post-treatment samples on each day of 
analysis (p < 0.01). However, when the Candida were quantified, we could not detect 
any significant difference in cell numbers within the treatment group pre- and post-
denture cleansing, despite highly significant differences between the treatment arm 
and control group from days 3–7 (p < 0.001). Figure 2.3 shows that total bacteria and 
Candida CFEs are higher in all control and treatment arms, suggesting dead cells make 
up a considerable component of the dead biofilm. Taken together, these data indicate 
that bacteria within the biofilm are more sensitive to denture cleansing than Candida, 
alternatively, bacterial numbers during regrowth can supress the ability of retained 
Candida cells to repopulate. Irrespective, significant numbers of Candida and bacteria 
are retained despite intense and frequent treatment regimens, suggesting some co-
operative protection or tolerance within an interkingdom biofilm. 
 
 
Figure 2.3 Quantitative live assessment of bacterial and Candida load following in 
vitro denture hygiene. Nine species of denture biofilms were grown on PMMA sections, 
followed by daily denture cleanser and brushing. Sonicate samples were taken pre- and post-
treatment, and an untreated positive control included. Live cell numbers were determined by 
qPCR or PMA treated samples (live cells) of (A) bacteria, and (B) Candida. Data was analysed 
by ANOVA with a Bonferroni correction (**p < 0.01, ***p < 0.001). 
 
One hundred and thirty-one (131) patients were recruited to this study, of which the 
primary demographics of these patients are shown in Table 2.3. The average patient 
age was 70.2 ± 11.5 years (min: 33, max: 95) with an average denture age of 4.5 ± 5.1 
years (min: 0.2 max: 40). In terms of gender, females represented the majority of the 
population at 64.9%, with males contributing only 35.1%. After clinical diagnoses, 




62.6% of participants were found to have healthy oral mucosa and the remaining 
37.4% were diagnosed with DS. These data were collected by Dr Robertson and Dr 
O’Donnell. 
 
Table 2.3 Patient denture hygiene demographics.  
 
Patients were classed as having either good or poor denture hygiene, in total 95 
(72.5%) patients had good denture hygiene and 36 (27.5%) had poor denture hygiene.  
When separated into healthy and diseased groups, 20.7% and 38.8%, respectively, 
were classed as having poor denture hygiene. Denture cleaning varied among the 
cohort, however, the majority reported cleaning their dentures either once or twice 
per day. Forty-two (32.1%) participants reported cleaning their denture once per day, 
whereas 86 (65.6%) cleaned theirs twice per day. Going to sleep whilst wearing a 
denture is a habit that was commonplace amongst study participants, as 73 (55.7%) 
of the total patients reported that they sleep with their denture in situ (Table 2.2). 
 




Additionally, patients were classified according to their oral health impact profile 
(OHIP) score calculated from the OHIP-14 questionnaire; each question had a 5-point 
scale to assess different aspects of oral health and quality of life. The sum of the 
questionnaire is used to assess their overall oral health with a maximum possible score 
of 56 (Allen and Locker, 2002). 
 
2.4.2 Influence of denture hygiene on the denture associated Candida 
The influence of Candida load on dentures was compared across several oral and 
denture hygiene practices, detailed in Figure 2.4. Regarding sleeping with the denture 
in situ, no statistical significance was observed between those who did and those who 
did not with respect to Candida load (Figure 2.4A). Whether the denture wearer had 
good, poor or excellent oral hygiene similarly appeared to have no effect on the 
Candida load (Figure 2.4B), nor did cleaning once or twice per day have an impact on 
Candida burden (Figure 2.4C). These data suggest that Candida species are not 
influenced by oral hygiene measures in vivo. 
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Figure 2.4 Candida load between hygiene variables and oral sites. Total 
Candida load (Log10 (ITS)) CFE within the denture, mucosal and plaque 
microbiomes. The Candida load is compared at each of these sites between 
those who slept in their dentures and those who did not (A) those with poor, 
good or excellent oral hygiene (B) and individuals who cleaned their dentures 
once or less than once a day and those who cleaned their dentures twice or 
more times a day (C). No significance was observed in the overall candida load 
between any of the conditions.  
 




2.4.3 Influence of denture hygiene on the oral microbiome 
Ordination plots utilising the weighted UniFrac distance measure as well as ANOVA on 
the Shannon diversity and Simpson diversity index were implemented to compare the 
diversity and dominance of the denture microbiome for the different oral and denture 
hygiene practices. When using abundance and phylogenic distances (Weighted 
UniFrac) to compare hygiene status, denture cleaning and sleeping with the denture 
in situ we observed no patterns in diversity between the different conditions (Figure 
2.5). Similarly, when using the diversity metrics Shannon and Simpson to compare 
between conditions observed no significant differences. The diversity is not 
significantly affected by the hygiene status, denture cleaning frequency or whether an 
individual sleep in their denture within this cohort (Figures 2.6-2.8). These data 
suggest that bacterial species, composition, and diversity are not influenced by oral 
hygiene measures in vivo.  
 
Despite their being no overarching consequence on the diversity and richness of the 
oral community between different hygiene measures, some individual changes in 
species abundance were observed with respect to oral hygiene status and those who 
did and did not leave their dentures in situ whilst sleeping (Figure 2.9). No significant 
changes in abundance of species were observed in the dental microbiome (Figure 
2.9A), however the mucosal microbiome (Figure 2.9C) had 1 genus significantly 
represented (Dialaster) in those who slept with denture in situ. The denture 
microbiome (Figure 2.9E) had a number of genus (Leptotrichia, Selenomonas, 
Moryella, Prevotella) in significantly higher abundance in those who slept with their 
denture in situ compared to those who did not. Within the dental, mucosal and 
denture microbiome a number of species are in significantly higher proportion in 
those with poor oral hygiene (Figure 2.9). The bacterial genus Scardovia was in 
significantly higher abundance in all three microbiome sites (Figure 2.9B, D and F) in 
those who had poor oral hygiene. Those with poor oral hygiene also had higher levels 
of Fusobacterium and Schwartzia in the denture microbiome (Figure 2.9F), and 
increased levels of Lactobacillus within their dental microbiome (Figure 2.9B). These 
data indicate that specific genera of bacteria are influenced by oral hygiene practices.




Figure 2.5 PCoA ordination plot based on phyloseq’s weighted UniFrac distances. Principal coordinates analysis (PCoA) of bacterial diversity based on weighted UniFrac 
distances from the microbiome of the mucosal (a, b), denture (c, d) and the dental (e ,f) surfaces. The patient variables: whether they sleep in their denture and their hygiene 
rating are coloured on individual plots. Additionally, the patient variable Denture cleaning, whether they clean their denture once a day/less once a day or twice a day/more 
than twice a day is represented by a shape. The largest amount of variation is visualised on the x axis with second largest on the y. Percentages represent the variance that 
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Figure 2.6 Microbiome diversity measures between poor, good and excellent oral hygiene. Diversity between patients with poor, good and excellent oral 
hygiene were measured for each of the three oral sites: denture (a), mucosal (b) and dental (c) using the observed OTUs, Shannon Index and the Simpson 
diversity index. The upper and lower quartiles are indicated by the top and bottom boundaries of the boxplots while the line within the plot indicates the 
median values. Analysis of variance was performed (ANOVA) between patients’ variables for each site on each of the diversity measures and was only reported 
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Figure 2.7 Microbiome diversity measures between denture cleaning once or twice. Diversity between patients who clean their dentures ≤ once a day and 
≥ twice a day were measured for each of the three oral sites: denture (a), mucosal (b) and dental (c) using the observed OTUs, Shannon Index and the Simpson 
diversity index. The upper and lower quartiles are indicated by the top and bottom boundaries of the boxplots while the line within the plot indicates the 
median values. Analysis of variance was performed between patients’ variables for each site on each of the diversity measures and was only reported if 
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Figure 2.8 Microbiome diversity measures between sleeping with or not sleeping with dentures in situ. Diversity(observed, Shannon and simpson) between patients that 
did and did not sleep with their denture in situ were measured for each of the three oral sites: denture (a), mucosal (b) and dental (c) using the observed OTUs, Shannon 
Index and the Simpson diversity index. The upper and lower quartiles are indicated by the top and bottom boundaries of the boxplots. Analysis of variance was performed 
between patients’ variables for each site on each of the diversity measures and was only reported if P<0.05. None of the variables fulfilled this criterion. None of the variables 
fulfilled this criterion so no significance bars are shown. while the line within the plot indicates the median values. Analysis of variance was performed between patients’ 
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Figure 2.9 Measure of taxa in significantly higher abundance between patient variables. MA plots, which are Log2 fold change plotted the against mean 
abundance, depict taxa that are in differing levels of abundance between patient variables. The patient variables are whether the patient sleeps with their 
denture in and their overall hygiene rating. The level of each genus between the two patient variables in the Dental (A, B), Mucosal (D, C) and Denture (E, 
F) microbiomes are indicated by each individual dot. The top ten taxa are labelled with their genus name and significant taxa, with an FDR adjusted p 
value < 0.01, are indicated in red. Plots A,C and E represent the Log2 fold change of those taxa in higher abundance in those who did sleep (+ve Log2 fold 
change) in their denture compared to those who didn’t (-ve). Plots B,D and F represent taxa that were in higher abundance in those with poor (+ve Log2 fold 
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2.4.4 Influence of Candida load on hygiene and microbial communities 
The levels of Candida were next compared, which were ascertained by qPCR and 
converted to colony forming equivalent (CFE) counts and normalised to bacterial CFEs 
using amplification of ITS and 16s (Kraneveld et al., 2012, O'Donnell et al., 2015b). The 
Candida load was then compared between the three denture hygiene metrics denture 
cleaning frequency, oral hygiene and whether the denture was left in situ whilst 
sleeping.  
 
When comparing the overall Candida load between those who did and those who did 
not sleep in their denture, we observed that there was no discernible difference 
(Figure 2.10A). This was found to be true at each of the oral microbiome sites denture, 
mucosal and plaque. We also found that there was not significant difference in the 
Candida load when testing with ANOVA. Similarly, when comparing the Candida load 
between those with poor, good or excellent oral hygiene at each of the three sites 
there was no significant difference in the overall Candida burden (Figure 2.10B). The 
frequency of denture cleansing appeared to have no visible effect on the Candida load 
on denture, mucosal or plaque samples and there was no statistical significance found 
when using an ANOVA to compare the two cohorts. 
 
In addition to the impact of oral hygiene we considered the relationship between the 
levels of Candida and the composition and diversity of the bacterial community. 
Diversity as measured using Bray-Curtis was used to elucidate differences in bacterial 
diversity due to Candida load. Candida was compared between low, medium and high 
loads. From the NMDs there is no distinct separation of clusters relating to the low, 
medium and high Candida loads due to little dissimilarity between the samples (Figure 
2.10A). However, a slight trend in the ordination of the points can be observed in 
relation to the abundance of Candida, as shown by the gradient of Candida load 
(Figure 2.10B).  
 
 





Figure 2.10 Non-metric dimensional scaling of OTU data based upon the Bray-Curtis distance 
measure. NMDS of Bray-Curtis beta diversity metric of oral microbiomes community data is 
indicated by oral site using shapes and Candida load is indicated as either low, medium or high 
by colour (A), community data is represented as a gradient of Candida load which is the total 
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When comparing diversity between the low, medium and high Candida loads we 
observed that the overall abundance of different OTUs slightly decreases. Similarly, 
when comparing the diversity between low, medium and high Candida with the 
Shannon and Simpson diversity measures there is a small reduction in diversity, from 
the low to the medium and high Candida load (Figure 2.11). No significance in diversity 




Figure 2.11 Microbiome diversity measures between Candida load low, medium and high. 
Diversity by the between patients with low, medium or high Candida burden were measured 
for all patients. The diversity metrics included are the Observed number of OTUs, Shannon 
and Simpson diversity indexes. The upper and lower quartiles are indicated at the top and 
bottom boundaries of the boxplots while the line within the plot indicates the median values. 
Analysis of variance was performed between patients’ variables for each site on each of the 
diversity measures and was only reported if p<0.05. None of the variables fulfilled this 
criterion. None of the variables fulfilled this criterion so no significance bars are shown. 
 
Finally, hygiene measures including the overall hygiene score, the OHIP score and 
denture cleaning frequency were all tested for correlations with genus of bacteria. 





































































































































































































































































































































































































































































































genera of bacteria, as illustrated in Figure 2.12. The bacterial genus Scardovia was 
positively correlated with oral hygiene, implying an increased level of Scardovia within 
the mucosal microbiome as oral hygiene measures diminishes. A higher Candida load 
was correlated with a significantly higher level of genera including Lactobacillus at all 
three oral sites. Within the mucosal microbiome the abundance of the genera 
Acineobacter, Faecalibacterium, Janthinobacterium, Halomonas and Shewentalla is 
positively correlated with and increased Candida load. Within the plaque microbiome 
Scardovia is positively associated with increased levels of Candida. Conversely specific 
genera such as Leptotrichia are negatively associated with Candida in both the plaque 
and denture microbiome. Other significant negative correlations include, Tannerala 
(plaque), Captnocytphaga (plaque), Fusobacterium (denture & mucosal), 
Oribacterium (mucosal) and Haemophilus (mucosal). These data suggest that Candida 
species have a subtle influence on the bacterial microbiome in denture patients and 
can significantly influence specific genera. Oral hygiene measures had less influence 
on bacterial genera comparatively.  
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Figure 2.12 Correlations of variables with the levels of specific Genus on the mucosal, denture and dental surface. Heatmap depicting the specific 
correlations between clinically relevant patient meta-data. This meta data is comprised of physician measured (Hygiene and OHIP Score) and patient reported 
data (Denture Cleaning Frequency) as well as the relative Candida load (ITS/16s). Correlations were performed using the Pearson (pears) coefficient and p-
values were corrected using the Benjamini Hochberg false discovery rate. Correlations are shown between the bacterial genus and the clinical measures for 
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As the elderly population expands, the number of denture wearers will coincidently rise. In 
the UK population, approximately 20% wear removable dentures, with 70% of UK adults older 
than 75 years old wearing dentures (Hannah et al., 2017). Dentures can influence oral health 
status, particularly in relation to the oral microbiome. Other patient related factors may also 
alter the environment, such as denture hygiene. Poor oral hygiene is often to blame for 
associated oral inflammation, exacerbated by denture cleanliness, age of denture, salivary 
flow, diet and smoking (Martori et al., 2014). Soft tissue inflammation results from persistent 
exposure to microorganisms, a characteristic of DS (O’Donnell et al., 2017). Numerous 
bacterial species and yeasts frequently adhere to the denture surface and form a biofilm 
amongst cracks and crevices of acrylic substrates (Hannah et al., 2017). Here it is reported for 
the first time the relationship between denture hygiene practices, the oral microbiome and 
yeasts. The data presented demonstrates importance and resilience of Candida species in the 
denture wearing population, and how its presence has a bearing on the bacterial microbiome. 
 
Currently there are a limited number of denture related microbiome studies available in the 
literature (O'Donnell et al., 2015b, Shi et al., 2016, Yitzhaki et al., 2017). However, we were 
able to utilise these data to develop a representative model of denture plaque based on the 
most dominant genera represented (Ramage et al., 2012c), a concept in vitro denture model 
based on an earlier concept (Sherry et al., 2016a). This in vitro denture cleansing study 
revealed that the bacterial component of a 9 species biofilm was significantly more sensitive 
to chemical and mechanical disruption than the C. albicans component. The study revealed 
that despite clear differentiation from an untreated biofilm, the levels of live C. albicans 
retained on the acrylic surface did not change when challenged. These data suggested that a 
baseline level of C. albicans was retained that was less sensitive to an oral intervention than 
bacteria. The use of a more sensitive molecular assay was a primary reason for observing this 
effect, one that would otherwise be missed using standard microbiological plating (Ramage 
et al., 2012c).  
 
The results from these analyses prompted us to revisit microbiome data we had obtained in 
a previous microbiome analysis, where primary outcome measures were focussed on disease 




subtypes (O'Donnell et al., 2015b). In this study design we had collected patient-related data, 
including oral hygiene information. Given the in vitro analysis outcomes, it was hypothesised 
that Candida species present in the clinical samples may also be less affected by oral hygiene 
interventions, with a caveat to the analysis that this was cross-sectional in nature. These data 
supported the notion of biofilm insensitivity, but instead of Candida being unimpacted alone, 
the bacterial microbiome was shown to also be uninfluenced by routine oral hygiene practices 
(composition and diversity). Interestingly though, the specific abundance of individual genera 
was observed, both on the denture and the mucosa, including genera such as Leptotrichia, 
Selenomonas, Moryella, Prevotella and Dialaster in those who slept with their denture in situ. 
Moreover, poor oral hygiene resulted in Scardovia and Lactobacillus at significantly higher 
abundance, along with Fusobacterium and Schwartzia in the denture microbiome. Whether 
these interactions constitute a synergistic or antagonistic relationship with Candida species 
remains to be determined, but at least suggest subtle dysbiosis correlating with reduced oral 
hygiene standards. 
 
Next, to establish the impact of Candida load on any microbiome changes, and how these 
were impacted by oral hygiene measures, we normalised both levels based on bacterial load 
by qPCR according to established methods (Kraneveld et al., 2012). Denture cleansing 
frequency and the other measures appeared to have no visible effect on the Candida load on 
denture, mucosal or plaque samples, a result mirroring our own in vitro observation. Indeed, 
there are no measurable changes in diversity indices across the different Candida loads. One 
of the caveats of the study design is the cross-sectional nature and lack of power, thus non-
significant results between these variables are not necessarily absence of effect, but rather a 
result of not achieving the optimum sample size required. Interestingly, although the bacterial 
microbiomes were not significantly influenced by Candida load, a slight trend can be observed 
in relation to the abundance. This suggests again that subtle changes to the microbial 
composition are reflected by changes in abundance of Candida rather than the oral hygiene 
intervention. 
 
Our final analysis involved correlation analysis at the genus level, looking at a range of 
parameters, including overall hygiene score, the OHIP score and denture cleaning frequency. 
This approach enabled us to observe clear positive and negative associations with different 




oral sites, including the denture surface, and pick out significant positive correlations. This 
was deemed this an important tactic, as the breadth and depth of literature is now beginning 
to demonstrate important interkingdom relationships (O'Donnell et al., 2015a). Neither OHIP 
score and denture cleaning frequency were shown to correlate significantly with any genera 
of bacteria, though Candida load and oral hygiene did reveal significant associations. As has 
been described elsewhere, a higher Candida load correlated with a significantly higher level 
of genera including Lactobacillus. Moreover, the bacterial genus Scardovia was positively 
correlated with oral hygiene. Conversely specific genera such as Leptotrichia and 
Fusobacterium are negatively associated with Candida on the denture microbiome. Given 
that it is now understand that C. albicans specifically interacts with Staphylococcus aureus 
and oral streptococci using agglutinin-like sequence adhesins (ALS3) (Peters and Noverr, 2013, 
Kean et al., 2017), and P. gingivalis using InlJ, an internalin protein family, to interact with the 
same ALS3 adhesin (Sztukowska et al., 2018a), then it is unsurprising that we are able to tease 
out specific interactions. These analytical approaches, while not hypothesis driven per se, will 
help pinpoint the bacterial genera we should consider when designing and developing new 
biofilm models of microbial pathogenesis. Moreover, understanding the important elements 
of polymicrobial interkingdom interaction, no matter how subtle, could provide useful 
direction in the development of novel antibiofilm strategies. The concept of the mycofilm 
(Kean et al., 2017), where bacteria utilise bacteria as a scaffold to support their own biofilm, 
is a prime reason we ought to consider C. albicans as the real keystone oral microorganism 
(Janus et al., 2016). Targeting this may be crucial in generating a wider anti-biofilm effect.  
 
Although we did not observe any consistent effects of hygiene on the microbiome within this 
work poor oral hygiene has been previously associated with a worse case of DS. Studies have 
previously highlighted that there is a tendency within the denture wearing population for 
poor maintenance of their dentures. Additionally it has been previously shown that there is a 
relatively low percentage (11.9% in one study) and that poor denture hygiene was associated 
with an increased incidence of DS (Dikbas et al., 2006). Differences in denture cleaning 
methods and sleeping habits have also been attributed to differences in the incidence of DS 
(Martori et al., 2014, Sadig, 2010). The prolonged isolation of the denture from the beneficiary 
effects of the normal salivary flow are hypothesised to be responsible for this effect. The 
microbial community under the denture is sealed and isolated from the rest of the oral 




environment allowing a pathogenic community to exist and thrive on the denture surface 
(Sobel et al., 1992). 
 
Microbiome analysis is relatively new in the context of the study of microbes and microbial 
communities. At the time of sequencing for this study the read depths were more limited with 
the read depth for some samples at <1000 bases; current platforms can generate >30,000 
reads per sample. Additionally, rarefication was used within this study as a method of 
determining the minimum acceptable sample depth and, in turn, subsampling all samples 
down to said minimum read depth. With the current data an alternative method would be to 
retain the entire resolution of the data with no rarefication and a repeat study would more 
than likely yield much higher levels of reads and hence improve the inferred taxonomic 
composition. In addition to this, at the time of study conception and design ITS sequencing 
for identification of fungal species was not widely adopted, although had been shown to 
speciate fungi, and therefore the cruder identification of fungal load by qPCR was utilised. 
The mycobiome is still under-utilised and is a weakness within this study and in future studies. 
As we have previously discussed, mycobiome studies are slowly on the rise and any future 
community profiling within the oral cavity would benefit from having joint ITS/16s sequencing 
such as in the case of recent studies carried out in dental caries (O'Connell et al., 2020). 
 
In summary, this study has been the first to specifically investigate the relationship between 
denture hygiene, the oral microbiome, and the influence of Candida species in denture 
wearers. The findings from this study suggest that maintaining good denture hygiene and 
hygiene practices do not appear to have a strong influence on altering the microbiome but 
taken positively this indicates a stabile microbial population. Candida species appear to be 
more resilient to the daily treatments which was mirrored in patient demographics, where 
denture cleaning and hygiene does not impact the fungal load. We predict this resilience is a 
key factor in Candida’s role within the oral microbiome. Therefore, future studies in oral 
microbiology and beyond should pay closer consideration to the mycobiome and the 
influence it can have on the bacterial microbiome. However, to better understand this it is 
important to understand the driving mechanisms that underpin biofilm formation in C. 
albicans.  






- Candida is less sensitive to a daily denture treatment regimen than oral bacteria 
species. The fungal load is not impacted by oral cleansing or oral hygiene measures 
indicating its high resilience and stability in the oral microbiome. 
- Candida load has an influence the overall denture and oral microbiome with shifts in 
the beta diversity being observed in response to fungi.  
- Hygiene measures have limited impact on the microbiome of individuals with few 
bacterial species being significantly different between good and poor oral hygiene. 
The diversity of the oral microbiome was not significantly affected by any of our oral 
hygiene or cleanliness measures.  
- Contrary to common assumptions correlations of co-existence of Candida and the 
Lactobacillus species in oral biofilms exist. Lactobacillus was positively correlated with 




















3 Transcriptomic profiling of phenotypically 








3.1  Background and Introduction 
 
Biofilms are a major clinical concern due to their persistence, antimicrobial resistance, host 
evasion and other tolerance mechanisms (Ramage et al., 2012b). Candida biofilms are 
typically defined as an aggregate of cells attached to one another and/or a surface and 
encapsulated within an extracellular matrix (Nobile and Johnson, 2015). It is this aggregation 
and encapsulation of the cells that confers microbial tolerance. Biofilm formation is an 
important factor in C. albicans pathogenesis, however, there is variability from strain to strain 
in biofilm forming capability (Tumbarello et al., 2007, Tumbarello et al., 2012). There are 
various environmental and physiological factors, including nutrient availability, interaction 
with host/bacterial species, hypoxia, pH, and temperature that influences the phenotype of 
Candida species. This variability in biofilm formation has been categorised in vitro from 
clinically derived isolates. Within a population C. albicans isolates can range from low biofilm 
forming (LBF [yeast-like poorly aggregated strains]) to high biofilm forming (HBF [hyphal and 
extremely aggregated in their phenotype]), under the same conditions. This was shown to be 
true in clinically derived samples of patients with candidemia. The biofilm phenotype within 
this cohort was associated with increased tolerance to antimicrobials and increased 
pathogenicity (Sherry et al., 2014). This variability is not unique to bloodstream isolates but is 
also observed within other sites such oral and vaginal infections (O’Donnell et al., 2017, Sherry 
et al., 2017). 
 
Previously, the role of different metabolic pathways including amino acid metabolism has 
been determined in C. albicans biofilm heterogeneity (Rajendran et al., 2016b). Our 
understanding of C. albicans adaptation to the host environment have to date been mostly 
achieved from studies concerned with planktonic cultures. For the first time this project 
aimed to dissect the role of adaptive phenotypes of C. albicans biofilms in response to 
nutrient stimuli/stress. The control of cellular physiology in response to immediate 
environmental changes involves reprogramming of gene expression regulatory systems. A 
distinct component of biofilm adaption in C. albicans is phenotypic switching and growth, 
which is stimulated by a variety of factors, including changes to the carbohydrate source and 
amino acid starvation (Tripathi et al., 2002, Brown et al., 2014a, Sudbery, 2011). Changes in 




functional and metabolic pathways impact C. albicans pathogenicity, which includes yeast-
hypha morphogenesis, phenotypic switching, adhesins, invasins, and secreted hydrolases 
(Brown et al., 2014a), factors all important to the biofilm phenotype (Nobile and Johnson, 
2015). Notably, biofilm related processes within C. albicans are driven by 6 key transcriptional 
regulators as part of a complex transcriptional circuitry (Nobile et al., 2012). C. albicans 
biofilm formation therefore seems to depend upon two factors: a genetic predisposition for 
enhanced biofilm formation and the correct external stimulus to induce the phenotype.  
 
The use of RNA-Seq, i.e., the identification of expressed mRNA transcripts through using high 
throughput sequencing technologies such as Illumina, has become common and, in some 
instances, routine within many medical and life science disciplines. The same is becoming true 
of microbiological research and the identification of transcriptional changes in Candida spp. 
(Chong et al., 2018b). Transcriptomics holistic identification of gene expression, this allows 
for identification of functional groups and network/pathway regulatory processes. Similarly, 
within fungal and Candida infection studies, RNA-Seq is a demonstrably powerful technology 
in discerning perturbations in the cellular response of C. albicans to different stimuli and 
environmental conditions as well as antimicrobial treatment responses (Romo et al., 2019, 
Burgain et al., 2019, Burgain et al., 2020). RNA sequencing has become a popular tool for 
discerning transcriptional changes, offering higher resolution compared to qPCR and 
microarray technologies at an ever-decreasing cost. This, in combination with the increase in 
bioinformatic pipelines, focussed upon discerning changes within networks and pathways 




It was hypothesised that molecular profiles could be discerned to differentiate LBF and HBF 
capacity. This chapter aims to interrogate the different gene expression and regulatory 
networks involved in biofilm formation. Additionally, it will build on our groups previous 
findings that metabolic adaptation is key to biofilm formation in C. albicans. The following 
work will interrogate clinical isolates identified as either low biofilm forming (LBF) or high 
biofilm forming (HBF) isolates both in the presence and absence of a biofilm inducing stimulus 
(serum).  




Specifically, this chapter aims to identify: 
- Differences in morphology and phenotype in HBF and LBF in both the presence and 
absence of serum.  
- Evidence of transcriptomic differences between HBF and LBF isolates both in the 
presence and absence of serum. 
- Functionally relevant pathways and networks responsible or related to both these 
phenotypic differences. 
- Transcriptomic and functional pathways/networks related to the biofilm induced 
phenotype. 
 
This work has been presented at the following conferences: 
Eurobiofilms, Amsterdam 2017 - Integration of Metabolomics and Transcriptomics in Biofilm 
Research (Poster, Recipient of a travel grant to attend from the organisers) 
ECCMID, Madrid 2018- De novo transcriptome assembly and annotation for analysis of the 
emerging pathogen Candida auris (Poster) 
OMIG, Gregynog 2018- Omics approaches to studying microbial biofilms in oral health (Talk, 
Recipient of a travel grant to attend from the organisers) 
IADR, London 2018- Omics and bioinformatics approaches to studying oral biofilms (Poster) 
Eurobiofilms, Glasgow 2019 - Transcriptomic and multi-omics data integration approaches 
to interrogate mono and interkingdom species Candida biofilms (Talk) 





3.3.1 Culture conditions and standardisation 
This chapter utilised clinical C. albicans (n = 10) bloodstream isolates, collected under the 
approval of the NHS Scotland Caldicott Guardian’s (Sherry et al., 2014, Rajendran et al., 2015). 
Isolates had been previously characterised in detail and classified as to their biofilm forming 
ability. Isolates were stored in Microbank® vials (Pro-Lab Diagnostics, Cheshire, UK) at -80°C 
until sub-cultured onto Sabouraud’s dextrose agar (SAB [Sigma-Aldrich, Dorset, UK]). C. 
albicans isolates were propagated in yeast peptone dextrose (YPD) medium (Sigma-Aldrich, 




Dorset, UK), cultured for ~16h in a shaking incubator at 30°C, washed by centrifugation and 
resuspension in PBS twice before being standardised into RPMI-1640 (Sigma-Aldrich, Dorset, 
UK) to 1 × 106 cells/mL, as described previously (Ramage et al., 2001b).  
 
3.3.2 Biofilm assay 
C. albicans biofilms were grown according to our established protocols (Rajendran et al., 
2015). Pre-characterised C. albicans isolates with high (HBF [n=5]) or low (LBF [n=5]) biofilm 
forming ability were used throughout this chapter (Sherry et al., 2014, Rajendran et al., 2015). 
For all experiments, biofilms were grown in polystyrene plates, 75 cm2 tissue culture flasks or 
Thermanox coverslips in RPMI (Sigma) for 90min, 4h or 24h at 37°C. For induction 
experiments, RPMI media was supplemented with foetal calf serum (FCS [25% (v/v)]) or 
dialysed serum (DS [25% (v/v)]). Small molecular components were removed from the serum 
using dialysis membrane tubing. The biofilm biomass of each isolate was assessed with the 
crystal violet (CV) assay as previously described (Rajendran et al., 2015). Before being 
quantified using the FLUOstar Omega plate reader (BMG, UK) at 570nm. Hyphal formation 
was quantified using a light microscope and eye piece graticule and stage micrometre.  
Measurements were taken for total hyphal length at 90 and recorded before comparisons 
between HBF and LBF after 90min growth.  
 
3.3.3 RNA extraction and sequencing 
Two isolates were selected 1 LBF (204) and 1 HBF (39) based on their biofilm forming 
capabilities and their inclusion in previous group studies. These isolates had previously been 
compared a 2016 study (Rajendran et al., 2016b). Following incubation, biofilms were washed 
with phosphate buffered saline (PBS) to remove any non-adherent cells before a cell scraper 
was used to dislodge the biomass into 1ml of TRIzol™ (Life Technologies, Paisley, UK). The 
TRIzol containing the scraped biomass was transferred to a bead beating tube containing 
0.5mm sterile glass beads. The biomass then disrupted using a Mini-beadbeater (Biospec 
Products) for 3 x 30seconds. Following bead beating 100μl of bromo-chloropropane was 
added to the sample before the sample was vortexed and centrifuged for 15mins at 
13000rpm at 4°C. Subsequent to centrifugation samples split into 3 layers, the upper aqueous 
layer was decanted by pipette into a nuclease free Eppendorf tube. To the Eppendorf an equal 
amount of ice-cold isopropanol was added ~500μl before being inverted 3-4 times to mix 
thoroughly and then stored in a - 20°C freezer overnight. The samples where then centrifuged 




for 10mins at 13000rpm at 4°C to pellet the RNA and the entire supernatant was removed. 
The pellet was then washed with 700μl of ice-cold 70% ethanol before being centrifuged for 
5mins at 6500rpm at 4°C. The ethanol was then removed, and the pellet allowed to air dry 
until no ethanol remained. 20μl of RNase free water was then added to resuspend the RNA 
pellet. Total RNA was DNase (Qiagen, Crawley, UK) treated and purified using the RNeasy 
MiniElute clean up kit (Qiagen, Crawley, UK), as per manufacturer’s instructions. RNA was 
quantified and quality assessed using a NanoDrop spectrophotometer (ND-1000, Thermo 
Scientific, Loughborough, UK). Each isolate was grown in triplicate and a minimum of 1 μg of 
total RNA was submitted for each sample and sent for sequencing to The GenePool 
(Edinburgh, UK). RNA integrity was assessed using a Bioanalyzer where an RNA integrity 
number (RIN) value >7.0 was deemed acceptable for RNA-Seq. TruSeq (Illumina v3 i7) 
stranded mRNA library prep kit was used to prepare libraries before sequencing on an 
Illumina HiSeq v4 yielding 50 base single end sequences. RNA-Sequencing is summarised in 
Figure 3.1. 
 
Table 3.1 Candidemia isolates used in each individual experimental design. Candida albicans isolates 
from blood stream infections categorised as either HBF or LBF by Ranjith Rajendran. + indicates that 
the isolates were used in each of the three study designs. Transcriptome profiling, metabolomic 
profiling or cell wall proteomics. Optical density from the original classification by crystal violet also 
indicated (OD). 
 
Isolate Number Biofilm classification OD (595 nm) Source Transcriptomics Metabolomics Proteomics
39 HBF 0.861 BSI + + +
48G HBF 0.542 BSI - + +
177A HBF 0.728 BSI - + +
17B LBF 0.015 BSI - + +
140 LBF 0.091 BSI - + +
204 LBF 0.1 BSI + + +





Figure 3.1 Overview of sample preparation, RNA-Sequencing, and analysis approaches. Schematic 
depicting methodology starting with growth of C. albicans biofilms from high and low biofilm formers, 
extraction of RNA by trizol and column clean-up followed by 50bp sequencing, data retrieved from 
Edinburgh Genomics was then QC followed by differential expression and pathway analysis.  
 
3.3.4 RNA-Seq analysis 
RNA-seq reads were processed by first quality controlled using the software Trimmomatic 
v0.38 (Bolger et al., 2014) to remove Illumina adapters low quality bases leading=3 and 
trailing=3 and reads with remaining length of less than 30 bases. An index of the Candida 
genome (CGD) database reference C. albicans genome (SC5313_A22) was then constructed 
using Hisat2 (Kim et al., 2019). The current genome maintained by the CGD is diploid, we 
utilised a haploid genome for RNA-Seq analysis by disregarding the B variants of the 
chromosomes from the fasta and gff annotation files. 
 
Hisat2 (v2.1.0) was then utilised to map the trimmed sample reads to the SC5314 genome 
(Kim et al., 2019). Subsequent SAM files containing the aligned reads were then coordinate 
sorted and converted to BAM format using Samtools (v1.7) (Li et al., 2009). Quality of the 
alignments was assessed using the software Qualimap (v.2.2.2) and the BAM files for each 




sample were counted to obtain gene counts using the corresponding SC5314_A22 gff file from 
the Candida genome database with the use of the program HTSeq-count (0.11.0) (Anders et 
al., 2015, Okonechnikov et al., 2016). All gene counts were then parsed into a single large 
array containing all the of the samples and the corresponding counts for each of the genes. 
The gene count array was then analysed within the R programming environment assisted by 
the R Studio GUI (http://www.rstudio.com/). Differential expression analysis was largely 
performed with the assistance of the DESeq2 (v1.26) R package (Love et al., 2014). DESeq2 
uses a negative binomial model to estimate gene abundance and differentia expression 
between variables. Differential expression was performed in a pairwise fashion between 
sample variables and significance was determined if genes had a Log2FC >1.5 and an FDR 
adjusted p-value of <0.05. In house scripts were written to perform analysis and 
visualisations. These scripts were based around many of the highly used and well validated R 
packages. These included Ordination plots MDS and PCA were performed using DESeq2 and 
the package pcaExplorer (v2.12.0) (Marini and Binder, 2019). Volcano plots were made with 
the R package EnhancedVolcano (v1.4.0) (Blighe K, 2020). Additional plots were also drawn 
with the use of the R package ggplot2 (v3.3.0) (Wickham, 2009). C. albicans transcripts that 
were significantly differentially expressed between pairwise comparisons underwent further 
functional analysis within the network software Cytoscape (v3.7.2) (Shannon et al., 2003). The 
plugin GlueGO annotated and grouped the genes into functional categories and significantly 
over-represented categories were found using the hypergeometric test which deemed 
functional categories to be enriched with an adjusted p-value <0.05. Networks of over-
represented functional categories using either the gene ontology or the KEGG databases were 
constructed using GlueGO (v2.5.5) plugin and drawn within the Cytoscape environment 
(Bindea et al., 2009). Additionally, fgsea (v1.12.0) was used to perform GSEA from within the 
clusterProfiler (v3.14.3) R package (Yu et al., 2012). Multivariate analysis and important 
feature identification were performed through the mixOmics (v6.10.9) R package utilising 
their sPLS and PLS-DA functions (Rohart et al., 2017). 
 
3.3.5 Electron microscopy 
Two C. albicans clinical isolates, utilised in transcriptomics experiments, HBF (39) and LBF 
(204) were grown on Thermanox™ in the presence or absence of serum for 24h (Table 3.1). 
After incubation period, biofilms were carefully washed with PBS and then fixed with a fixative 




solution containing 2% paraformaldehyde, 2% glutaraldehyde and 0.15 M sodium cacodylate, 
and 0.15% w/v alcian blue (pH 7.4) and left in solution for 18h. The fixative was discarded, 
and the biofilms were then covered with 0.15M sodium cacodylate buffer and stored at 4°C 
until processing (Erlandsen et al., 2004). Briefly the samples were washed 3 × 5min with 0.15 
M cacodylate to remove the glutaraldehyde. Following this samples were treated using a 1% 
osmium tetroxide solution containing 0.15 M sodium cacodylate (1:1). Samples were then 
incubated in the fume hood for 1h. Samples were rinsed 3 × 10min with distilled water and 
then treated with 0.5% uranyl acetate and incubated in the dark for 1h. Uranyl acetate was 
removed from the samples and quickly rinsed with water before a series of dehydration steps 
were carried out. The biofilms where then washed twice for 5 min each of 500µL 30, 50, 70 
and 90% ethanol this was then followed by 4 × 10min washes of 500µL absolute followed 
again by 4 x 10min washes with 500µL molecular sieved absolute alcohol. 
Hexamethyldisilazane (HMDS) was used to dry the specimens by soaking the samples for 5min 
before transferring to a plate containing fresh HMDS. All samples were then placed in a 
desiccator overnight to allow evaporation of any residue and drying. The specimens were 
then mounted and sputter-coated with gold in an argon filled chamber, and then viewed 
under a JEOL JSM-6400 scanning electron microscope. 
 
3.3.6 Cell wall proteomic analysis 
Cell wall processing was performed by the postdoctoral researcher of the University of 
Glasgow Dr. Ranjith Rajendran. Furthermore, the processing and acquiring of data was 
performed by Dr. Ranjith Rajendran at the University of Aberdeen under the supervision of 
Prof. Carol Munro. 
Cell walls were extracted as described previously (Mora-Montes et al., 2007). Briefly, C. 
albicans, (HBF [n=3]) or low (LBF [n=3]) as described in table 3.1, biofilms grown in the 
presence and absence of FCS for 24h which were then dislodged and centrifuged at 3,000 × g 
for 5min, washed once with chilled deionized water, resuspended in deionized water, and 
mechanically homogenised with glass beads in a FastPrep machine (Qbiogene, Fisher 
Scientific, UK). The disrupted cells were collected and centrifuged at 5,000 × g for 5min. The 
pellet, containing the cell debris and walls, was washed five times with 1 M NaCl, resuspended 
in buffer (500 mM Tris-HCl buffer, pH 7.5, 2% [wt/vol] SDS, 0.3 M β-mercaptoethanol, and 1 
mM EDTA), boiled at 100°C for 10min, and freeze-dried. 




Proteomics analysis was performed on the freeze-dried cell wall fractions by Aberdeen 
Proteomics at the University of Aberdeen. The pellets were digested with trypsin according 
to the PRIME-XS protocol. Mass spectrometry analysis was performed using a Q-Exactive Plus 
(Thermo Fisher Scientific) and tryptic peptides were identified using the MASCOT searching 
engine (Matrix Science). Data was processed using the Proteome discoverer v1.4 software 
quantifying and identifying proteins with >2 peptides against protein database derived from 
the Candida Genome Database (CGD) http://www.candidagenome.org/.  
 
3.4 Results  
 
3.4.1 Assessing the Biofilm Phenotype 
Initially the biofilm phenotype was assessed comparing LBF/HBF isolates in the presence (+ 
FCS) and absence (-FCS) of FCS. Addition of FCS was shown to significantly induce biofilm 
formation of LBF isolates by 5 to 7.4 times compared to isolates grown in RPMI control 
(p<0.01) (Figure. 3.2A). At 90min LBF+FCS samples showed more hyphal cells with greater 
extracellular matrix compared to predominantly yeast cells in control LBF-FCS samples. At 24h 
matured biofilm phase, LBF+FCS formed multi-layered hyphal structures with the appearance 
of being ‘glued’ together with extracellular matrix (Figure. 3.2B). HBF isolates have an 
increased biomass compared to LBF in RPMI and this does not significantly change with 
supplementation of serum (Figure 3.2A). LBF on the hand have a more comparable biomass 
to the HBF in the presence of serum. These observations seem to consistently find that the 
supplementation of LBF with FCS produces many of the features of HBF. 
 
Both the serum supplemented and non-supplemented HBF showed similar phenotypes 
regarding hyphal and biofilm formation, however, there was observably larger amounts of 
material attached to the hyphae (Figure 3.2B). 
 




Figure 3.2 Variation in C. albicans biofilm formation in the presence and absence of FCS. Biofilm 
formation after 24h assessed using crystal violet assay of 5 low biofilm forming (LBF) and 5 high biofilm 
forming (HBF) isolates grown in RPMI or RPMI supplemented with serum (A). Scanning electron 
microscopy (SEM) images of high biofilm forming (HBF) or low biofilm forming (LBF) isolates 
morphology grown similarly in the presence and absence of serum grown on coverslips for 90min or 
24h (B). 
 
Overall, the biomass assays show an increase in biofilm formation in the presence of serum. 
This is consistent with an observation of a shift in cell morphology, increased hyphal 
formation and extracellular material.  
 
Additionally, germ tube formation was measurably different at 90min in both HBF and LBF 
Candida isolates. Germ tube formation was shown to be 3.5 and 1.8-fold higher in the 
presence of serum at 90mins in LBF and HBF respectively (Figure 3.3B). These observations 
seem to consistently find that the features associated with biofilm formation in C. albicans 
are apparent in the non-biofilm formers when they are grown in the presence of serum. 




Figure 3.3 Biomass of LBF isolates grown in RPMI and RPMI supplemented with 25% serum. 
The effect of dialysation on the serum prior to supplementation was tested with biofilms 
grown in RPMI, RPMI supplemented with 25% serum or 25% dialysed serum for 24h. 
Significance was measured compared to RPMI control to RPMI supplemented with serum or 
dialysed serum by ANOVA with multiple comparison test showing significant differences 
(p<0.01**) between RPMI and serum (A). Bar chart depicting the overall length of hyphae in 
LBF and HBF candida isolates in the media RPMI and RPMI supplemented with 25% serum 
after 90min. Germ tube length measurements were taken and compared between groups 
using ANOVA with multiple comparison test displaying significant differences between germ 
tube length in RPMI compared to RPMI supplemented with serum in HBF and LBF (p<0.01**) 
(B).  
 
3.4.2 RNA-Seq read quality 
The HiSeq platform from Illumina provided an average of 24.4 million reads per sample. With 
the lowest sample (90m_S39_3) having 13.6 million reads and the highest sample having 52.4 
million reads (4h_S39_2) following Trimmomatic quality and adapter removal. The average 
GC of all reads was 39% and the average duplication rate per sample was 83%. All samples 
were deemed to have sufficient sequencing depth, greater than >10 million reads per sample, 
and were processed with Hisat2 with a 95% average alignment rate to the reference genome. 
These alignments were then assigned to a feature within the C. albicans (v22) gene feature 
format (GFF/.gff) file and the number of assignments counted by the software HTSeq-counts. 
Of the aligned reads an average of 75% of them were assigned a gene feature. These feature 
counts were subsequently analysed between samples for differential gene analysis. All 
sequencing statistics, alignment and assignments are summarised in Table 3.2.  




Table 3.2 RNA-Sequencing, quality control and alignment statistics. Table depicting the total number of sequences for each sample before trimming, total 
following trimming and the percentage of duplicate reads and the GC percentage of all reads per sample. Hisat2 was used to align reads and the total number 
of reads aligned to the reference genome per read are shown with number of reads aligned once, multiple times or not at all shown. HTSeq was utilised to 
count the number of aligned reads that corresponded to a feature (exon) the percentage and total number of identified features per sample are shown. 
 




3.4.3 RNA-Seq multivariate analysis 
Counts for features produced by Hisat2 and HTSeq counts were utilised to produce estimates 
of the abundance of each gene within each of the samples. DESeq2 models the gene counts 
following a negative binomial distribution and applies normalisation factors to account for 
differences in sequencing depth between samples. These normalised gene counts were then 
further used to calculate the distances between our samples. We then projected the two 
dimensions that represented the largest distance between our samples. The dimensional 
reduction of multifactorial data common referred to principal component analysis (PCA) 
allows for the differentiation of the samples with largest difference in its variables (PC1) and 
second largest difference (PC2). We visualised the component spaces of the 1st three 
components.  
 
From the first component it is possible to see that there is little variance between our 3 
replicates per sample and that the largest separation, i.e., the x axis PC1 representing 34% of 
the explained variance, is due to difference in time variable of biofilm formation primarily 
between early (90min and 4h) and late-stage (24h) biofilm formation (Figure 3.4A). Visualising 
the ordination of the 1st and 3rd components reveals larger separation of the components 
according to the two medias over the 3rd component (Figure 3.4B). Similarly, visualising the 
2nd and 3rd components there is visible distinction and clustering between the two strains 
across the 2nd component and 3rd component according to whether they were grown FCS or 
RPMI. The PC2 and PC3 account for 19.92% and 15.32% of the variability observed within the 
samples, respectfully (Figure 3.4C). The first 3 components are responsible for the >70% of 
the total variability as is shown within the scree plot (Figure 3.5A).  
 
Our observations in ordination were further confirmed when visualising the relationship of 
our components and covariates. The first component is influenced by the time covariate. The 
media, and strain covariates have a much larger influence on the second and third 
components (Figure 3.5B). In summary the difference between late and early-stage biofilms 
accounts for most of the variation between the samples.  
  





Figure 3.4 Principal Components Analysis (PCA) of C. albicans transcriptome. Gene count data was submitted to DESeq2 for normalisation before the data 
was reduced to a two-dimensional space within R. This data was then subsequently visualised, and samples were coloured according to whether they were 
grown in RPMI or RPMI supplemented with Serum (FCS). Additionally, a shape was overlayed on the samples according to the length of time the biofilms 
were grown for. This was either 1.5, 4 or 24h. Samples are also labelled in the to indicate whether they were from HBF (39) or LBF (204) strains. PCA of RNA-
Seq on the HBF and LBF in the presence and absence of serum shown within a plot of PC1 /PC2 (A), PC1 /PC3 (B) and PC2/PC3 (C).
A B C





Figure 3.5 Scree plot of PCA components. Scree plot depicting components 1-10 from the principal 
component analysis (PCA) of all RNA-Seq data for all samples. The yellow line indicates the total 
explained variation, when summing components, whilst each bar indicates the percentage variation 
explained by that component. Dotted line indicates the point at which the total variation crosses an 
80% threshold (A). Plots depicting the significance, indicated by the -log10 p-value, of the correlation 
of each grouping variable within the data versus components 1 and 2. The p-value is inverted so the 
higher the value the higher the significance and therefore the correlation between the covariate and 
that component (B). 
 
3.4.4 Candida albicans differential expression in response to nutrient stress 
We initially performed a pairwise comparison which only considered the grouping of samples 
as either grown in the presence of absence of serum. When considering the overall effect of 
serum on the gene expression of C. albicans, large numbers of differentially expressed genes 
were noted as discerned by using DESeq2 and grouping the samples as either serum 









Figure 3.6 Volcano plot depicting gross changes of C. albicans grown in RPMI vs Serum. Differential 
expression of counts as calculated between RPMI vs Serum by DESeq2. Log2 fold change plotted 
against the inverse of the log10 p value. Genes upregulated in Serum are represented by a +ve Log2 
fold change and those upregulated in the RPMI only media are represented with -ve Log2 fold change. 
Larger negative or positive values indicate a larger upregulation and the increased significance 
between the conditions is indicated by a larger negative Log10 p-value (-Log10P). Vertical dotted lines 
indicate a cut-off of Log2FC 1.5 coloured green, horizontal dotted lines indicate a cut-off of the p-
value<0.001, coloured blue or red if both cut-offs are met for illustration of the high levels of 
upregulated genes. 




1309 genes were upregulated in strains supplemented with serum and 1184 genes were 
upregulated in media without supplementation, or conversely downregulated in the serum 
condition. Through the gene set enrichment (GSEA), which enriches based upon functional 
pathways, it is possible to quantify whether significant levels of differential expression across 
entire metabolic pathways. Gene Ontology (GO) terms and other functional groupings, such 
as those supplied by the KEGG database, of genes are shown significantly enriched between 
two conditions. We observed that between the two medias there was enrichment of 
numerous GO functional terms. These terms are groupings of genes belong to the same 
pathways and/or to the same functional groups. GSEA compared to over-enrichment analysis 
considers the expression profile of the all the genes of an organism and therefore considers 
even genes who’s differential expression is modest. 
 
GSEA identified several enriched GO pathways between our two medias. Fluctuations across 
multiple biological processes that include polysaccharide, lipid, glycoprotein, and protein 
metabolic processes were influenced (Figure 3.7A). The enrichment in pathways involved in 
multiple metabolic processes was mirrored when GSEA was performed against the C. albicans 
KEGG database. Fatty acid metabolic pathways which included the peroxisome, amino acid 
metabolism as well as carbon metabolism are all enriched within the strains grown in Serum.  
 
These pathways maintained and curated through the KEGG database also included changes 
in enrichment in the sugar, protein, and lipid pathways. Serum supplementation altered the 
regulation of metabolic functions throughout most super pathways in C. albicans (Figure 
3.7B). We observed that serum has a large effect on both ontological functions and the 
metabolic pathways in both of our strains. However, to determine which of these upregulated 
processes are conserved between the two strains and which are differing in HBF and LBF it 
was necessary to perform differential expression analysis of the strains independently in the 
presence and absence of serum.





Figure 3.7 Bar plot depicting the differentially regulated Gene Ontology and KEGG pathways. Gene set enrichment analysis (GSEA) was performed on the 
total up and downregulated genes in the presence of serum vs the absence. Genes were ranked according to their log2FC highest positive to lowest negative. 
Positive normalised enrichment score (NES) as calculated by fgsea in R indicates those pathways enriched in serum and negative enrichment indicates those 
upregulated in the absence of serum for both Gene Ontology pathways (A) and KEGG pathways (B). Large +ve NES indicates a greater enrichment of genes 
within the samples grown in serum and a smaller -ve value represents a greater enrichment of genes in the samples grown in RPMI media. The intensity of 
the colour indicates the significance of the enrichment according to the nominal p-value which is indicate in the legend.
BA




3.4.5 Gene expression of strain and time dependant genes in the nutrient stress response 
of Candida albicans  
Differential expression was calculated using the DESeq2 package, we performed pairwise 
comparisons between sample groups considering the variables media, time, and strain. 
Pairwise comparisons or contrasts were made between serum supplemented conditions and 
non-supplemented conditions for each of the strains at each of the three time points. We 
observed large numbers of differential expression between each of these conditions. The 
differences observed in HBF were much higher across each of the time conditions than the 
LBF, i.e., greater upregulation in RPMI and Serum were observed in HBF (Figure 3.8). Genes 
that had a log2 fold change (log2FC) ≥1.5 and FDR adjusted p-value of ≤0.05 were considered 
differentially expressed between our two conditions for subsequent analysis. LBF had a much 
lower number of differentially expressed genes, that met our cut off criteria, compared to 
HBF (Figure 3.8 and 3.9).  
 
 
Figure 3.8 Number of up or downregulated at each time point for each strain in the presence of 
Serum. Up or downregulated determined based upon Benjamini-Hochberg (FDR) cut-off of ≤0.05 and 
log2 fold change of ≥1.5. Total number of genes differentially expressed are either upregulated (Up) 
in Serum or downregulated in Serum (Down). This comparison Serum vs RPMI was performed for the 
HBF and LBF strains at each time point 1.5, 4 and 24h as indicated by the x axis labels. 
 






Figure 3.9 Volcano plots depicting the 
levels of gene expression at each time and 
within either the HBF or LBF C. albicans 
strain. Differential expression of counts as 
calculated between RPMI vs Serum by 
DESeq2. Log2 fold change plotted against 
the inverse of the log10 p value. Genes 
upregulated in Serum are represented by a 
+ve Log2 fold change and those 
upregulated in the RPMI only media are 
represented with -ve Log2 fold change. 
Larger negative or positive values indicate a 
larger upregulation and the increased 
significance between the conditions is 
indicated by a larger negative Log10 p-value 
(-Log10P). Vertical dotted lines indicate a 
cut-off of Log2FC 1.5 coloured green, 
horizontal dotted lines indicate a cut-off of 
the FDR p value <0.05, coloured blue or red 
if both cut-offs are met for illustration of 
the high levels of upregulated genes. This 
analysis is plotted for all time points 
90mins/1.5h, 4h and 24h. Additionally this 
was performed for both the LBF (204) strain 
and the HBF (39) strain. 
 




The genes expressed at each time point had little overlap between each time point. Genes 
that were differentially expressed in either strain at either 90min, 4h and 24h seemed to be 
time dependent expression and distinct to that time point (Figure 3.10A, B). 
  
 
Figure 3.10 UpSet plots depicting the overlap of differentially expressed genes. UpSet plots 
performing a similar function to Venn displaying the overlap in upregulated genes between 
the high and low biofilm forming strains (A) or the overlap of up or down regulated genes at 
each time point in the LBF (B). Plot A illustrates the overlap between upregulated genes in 
LBF and HBF with most LBF upregulated genes being upregulated in HBF and high levels of 
HBF genes being unique to HBF. Plot B indicates overlap of upregulated genes in the LBF strain 
in serum between the timepoints with many of the genes being unique to the individual time 
points. Total set size for each sample, which is the total number of differentially expressesed 








From DESeq2 the topmost differentially up (FCS) and down (RPMI) regulated genes are shown 
in tables 3.3-3.4. This data mirrors the most differentially expressed genes that are annotated 
within the volcano plots detailed in figure 3.9. In the HBF we can see that at 90min and 4h in 
FCS there are several Secreted Aspartyl Proteinases (SAP) families’ transcripts SAP6, 4 and 5 
which are involved in early biofilm formation, virulence, and nutrient acquisition. Hyphal wall 
related protein transcripts such as hyphal regulated cell wall protein 1 (HYR1) and hyphal wall 
protein (HWP1) are also upregulated in FCS in the early biofilm time points. Top genes in the 
later 24h biofilm with annotation where the spore wall formation SPO75 and marvel domain 
protein of unknown function MRV4 and the heat shock proteins SSA2, HSP21, HSP104. Heath 
shock proteins are a family of proteins by yeast in response to external stimuli and stress such 
as heat, pH and oxidative stress (Gong et al., 2017).  
 
The gene with the highest upregulation in the LBF grown in FCS is Endothelin-converting 
enzyme ECE1 at 90min and 4h time points. Following ECE1 is the biofilm related gene HWP1. 
Also, at these early biofilm time points are the ALS3 and SAP genes which as we have 
discussed in chapter 1 are typical biofilm response genes. Also, at 4h there is upregulation of 
the mating factor alpha MFALPHA. The MRV2 and MRV4 genes like HBF are upregulated 24h 
although little is known regarding their function. MFALPHA is one of the top upregulated 
genes also at the 24h time point. 
 
Several common genes feature within the top downregulated genes in FCS or upregulated 
genes in RPMI. Including the JEN family and ZRT family genes. In the LBF within the top 10 
genes the ALS2 and ALS4 are notably downregulated in FCS in contrast to the. The ZRT genes 
1 and 2 are downregulated in LBF at 90 min and 24h in the top 10 genes. These genes encode 
the transporter for high affinity to zinc. ZRT is thought to be regulated by the extracellular 
levels of zinc (Zhao and Eide, 1996). These genes also feature in the top downregulated genes 
in FCS in the HBF strain. With the JEN2 and JEN1 genes being in the top 10 at 90min and the 
ZRT1 and ZRT2 appearing in the top downregulated in 4h and 24h. There is a conserved 
response of downregulation of carboxylic acid transport through JEN1/2 and zinc metal 
transport through PRA1 and ZRT1/2 in the FCS (Table 3.3-3.4).  
 
 




Table 3.3 DESeq2 results of the top 10 up and top 10 down regulated genes in HBF. Differential expression of genes from biofilms grown for 90min, 4h or 
24h in RPMI or RPMI supplemented with serum. Table includes the candida genome database identifier (GeneID), common name or gene symbol (Symbol), 
the FDR adjusted p value (pvalue adj) from DESeq2 and the log2 transformed fold change (Log2FC) between RPMI and RPMI+serum (FCS). 
 
  




Table 3.4 DESeq2 results of the top 10 up and top 10 down regulated genes in LBF. Differential expression of genes from biofilms grown for 90min, 4h or 
24h in RPMI or RPMI supplemented with serum. Table includes the candida genome database identifier (GeneID), common name or gene symbol (Symbol), 
the FDR adjusted p value (pvalue adj) from DESeq2 and the log2 transformed fold change (Log2FC) between RPMI and RPMI+serum (FCS). 
  
90min 4h 24h





C4_03470C_A ECE1 <2.21E-308 12.67869901 C4_03470C_A ECE1 3.38E-245 8.105597402 C6_03600C_A C6_03600C 2.37E-296 9.442059298
C4_03570W_A HWP1 <2.21E-308 8.255221261 C1_13100W_A C1_13100W 8.19E-32 7.794597779 C2_08890W_A C2_08890W 1.63E-32 6.117204395
C6_02710C_A SAP6 4.24E-124 6.704516738 C4_03570W_A HWP1 1.06E-270 5.612377382 C1_04050C_A MFALPHA 0.000844085 6.084347752
C1_00780C_A HGC1 3.87E-52 6.472925756 C1_05830W_A C1_05830W 7.22E-12 5.147552394 C5_04370C_A PGA37 1.18E-71 5.876146652
C1_13450W_A HYR1 <2.21E-308 6.390079623 C1_04050C_A MFALPHA 0.02461027 5.125264634 C3_06660C_A C3_06660C 1.25E-61 5.666000006
CR_02750C_A PGA34 2.86E-24 6.028796729 C1_00780C_A HGC1 1.53E-22 4.930894311 C3_07840C_A C3_07840C 0.020310915 5.62512508
CR_07070C_A ALS3 <2.21E-308 5.628778798 C4_06920C_A CSA2 0.035162412 4.881475088 C5_04980W_A C5_04980W 3.58E-154 5.356780975
C2_08890W_A C2_08890W 6.33E-20 5.526122836 C4_06560W_A PGA15 5.80E-08 4.823173405 C5_04190W_A MRV2 <2.21E-308 5.349207219
C4_01940W_A PHO89 1.54E-121 5.255040098 C2_00670C_A C2_00670C 0.006120667 4.62664836 C5_04210C_A MRV4 4.75E-16 5.271240515






C4_06980W_A PRA1 1.01E-45 -6.204797538 C3_00220W_A HGT19 1.42E-24 -2.551670194 C1_04140W_A IFD6 2.16E-183 -10.35092483
CR_00930W_A ATO10 0.003265017 -5.605518716 C6_04380W_A ALS2 7.81E-16 -2.382991051 C4_06980W_A PRA1 9.35E-130 -9.329122823
C3_01540W_A C3_01540W 3.91E-56 -5.495682951 C6_04130C_A ALS4 6.83E-24 -2.382118599 CR_09390C_A CR_09390C 1.60E-23 -8.776433392
C2_08590W_A YWP1 <2.21E-308 -5.316051485 CR_03810W_A PRP13 9.42E-12 -2.232144112 C1_04010C_A C1_04010C <2.21E-308 -8.638735101
C4_06970C_A ZRT1 6.33E-35 -4.924355183 C7_00110W_A SOD3 3.70E-12 -2.203643359 C4_06970C_A ZRT1 <2.21E-308 -6.818469056
C1_04870W_A SAP7 4.64E-07 -4.825915327 CR_08420W_A CR_08420W 4.55E-16 -2.146439929 C6_03170C_A MDR1 <2.21E-308 -6.661184653
C1_04930C_A C1_04930C 0.029925725 -4.774792288 C3_03500W_A SKN2 3.47E-27 -2.143715118 C3_02800W_A ADH4 2.87E-126 -5.863051659
C3_06580W_A JEN1 0.046596771 -4.559240043 C2_09280C_A C2_09280C 3.96E-26 -2.116924199 C2_02590W_A ZRT2 <2.21E-308 -5.761689161
C4_05730W_A C4_05730W 4.64E-25 -4.559070311 CR_10800C_A CR_10800C 3.15E-10 -2.09767697 C5_01380W_A CFL5 7.70E-250 -5.744757463
CR_02920C_A AQY1 2.30E-110 -4.311441571 C6_04650W_A C6_04650W 1.95E-10 -2.097637894 C2_01270W_A CHA1 1.12E-67 -4.851203764




Using the Upset plot technique, which is analogous to Venn diagrams, and the UpsetR 
package it was possible to visualise all the combinations of gene expression between the up 
and down regulated in RPMI vs FCS (Conway et al., 2017). From this it was observed that the 
large proportion of genes was unique to the condition with only a small proportion of the 
genes sharing an overlap with the other conditions (Figure 3.10A). When comparing 
expression between the Low and High biofilm formers it was observed that the HBF formers 
had many genes expressed in FCS compared to RPMI that were not observed in the LBF strain 
(Figure 3.10B). However, most of the genes upregulated in the LBF strains at any of the time 
points was also upregulated in the HBF as shown by the overlap. These seems to indicate a 
unique HBF expression profile that is not present in the LBF. Lower overall up and down 
regulation of genes within the LBF may explain some of these differences as less genes for the 
LBF are represented by our cut-offs. LBF shows the most drastic change in morphology in the 
presence of serum but a lower level of overall differential expression.  
 
We observed differences in gene regulation between the time points and the two strains in 
response to Serum stimulation. We wished to investigate this further by determining the 
pathways that are influenced by this phenotypic change. To achieve this, we employed 
functional over-representation analysis. Networks of related functionally enriched pathways 
were calculated and visualised using GO term functional enrichment in the Cytoscape plugin 
GlueGO.  
 
We began by comparing the overrepresented pathways in the LBF at 1.5, 4 and 24h to identify 
both serum induced and temporal changes A large network with acyl-coA oxidase and 
carboxylic acid catabolic process at the centre was found to be over-represented in LBF in 
serum compared to RPMI. When referring to p-value throughout this it is the FDR corrected 
p-value for the overrepresentation of pathways in the ClueGO overrepresentation test were 
pathways that were considered significantly overrepresented with FDR adjusted p-
value<0.05. 
 
Fatty acid metabolism related processes make up a large component of this network 
predominantly at the 24h biofilm time point (Figure 3.11 A,B). Within this central network the 
top upregulated processes acyl-coA oxidase activity is significantly overrepresented 




(p=0.0045, nr genes=3) and fatty acid binding ((p=0.0045, nr genes =3) with the 3 genes POX1, 
POX1-3 and PXP2 resulting in the enrichment of this pathway. Similarly, over enriched was 
the carboxylic acid catabolic process (p=0.0046, nr genes =17). With many genes within this 
pathway being non-specifically expressed including POT1, POX1, POX1-3 and ARO10 and 
PXP2. 
 
Additional networks of gene pathways were over-represented, including plasma membrane 
and transmembrane transport were also represented within the upregulated genes in FCS in 
the LBF strains at 24h. Overrepresented terms included the plasma membrane acetate 
transporter (p=0.006, nr genes=5), which was enriched by the genes ATO1, ATO10, ATO9, 
FRP3, FRP5. This pathway was non-specific and over enriched at all time points. The pathway 
monocarboxylic acid transmembrane acid transport (p=0.026, nr genes=6) was 
overrepresented in this subnetwork also by the same genes with the addition of JEN1. 
 
Fungal cell wall terms were found to be over-represented at all time points with a couple of 
nodes or terms being specific to later biofilms. Cell wall and membrane component terms 
were also enriched at all time points, except for the anchored component of the cell 
membrane being unique to 24h. Fungal type cell wall (p=0.007, nr = 30) and hyphal wall 
(p=0.04, nr genes=14) GO terms where significantly overrepresented the cell wall 
subnetwork. Genes of families ALS, HWP SAP and SOD were over enriched at all time points 
including ALS1/3, HWP1, ECE1 and SAP4/5/6. 
 
Many enriched terms belong to either the 24h time or are considered non-specific, with only 
pre-ribosome (p=0.009, nr genes=14) being unique to 4h. Top genes enriching this pathway 
include BUD21, CICC, DIM 1, ECM1 and ENP1. The terms cellular meta homeostasis (p=0.009, 
nr genes=16) and dioxygenase activity (p=0.042, nr genes=6) were additionally specifically 
over-represented at 90min as shown by the two nodes although they are part of the much 











Figure 3.11 ClueGO analysis of the upregulated genes in LBF in presence of serum and their 
associated pathways. Over representation analysis of pathway analysis performed within ClueGO 
representing pathways as nodes linked based upon their kappa score. Nodes are coloured to show the 
representation of either 90min (Green), 4h (Blue) and 24h (Red). Nodes shared by the different time 
points strains are colourised grey. An exploded view illustrates the pathways and subnetworks which 
are colourised to illustrate nodes belonging to related pathways (A) Pie charts for each time points 
90min, 4h and 24h and shared features summarise the percentage of terms related to a specific 
subnetwork of pathways also colourised to highlight the subnetwork (B). 
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A similar pattern is observed when considering the down-regulated pathway constructed 
from the RPMI enriched genes at 1.5, 4 and 24h in the low biofilm forming strains. Many of 
the over-enriched pathway nodes belong to the 24h time point or are considered non-specific 
to a particular time point, as shown by the points coloured in red or grey. This indicates that 
these pathways are either activated throughout biofilm formation or specifically at the 24h 
time point. A small number of nodes and sub-networks of 90mins downregulated genes can 
be seen related to protein translocation and post replication repair. Specifically, the terms at 
downregulated in serum at 90min are organic ion transmembrane transporter activity and 
chaperone cofactor-dependent protein refolding and many of the nodes are part of the larger 
sub-networks comprised of non-specific and 24h genes. (Figure 3.12B). 
 
Genes represented at 24h and non-specifically comprise nodes within the 3 largest 
subnetworks. A subnetwork comprised mostly of terms upregulated at 24h that includes 
small molecule catabolic processes, e.g., terms such as serine catabolism and other amino 
acid related metabolic processes (p= 0.021, nr genes=21). Genes involved in serine 
metabolism downregulated include ADE6, ARO9, CHA1 and MET, SHM family of genes.  
 
The largest sub-network and group of terms is summarised as transmembrane and iron 
transport and is comprised primarily of genes enriched either non-specifically, i.e., at all-time 
points or the 24h time point. Figure 3.12A and 3.12B. This network and linked networks show 
downregulation in the pathways involved in transmembrane transport, particularly with 
regards to ion homeostasis in LBF strains grown in FCS. Pathways involved in ion homeostasis 
represent the most some of the top overrepresented. The pathways ion transport (p= 
<0.00001, nr genes=64), anioin transport (p= 0.0034, nr genes=22) and ion transmembrane 
transport (p=<0.00001, nr genes=48) are all overrepresented. It can be observed large 
numbers of genes related to ion transport are downregulated. Common genes include AGP2 
and ATO10. ZRT2 is also a common gene within these pathways and is one of top 











Figure 3.12 ClueGO analysis of the downregulated genes in LBF in presence of serum and their 
associated pathways. Over representation analysis of pathway analysis performed within ClueGO 
representing pathways as nodes linked based upon their kappa score. Nodes are coloured to show the 
representation of either 90min (Green), 4h (Blue) and 24h (Red). Nodes shared by the different time 
points strains are colourised grey. An exploded view illustrates the pathways and subnetworks which 
are colourised to illustrate nodes belonging to related pathways (A). Pie charts for each time points 
90min, 4h and 24h and shared features summarise the percentage of terms related to a specific 
subnetwork of pathways also colourised to highlight the subnetwork (B). 
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Many terms related to transmembrane transport are also downregulated in the LBF strains in 
Serum. These include integral component of the membrane (p=<0.00001, nr genes=152) and 
the transmembrane transport (p=<0.00001, nr genes=84). These terms are overrepresented 
at all time points. Transmembrane transport and ion transport are represented by brown 
nodes and comprise a large proportion of the overrepresented terms in the network. Pink 
nodes. The pink node related to serine and other amino acid metabolism is also comprised of 
oxireductase terms.  
 
When comparing the enriched terms in the high biofilm forming strain in FCS compared to 
the LBF there are numerous more nodes enriched in the HBF (Figure 3.13-3.15). In total there 
are 80 significantly overrepresented pathways FDR p-value <0.05 with 79 of these belonging 
to the HBF. Only nitric oxide dioxygenase (p= 0.0066, nr genes=3) activity was specific to LBF 
and there was no overlap in non-specific nodes between the LBF and HBF at 90min. There are 
large subnetworks of genes overrepresented in HBF that are not present in the LBF strain. 
Covering many areas of cell regulation including transcriptional control, nucleolus processes, 
microtubule and cytoskeleton and binding. Ras transcriptional control was overrepresented 
in HBF as well as single species biofilm. Indicating biofilm specific responses that are present 
at 90 mins that are not present in the LBF or at least at high levels. The top overrepresented 
pathways include genes involved in nucleolus (p=<0.00001, nr genes=49), ribosome 
biogenesis (p=<0.00001, nr genes=49) and rRNA processing (p=0.000042, nr genes=38).  
 
Additionally at 90 min the subnetworks were comprised for the genes upregulated in FCS for 
the HBF strain including cell adhesion and biofilm formation related terms, regulation of 
transcription terms, nucleolus, pre-ribosome and protein modification (Figure 3.13-3.15).  
 
At 4h, shown in Figure 3.14 there is more representation of nodes from the LBF strains 
compared to the 90min time point shown in Figure 3.13. There are several subnetworks 
containing terms related to ribosome and pre-ribosome, nitric acid dioxygenase activity and 
snRNA pseudo uridine synthesis overrepresented in the LBF. Although much larger 
subnetworks of overrepresented terms related to HBF similar to the 90 min network. There 
is a total of 37 significant pathways FDR p-value <0.05. 8 of these are specific to the LBF strain 
at 4h while 7 are non-specific, or overrepresented in both the LBF and HBF strains. The 




remainder are specific to HBF strain. The top pathways in the LBF only are ribonucleoprotein 
complex biogenesis (p=0. 0.001, nr genes =30 genes) and the preribosome (p=0.001, nr genes 
=14). The top non-specific overrepresented terms include ribosomal large subunit biogenesis 
(p=0.001, nr genes =10), response to nitrosative stress (p=0.0061, nr genes =3). Nitrosative 
stress and nitric oxide catabolic process are enriched by the YHB1 and YHB5 genes that are 
involved in nitrosative and oxidative stress in yeasts. Additionally, of interest there are hyphal 
cell wall terms that are overrepresented in HBF in the presence of serum that aren’t present 
in the LBF. These include the fungal (p=0.009, nr genes=19) and hyphal cell wall (p=0.0091, nr 
genes=11). However not overrepresented many of the usual hyphal and biofilm related genes 
including ALS1, ECE1, HWP1, and SOD5 upregulated in both HBF and LBF. 
 
At 24h the representation of nodes and subnetworks comprised of HBF enriched terms is 
much more apparent than those by the LBF enriched terms shown in Figure 3.15. There are a 
total of 37 significantly overrepresented pathways with an FDR p value <0.05. 5 of these 
pathways were specific to LBF, 1 was non-specific and 31 were specific to HBF. 
 
LBF is terms comprise 2 singular nodes and a small subnetwork. The subnetwork is related to 
acyl-CoA and fatty acid oxidation activity and the two independent nodes are related to the 
anchored component of the cell wall and plasma membrane acetate support. The top 
pathways are fatty acid binding (p=0.00075, nr genes=3), acyl-CoA oxidase activity 
(p=0.00075, nr genes=3) and fatty acid beta-oxidation using acyl-CoA oxidase (p=0.00075, nr 
genes=3). Which all share the same 3 genes POX1, POX1-3 and PXP2. We previously observed 
these genes to be involved in a Serum specific response, they now seem to be a LBF specific 
response. Plasma membrane transport (p=0.00078, nr genes=5) is also overrepresented in 
only the LBF which is comprised of the ATO1, ATO10, ATO9, FRP3 and FRP5 genes. The 
functional term positive regulation of multi-organism process (p=0.047, nr genes= 16) was 
non-specific. This pathway includes genes that may be involved in influencing organisms of 
the same species. These genes may be involved in communication between Candida within 
the biofilm. Genes include the virulence ACE2, adhesin ALS1 and the mating pheromone alpha 
factor MFALPHA. A large, overrepresented sub-network and smaller subnetworks in the HBF 
strain in FCS at 24h is related to transcriptional regulation and control. Whilst other individual 
nodes and subnetworks represent mitotic cell cycle control (Figure 3.15). The top 




overrepresented pathways that are specific to HBF at 24h in Serum are intracellular organelle 
(p=<0.00001, nr genes=197) and intracellular membrane organelle (p=<0.000001, nr genes 
=178). A subnetwork of transcriptional controlled processes including regulation of cellular 




Figure 3.13 ClueGO analysis of the upregulated genes in LBF and HBF strains in the presence of 
Serum at 90min. Over representation analysis of pathway analysis performed within ClueGO 
representing pathways as nodes linked based upon their kappa score. Nodes are coloured to show the 
representation of either High (Red) and Low (Blue). Nodes shared by the two strains are colourised 
grey. An exploded view illustrates the pathways and subnetworks which are colourised to illustrate 
nodes belonging to related pathways (A). Pie charts for each strain and shared features summarise 
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Figure 3.14 ClueGO analysis of the upregulated genes in LBF and HBF strains in the presence of 
Serum at 4h. Over representation analysis of pathway analysis performed within ClueGO representing 
pathways as nodes linked based upon their kappa score. Nodes are coloured to show the 
representation of either High (Red) and Low (Blue). Nodes shared by the two strains are colourised 
grey. An exploded view illustrates the pathways and subnetworks which are colourised to illustrate 
nodes belonging to related pathways (A). Pie charts for each strain and shared features summarise 
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Figure 3.15 ClueGO analysis of the upregulated genes in LBF and HBF strains in the presence of 
Serum at 4h. Over representation analysis of pathway analysis performed within ClueGO representing 
pathways as nodes linked based upon their kappa score. Nodes are coloured to show the 
representation of either High (Red) and Low (Blue). Nodes shared by the two strains are colourised 
grey. An exploded view illustrates the pathways and subnetworks which are colourised to illustrate 
nodes belonging to related pathways (A). Pie charts for each strain and shared features summarise 
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3.4.6 Gene set enrichment analysis of strains in the presence of serum 
GSEA utilising the entire gene set of differentially expressed genes of Serum vs RPMI at 24h 
were utilised to identify the top enriched pathways according to their adjusted p-values. 
Comparable to over representation analysis such as those performed by ClueGO the entire 
gene set is utilised and the genes are ranked. In this case genes were ranked according to 
their log2FC determined by differential expression analysis by DESeq2. The high biofilm 
formers display larger levels of both activated and supressed pathways in the presence of the 
serum (Figure 3.16A). Larger numbers of pathways activated in HBF are unique to this strain 
like the ClueGO over representation analysis. However, there is a unique set of differentially 
enriched pathways in the LBF. 25 pathways that are enriched in the LBF in the presence of 
serum are unique to serum. Many of the pathways are involved in cell-to-cell fusion that and 
conjugation in the LBF strain. Also, the metabolic pathways of fatty acid oxidation and beta-
oxidation are enriched in the LBF compared to the HBF.  
 
When comparing the top enriched gene ontology pathways in HBF and LBF we see that most 
of the top pathways follow the same enrichment pattern in both LBF and HBF. The enrichment 
in HBF is usually higher than the LBF strains. There are several terms related to DNA 
replication the ribosome and nucleolus that are downregulated in LBF in serum but 
upregulated in HBF in serum at 24h. This concurs with our pathway analysis by ClueGo which 
identified significant networks of similar terms. (Figure 3.16B). Enrichment between the two 
strains does diverge in a few instances but many of the RPMI enriched terms are similarly 
enriched in both HBF and LBF. The term Oxidoreductase is downregulated in serum for the 
LBF strain, and it is downregulated and enriched in the absence of serum in the high biofilm 
formers. Transport is similarly enriched in both strains but more enriched in HBF. Metal ion 
terms are enriched in RPMI or downregulated in Serum in both which agrees with our 
previous pathway and gene expression. In this instance however the enrichment score is 











Figure 3.16 Gene set enrichment analysis demonstrating differentially regulated pathways in the 
presence/absence of serum in high and low biofilm formers at 24h. Venn diagram depicting all the 
enriched pathways with an adjusted p-value <0.05 in either the low or high biofilm formers (A). 
Enriched pathways are either up in serum or down in serum. Gene set enrichment analysis of the top 
enriched 15 pathways at 24h from LBF and HBF according to the Benjamini-Hochberg adjusted p-
value. GSEA shows enrichment of genes in presence of serum(+NES) and downregulated genes, i.e., 
in enriched the absence of serum (-NES) (B). Normalised enrichment score was calculated for each 
pathway by the fgsea algorithm within the ClusterProfiler R package. 
 




3.4.7 Biomarker analysis 
Partial least squares-discriminant analysis (PLS-DA) is a method of multivariate reduction that 
differs from PCA in that it identifies the variables, in this case genes, that explain the highest 
variation in the response variable. PLS uses the response variable i.e., strain and media to 
maximise the variance in the different classes. Usefully in RNA-Seq it removes irrelevant or 
misleading variation and allows for a better prediction of markers, i.e., expressed genes that 
vary the most between our classes. Within the context of our analysis the PLS-DA 
methodology from the R package mixOmics was able to select the optimal number of genes 
and the most optimal number of components to depict the variation between HBF/LBF in 
Serum compared to RPMI. PLS-DA shows separation of the strains grown in RPMI and Serum 
with large separation based upon the 120 variables selected (Figure 3.17A). The relative effect 
on the variation on component 1 are shown with the relative effect on the variation between 
the strains grown in RPMI vs Serum. The loadings plot of the top 50 variables from the 1st 
component are shown (Figure 3.17B). It is also possible to see the distribution of our variables 
on component 1. Variables are those that have the most contribution to that component and 
the value is the loading of the sample with the highest contribution on that the component. 
Variables are coloured according to a group have the highest contribution or expression 
within that group. Indicating that they are more highly expressed within that group. The PLS-
DA here classifies our samples according to the molecular signatures which are the most 
optimum for our identifying samples in the groups (media and time). A heatmap of our 
signature variables and their relative expression are shown in Figure 3.17A. Many of the genes 
identified are unclassified and are only indicated by their CGD accession IDs. The top 
discriminatory annotated genes with higher relative expression in FCS were SWC4, CUP2 and 
BUD14. SWC4 is of the histone acetyltransferase complex involved chromatin remodelling, 
CUP2 is a copper binding response and BUD14 which has a predicted role in bud site selection. 
Two molecular signatures were determined to explain the classification of samples on our 
second component between our two strains. This included a gene expressed in RPMI 
C7_03580C and the gene C1_12890. Both genes are unclassified within the current literature. 
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Figure 3.17 Supervised analysis 
of HBF and LBF strains in the 
presence/absence of serum 
using PLS-DA. Partial least 
squares discriminant analysis 
(PLS-DA) multivariate analysis 
displays separation of our 
groups based upon biomarkers 
showing large separation 
between groups (A). The 
mixOmics R package allows for 
the tuning of data to select the 
most discriminant variables 
between our groups of interest. 
These are the two biofilm 
forming phenotypes HBF and 
LBF grown in either RPMI or 
RPMI+FCS. The separation of 
variables according to FCS or 
RPMI can be seen on the x-
variate. The loadings that have 
the largest impact are shown in 
the loadings plot (B) Loadings 
plot of the top 50 features that 
separate our groups on the first 
component and are colourised 
according to the sample with 
the largest loading for that 
variable. Clustered image 
heatmap of these discriminant 
features shows patterns of up 
and downregulated genes in 
RPMI and Serum (C). 
 




3.4.8 Cell Wall Proteomics 
A cell wall proteomic analysis was performed on 3 separate clinical isolates previously 
classified as high biofilm forming and 3 strains classified as low biofilm forming. The isolates 
used are summarised in section 3.3.3 in Table 3.1. 
 
Cell wall proteomics was performed only once for every strain in each growth conditions. 
These were biofilms grown for 24h with or without the presence of serum. Proteins with 
peptides per protein ≥ 2 were quantified according to their relative peak area. Proteins were 
filtered so that there was consensus of at least two of our 3 strains per group with that protein 
present. Within the cell wall proteomics analysis, a limited number of samples were used 
without any technical replication. Due to this limitation proteins were considered only in 
regard to their presence or absence within the two phenotypic groups in the presence and 
absence of serum. This data was used to create Venn diagram like plots of overlaps between 
the different phenotypic groups (Figure 3.18A). Additionally, we visualised the log10 peak 
area of the proteins with each sample in the form of a heatmap to summarise the presence 
and absence levels between our two phenotypes and our two growth conditions (Figure 3.18). 
We hypothesised that there may be differences in the cell wall composition between high 
and low biofilm formers in how they remodel their cell walls in the presence of serum. 
However, due to limitations in the procedure, for example, its ability to discern only the cell 
wall proteins and the lack of technical replicates it was deemed inappropriate to form any 
statistical inference. For this reason, visual analysis only was performed, and the experiment 
was used for hypothesis formation only with no strong conclusions possible. 
 
The Venn diagram like, Upset plot, shows the overlap of cell wall proteins identified between 
our different groups of HBF and LBF and in our two nutrient conditions (Figure 3.18A). Within 
our different groups 10 unique proteins were identified in the LBF serum group, 3 in the HBF 
serum group, 2 in the LBF no serum and 1 in HBF no serum group. The remainder of the 
proteins showed some level of overlap with one or more of the different groups with 20 
proteins being extracted from all groups. 
 
In the LBF strains 10 proteins were found in the cell walls in the presence of serum. These 
included the heat shock protein Hsp70, Essential beta-1,3-glucan synthase subunit Gsc1, the 




small (40S) subunit Rps21, the ATP synthase alpha subunit Atp1, the secreted yeast wall 
protein Ywp1, the ATP carrier protein Pet9, the Phosphoglycerate kinase Pgk1, the 
Hexokinase II Hxk2, putative histone H4 Hhf1 and a protein of unknown function. The 
translation elongation factor Tef2, Pyruvate decarboxylase Pdc11, Alcohol dehydrogenase 
Adh1 and the mRNA binding and RNA processing Sik1 were identified only in serum but 
appeared in both the LBF and HBF strains. Interestingly the Enolase protein Eno1 was present 
in LBF in serum but not in the absence of serum. It is important to note that many of these 
proteins are mitochondrial proteins and therefore could cloud or results. Some may be due 
to moonlighting proteins however the likelihood is that they are present due to poor 
separation of cell wall during processing or due to contaminants from serum 
supplementation. Many of these potentially contaminant proteins however are consistently 
and uniquely in the LBF cells supplemented with FCS. This may be due to differences in the 
LBF cells or response to stress which have meant that extraction from this group was 
particularly difficult. This is not true of all LBF+FCS specific proteins however, the yeast wall 
protein YWP1 protein for example is a cell wall protein and is thought to be involved in the 
maintenance of biofilm formation in some instances despite its name indicating otherwise.  
 
Between LBF and LBF+FCS there were 22 shared proteins, 5 only present in the LBF and 16 
unique to the LBF+FCS. Between HBF and HBF+FCS there were 24 shared proteins, 3 that were 
unique to HBF and HBF+FCS. Between the HBF and LBF cells there were 24 proteins shared 
and 3 unique to HBF and 3 unique to LBF. Similarly, in HBF+FCS and LBF+FCS there were 27 
proteins shared, 6 unique to HBF+FCS and 11 unique to the LBF+FCS. Shared proteins between 
all the phenotypes and media included ALS family proteins involved in adhesion between cells 
and surfaces. The GPI-Anchored Sap9 was also present across all phenotypes and nutrients 
and as previously discussed is consistently expressed in biofilm conditions. Cell surface 
mannoproteins are consistent across all biofilm conditions in the of Mp65 and the superoxide 
dismutase Sod5 which are involved in biofilm persistence (Bink et al., 2011). Most proteins 
seem to by typical cell wall proteins present in C. albicans and this can be observed by the 
overlap of the proteins in the Upset plot and the heatmap (Figure 3.18). Due to limitations 
with the methodology many of the atypical proteins observed could be erroneous due to poor 
extraction and or limited replication. Additionally, these results are summarised in the 
heatmap depicting the presence/absence and relative abundance indicated by log peak area 




(Figure 3.18B). Presence/absence of identified proteins within each group and a description 
of their function are summarised in Table 3.5.  
Figure 3.18 Cell wall proteomics of HBF and LBF C. albicans isolates. Cell wall proteins were extracted 
from C. albicans high biofilm forming (HBF) or low biofilm forming isolates after 24h of incubation in 
either RPMI or RPMI+FCS. Proteins that were present in each of our groups were overlayed in the 
Venn diagram like upset plot (A). All proteins identified within that sample set are described as set 
size with the overlap between the other groups being represented by the connecting points and 
barplots. A heatmap also indicates the log transformed peak area of each of the proteins indicated 
the identified levels in each of our sample groups (B). Samples are clustered based upon similar 






































































































Table 3.5 Table of identified cell wall proteins and their presence/absence within each group of strains. Proteins also contain short description as maintained 
by the CGD. Proteins are indicated by presence (+) or absence (-) in each of groups. Groups are formed of the two phenotypes and the two nutrient conditions. 
Names Description mycol HBF HBFSerum LBF LBFSerum Names Description mycol HBF HBFSerum LBF LBFSerum
C1_00220W Glycosidase Phr2 + + + + C4_03520C Cell wall protein with similarity to Hwp1 Rbt1 + + + -
C1_01480C Protein component of the small (40S) subunit Rps21 - - - + C4_04050C
GPI-anchored yeast-associated cell wall 
protein Rhd3 + + + +
C1_02420C Essential beta-1,3-glucan synthase subunit Gsc1 - - - + C4_04530C Cell surface glycosidase Phr1 + + + +
C1_03190C GPI-anchored cell wall protein Ecm33 + + + + C4_04530C Cell surface glycosidase Phr1 + + + +
C1_04240C Putative histone H4 Hhf1 - - - + C4_06570C Pyruvate decarboxylase Pdc11 - + - +
C1_04610W ATP synthase alpha subunit Atp1 - - - + C4_06980W
Cell surface protein that sequesters zinc 
from host tissue Pra1 + - + -
C1_08230C
Putative GPI-linked phospholipase B, fungal-
specific (no mammalian homolog) Plb5 + - + + C4_06980W
Cell surface protein that sequesters zinc 
from host tissue Pra1 + - + -
C1_08380W Translation elongation factor 1-alpha Tef2 - + - + C5_00590W
Mitochondrial ADP/ATP carrier protein 
involved in ATP biosynthesis Pet9 - - - +
C1_08500C Enolase Eno1 + + - + C5_04130C GPI-linked chitinase Cht2 + + + +
C1_10290W
Extracellular/plasma membrane-associated 
glucoamylase Gca1 - - + - C5_05050W Alcohol dehydrogenase Adh1 - + - +
C1_13450W GPI-anchored hyphal cell wall protein Hyr1 + + + - C5_05050W Alcohol dehydrogenase Adh1 - + - +
C1_13480W Putative hsp70 chaperone Hsp70 - - - + C5_05390C GPI-anchored cell surface protein Pga4 + + + +
C2_00680C Cu-containing superoxide dismutase Sod5 + + + + C6_00370C Ortholog of S. cerevisiae Nop58 Nop5 + + - +
C2_02410W Unknown Unknown - - - + C6_00750C Phosphoglycerate kinase Pgk1 - - - +
C2_08590W Secreted yeast wall protein Ywp1 - - - + C6_03700W Cell-surface adhesin Als1 + + + +
C2_08870C 1,3-beta-glucan-linked cell wall protein Pir1 + + + + C6_04130C GPI-anchored adhesin Als4 - + + +
C2_10030C Cell surface mannoprotein Mp65 + + + + C6_04380W ALS family protein Als2 + + + +
C2_10030C Cell surface mannoprotein Mp65 + + + + C6_04380W ALS family protein Als2 + + + +
C3_00720W Plasma membrane H(+)-ATPase Pma1 + + + + C7_00860W
Beta-glucan associated ser/thr rich cell-wall 
protein with a role in cell wall structure Ssr1 + + + +
C3_01550C
Protein similar to alpha agglutinin anchor 
subunit Tos1 + + + + C7_02300W
Putative aspartic-type endopeptidase with 
limited ability to degrade alpha pheromone Yps7 - - + -
C3_01730C Putative GPI anchored cell wall glycosidase Utr2 + + + + CR_04510W Hexokinase II Hxk2 - - - +
C3_03870C Secreted aspartyl protease Sap9 + + + + CR_04510W Hexokinase II Hxk2 - - - +
C3_06870W
NAD-linked glyceraldehyde-3-phosphate 
dehydrogenase Tdh3 + + + + CR_07070C Cell wall adhesin Als3 + + + +
C4_00130W GPI-linked cell wall protein Rbt5 + + + + CR_09950C Putative U3 snoRNP protein Sik1 - + - +
C4_02900C
GPI-anchored cell wall transglycosylase, 
putative ortholog of S. cerevisiae Crh1p Crh11 + + + +






Within clinical cohorts in which C. albicans is found, we have observed that there is variability 
within those populations of this yeast’s biofilm forming ability. It has also been long 
understood that the biofilm forming phenotype is inducible. In experiments, primarily 
involving type and laboratory strains, it has been observed that numerous stimuli including 
nutrient sensing is able to invoke this phenotype (Kean et al., 2018a). This ability is not unique 
to nutrient stimulation and it has been discussed in greater depth within the introduction the 
numerous conditions that can moderate biofilm formation.  
 
Through the work outlined here we observed that seemingly biofilm inefficient clinical strains 
are inducible to form a biofilm under stimulation with foetal calf serum. This effect of FCS 
outlined within the literature and in certain instances utilised to assure this phenotype within 
in vitro experiments (Chandra et al., 2001, Tammer et al., 2014). The use of FCS in C. albicans 
biofilm research has been leveraged to gain insights into the molecular and physiological 
changes that occur during biofilm formation (Pierce et al., 2015). Due to the clinical 
implications of biofilm formation and the consensus that biofilms result in a worse clinical 
outcome in many pathologies, then our increased understanding of the C. albicans biofilm 
allows for improving our knowledge of virulence and potential modes of interfering with the 
yeasts ability to harm in vivo (Cavalheiro and Teixeira, 2018).  
 
We observed that FCS could induce biofilm formation into those strains that we had 
previously categorised as LBFs from the clinical cohort. Although the growth of C. albicans is 
sufficient to induce hyphal and biofilm growth in many isolates, it has been demonstrated 
that certain clinical isolates will more readily form biofilms than others. They took on the 
phenotypic properties visually of the HBF and their biomass and hyphal formation became 
much more comparable to the HBF strains. This effect was not seen in dialysed serum which 
has small molecules removed. 
 
Transcriptomic profiling was hypothesised to identify similarities, deficiencies and contrasting 
changes that were occurring in the low biofilm forming strains. This allowed us to identify 
how the LBFs were regulating this phenotypic switching. RNA sequencing was utilised within 




this research to identify changes in the transcriptional changes between two distinct clinical 
isolates with and without the nutrient stimulation of serum. RNA sequencing using the 
Illumina HiSeq platform was successful for all samples with all samples receiving adequate 
sequencing depth. There was a wide range of reads from ~11 to greater than 30 million for 
some of the samples. Average alignment rates were adequate as were the percentage of 
assigned genes. The Illumina platform provided adequate quality with no obvious failings 
within the data. The data was derived from single end reads which comparative to paired end 
reads do not allow for identification of novel features such as fusions or splice isoforms 
(Rossell et al., 2014). Single end reads are a simple and effective and high throughput method 
to achieve adequate read depth for broader RNA-Sequencing applications such as those 
utilised here. The identification and counting of features within our different conditions was 
our primary goal and this sequencing methodology was sufficient.  
 
Both clinical C. albicans strains displayed a great deal of transcriptional plasticity when 
confronted with the FCS supplemented media. It would seem however that the degree of 
differentiation in gene expression is greater within the high biofilm forming. A larger number 
of genes were both up and down regulated in the HBF strain compared to the LBF strain. 
However, the largest determinant of transcriptional variability within our experimental 
samples was early and late biofilm formation. Which is perhaps not unexpected, variability 
due to strain and media changes was the 2nd and 3rd largest contribution to variability, 
respectively. Gene Ontology and over representation or enrichment analysis has become a 
popular tool for identifying patterns in gene expression (Conesa et al., 2016b). 
 
Interestingly when considering our top differentially expressed genes between FCS and RPMI 
we observed that zinc transport was more upregulated in the RPMI only grown biofilms. 
ZRT1/2 zinc transport and PRA1 zincophore was consistently down regulated to a high level 
across all of our time points and biofilm conditions in FCS. The interaction between Pra and 
Zrt complexes allows for the efficient uptake of zinc in C. albicans (Łoboda and Rowińska-
Żyrek, 2018). Zinc is required by many enzymes in yeasts and is thought to be a factor in 
Candida virulence and host interactions (Jung, 2015). Iron homeostasis has been linked to 
both fitness and biofilm formation in C. albicans however the intricacies of these factors and 
their roles are not fully understood (Mayer et al., 2013). Preliminary work by researchers in 




Tokyo seemed to imply the increase of zinc in biofilm formation in C. albicans (Kurakado et 
al., 2018). Our data is slightly confounded by the HBF and LBF in RPMI where it is upregulated 
in both. HBF does form biofilms in RPMI and therefore may be biofilm related and LBF only 
form weak biofilms in RPMI, but it is still upregulated. Therefore, it is difficult to determine a 
role for zinc in biofilm formation with our dataset. It is however interesting to note that the 
supplementation of FCS is downregulating this response in both strains. This may indicate 
that zinc homeostasis is a key factor in biofilm formation and cellular elongation. Zinc maybe 
so readily available within the FCS that its metabolic needs are met earlier in biofilm 
formation. An even closer look at the initial stages of biofilm development and 
experimentation with increased zinc and zinc starvation in future experiments may help to 
decipher the role of zinc in biofilm formation.  
 
From functional analysis it was possible to identify differentially programmed pathways and 
ontologies in the LBF in the presence of serum. Predictably, genes implicated in biofilm 
formation were changing at all time points. Cell adhesion and biofilm formation were also 
terms appearing in both HBF and LBF. Cell wall related terms, including fungal type and hyphal 
cell wall terms were represented at all time points and both HBF and LBF. Early biofilm 
formation in the LBF stimulated by the serum involved dioxygenase and preribosome. Late 
biofilm formation transcribed functional groups involved a larger number of processes. The 
largest majority was functional groups related to Acyl-CoA oxidase activity and fatty acid 
metabolism. β-oxidation of fatty acids in C. albicans takes place within the peroxisome. Acetyl 
units can then be integrated into the glyoxylate cycle or exported outside of the peroxisome 
by the carnitine shuttle system (Strijbis and Distel, 2010). These pathways are also 
overrepresented in the LBF in serum when compared to the HBF strains. Also distinct to LBF 
in serum compared to RPMI in the presence of serum is plasma membrane acetate transport.  
C. albicans utilising non-sugar carbon sources such as β-oxidation of fatty acids is known to 
be flexible and important for virulence in C. albicans. The fatty acid metabolites eicosanoids 
such as prostaglandin E2 and thromboxane B2, present in serum have been shown to 
influence germ tube formation in C. albicans (Noverr and Huffnagle, 2004). LBF strains can 
utilise alternative carbon metabolic pathways to enable yeast-hyphal morphogenesis and 
biofilm formation. We observed fatty acid metabolism and acetyl-CoA were distinctly LBF 
enriched terms in our low biofilm strains. The fatty acid binding and acyl-coA related genes 




for Acyl-coenzyme A oxidase POX1 and POX 1-3 and PXP3 were specifically overrepresented 
in LBF. GSEA also revealed the fatty acid metabolism related genes FOX3, FOX2, ECI1, CAT2, 
FOX3, PEX11 and ANT1 were also upregulated and lead to the enrichment of the fatty acid 
oxidation related term. The fox 3-hydroxyacyl-CoA epimerase genes are involved in beta 
oxidation and induced in phagocytosis. PEX11 is a peroxisomal protein required for 
peroxisome proliferation and ANT1 is also described as a peroxisomal adenine nucleotide 
transported. EC1 and CAT2 are putatively linked to beta oxidation of medium chain fatty acids 
like the other genes. These genes are putatively assigned functions from the S. cerevisiae 
database with little annotation according to the STRING database. 
 
Members of the ATO gene family ATO1, ATO10 and ATO9 were over-represented in the term 
“plasma membrane acetate transport” and they are upregulated in the LBF forming strains in 
the presence of FCS which are linked to acetate membrane transport and mutations in the 
ATO family have been demonstrated to affect the yeast to hyphal switch (Danhof and Lorenz, 
2015). ATO genes are also thought to be dependent upon the transcription factor Stp2 
(Danhof and Lorenz, 2015). Similarly, the associated genes FRP3 and FRP5 were upregulated 
associated with this pathway. FRP3 is a putative ammonium permease candidate. This 
pathway is associated with C. albicans’ ability to induce alkalinisation through ammonia 
release and overcome macrophages (Danhof and Lorenz, 2015). They are involved in amino 
acid catabolic change and are induced to mitigate changes in pH. This need for alkalinisation 
may be a response from the LBF to account for changes in pH influenced by alternative carbon 
metabolism. pH is a known promoter of hyphal formation and is hyphal formation has been 
previously linked with alkalinisation (Vylkova et al., 2011a). 
 
Iron homeostasis is upregulated at 4h in LBF in serum and downregulated at 24h. This could 
be indicative of C. albicans responding to higher levels of iron availability in serum compared 
to RPMI only. Iron concentrations previously being shown to instigate shifts from yeast to 
hyphal forms which previously has been theorised to be and an environmental trigger for C. 
albicans to reprogram its metabolism.  
 
The C. albicans cell wall plays an important role in the cell morphology and protection against 
external insults. Adaptively, C. albicans remodels their cell walls in response to environmental 




changes, a process controlled by well-known stress (Hog1) and cell integrity (Mkc1, Cek1) 
signalling pathways (Ene et al., 2015). The cell walls mainly comprised of β-glucans (glucose 
polymers [50-60%]), chitin (N-acetylglucosamine polymer [1-2%]), and mannoproteins (30-
40%) (Poulain, 2015). Hsp70 has been evidenced previously in the cell wall of C. albicans 
indicating although not commonly found outside the cell membrane it has been hypothesised 
that they are molecular chaperones performing roles in cell wall biosynthesis (López-Ribot et 
al., 1996, López-Ribot and Chaffin, 1996). Hsp70 is responsible for protein folding under heat 
shock conditions and although it has been observed within the cell wall little is known about 
its function there. Gsc1 is an S. cerevisiae homolog where it is a subunit of the beta-1,3-glucan 
synthase (Mio et al., 1997) where it has a role in the production of beta-glucan a major 
component of the hyphal cell wall. Although similarly this is usually a membrane bound 
protein so its presence in the cell wall is unusual. The Rps21 ribosomal protein is localised 
within the endoplasmic reticulum but in the case of LBF in serum it was observed in the cell 
wall. Pet9 the ATP carrier is also localised within the mitochondria and not usually within the 
cell wall. Tef2, and Pdc11 are also not typically present on the cell wall. Pdc11 as well as 
several other proteins including Eno1 have previously been described as “moonlighting” 
proteins. Moonlighting proteins have been observed in response to chemical and host-
interactions. It is perhaps only possible to say that LBF in serum is modulating the composition 
of its cell wall. We can only hypothesis that this is response to stress or compensating for 
deficiencies in cell wall biosynthesis comparative to HBF. This is an interesting question that 
cannot be answered within the work here but warrants further investigation. Additionally, as 
we discussed in the results the issues with cell wall protein extraction cannot be overlooked. 
Complications with proteomics methodology and preparation of cell wall fraction meant that 
potentially spurious results were introduced by presence of mitochondrial proteins. Although 
classified as an omics technology the cell wall proteome showed very little coverage and was 
not representative of the whole cell wall proteome. This again points to issues with extraction 
and processing that have been introduced through experimental design. It would be 
advantageous for this experiment to be repeated with greater number of replicates to both 
improve the power and to rule out any issues with contaminants. Results obtained were both 
limited and relative, so future experiments should aim to address the extraction of cell wall, 
processing to maintain a clean cell wall fraction and improve processing measurements to 
allow for quantitative measurements between sample groups.  




It is fair to conclude that transcriptome analysis of our two strains has been successfully in 
determining that there is transcriptional reprogramming between these two strains. 
Biomarker analysis, however, found that their a select group of features that are consistent 
between the two strains and that can distinguish between RPMI and serum grown biofilms. 
With many transcriptional studies it drives hypothesis and creates as many questions as it 
answers. It is perhaps interesting that although LBF seem deficient, it is inducible through 
alternative pathways that we have shown here, and these are also pathways that have been 
observed within the host to induce hyphal morphogenesis such as the alkalinisation induced 
mechanisms within the macrophage. Therefore, these strains may still be capable of 




- C. albicans clinical isolates display heterogeneity in their ability to form biofilm but 
additionally in their morphological response to external stimuli. 
- High and Low biofilm formers have drastically different gene expression profiles in 
response to foetal calf serum. 
- The Low biofilm specific response to serum involves fatty acid metabolism and acyl-
coA activity. 
















4 Metabolomic profiling of phenotypically 





















The discipline of metabolomics continues to grow and so does its application to studying 
microbial biofilms (Burgain et al., 2020, Wong et al., 2018). It is becoming clear that primary 
and secondary metabolites play important roles in the biofilm formation of microbes, and 
therefore targeted and untargeted metabolomics have become an invaluable tool in the 
microbiologist’s arsenal. Metabolomics offers a systematic and holistic method of identifying 
the metabolic profile during biofilm formation, and in turn the opportunity to identify 
important pathways and therapeutic targets. Recently metabolomics was used in C. albicans 
to identify all the key metabolic pathways that were reprogrammed in response to hypoxic 
stress and has previously been utilised metabolomic changes during morphogenesis and the 
metabolome in response to bacterial species such as S. aureus (Weidt et al., 2016, Burgain et 
al., 2020, Han et al., 2012). 
 
C. albicans is a polymorphic fungus which can sense and adapt to its environment (Mayer et 
al., 2013). The “metabolic flexibility” has been linked and associated with C. albicans virulence 
and its interaction with host (Brown et al., 2014b). C. albicans and other fungal species 
possess mechanisms for metabolic adaption to amino acid and sugar metabolic pathways. 
Amino acid metabolism has been associated with the induction of hyphal morphogenesis 
through cAMP/PKA signalling pathways and through the alkalinisation of the environmental 
conditions (Silao et al., 2019, Vylkova et al., 2011b). Arginine metabolism in Candida spp. has 
been studied in some detailed and is reported to induce C. albicans hyphal formation and 
elongation. This is linked to the cAMP-dependent protein kinase A (PKA) pathway and through 
CO2 production thought to induce germ tube formation (Ghosh et al., 2009). Prior to interest 
in C. albicans as a biofilm forming opportunistic pathogen, it was well understood that 
morphogenic switching was observed in the presence of different nutrient sources, such as 
serum, amino acids (such as proline) and the monosaccharide N-acetylglucosamine (Feng et 
al., 1999, Dabrowa et al., 1976, Holmes and Shepherd, 1987). 
 
Serum has been known for some time to be a potent inducer of hyphal morphogenesis and 
biofilm formation, through activation of the GTPase Ras1 dependent cAMP signalling leading 
to the phosphorylation of Efg1p (Ramage et al., 2002b). The leads to hyphal production in C. 
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albicans, and key structural component of biofilms. Hypoxia is another common stress and 
virulence response known to induce hyphal morphogenesis and biofilm formation. 
Metabolomic profiling by Burgain et al (2020) identified high levels of metabolomic 
reprogramming in C. albicans type strains in response to hypoxic stress (Burgain et al., 2020). 
Importantly, early hypoxic stimulation leads to a response that causes a reprogramming of all 
major components of C. albicans metabolism, including carbohydrate, nucleotide, lipid and 
amino acid pathways. Similarly, it has previously been shown that sugar sensing or adaption 
to different sugar sources can influence the biofilm forming morphology of C. albicans 
(Pemmaraju et al., 2016, Ng et al., 2016). Availability of dietary carbohydrates can influence 
hyphal formation and biofilm development (Santana et al., 2013). Most recently, through the 
use of heterogenous C. albicans clinical isolates it was shown that metabolic pathways 
including arginine, proline and pyruvate metabolism were transcriptionally upregulated in 
biofilm competent, or high biofilm forming isolates, compared to strains which were deficient 
in biofilm growth (Rajendran et al., 2016a). This study indicated that amino acid metabolism 
was a key pathway supporting this phenotype. 
 
Exploiting C. albicans metabolism has become an area of interest for therapeutic targets. It 
has been suggested that drugs could target and inhibit metabolic pathways, thereby reducing 
the virulence capacity of C. albicans. For example, through interruption of the glucose 
metabolism pathways in C. albicans through compounds that target the gluconeogenesis 
glyoxylate pathway. Recent examples include the uncompetitive inhibition of the trehalose-
6-phospte synthase and inhibition of the glucosamine-6-phospate synthase inhibitors via N3-
(4-methoxyfumaroyl)-(S)-2, 3-diaminopropanoic amide derivatives (Pawlak et al., 2016, 
Magalhães et al., 2017). Glycolysis has been the target of interest in a number of studies. 
Similarly, numerous studies have discussed potential, and in some cases, tested amino acid 
metabolism as a target for therapeutics because of their key roles in virulence and 
morphogenesis (Garbe and Vylkova, 2019). Similarly, reports exist on effects of attenuation 
of amino acid pathways in other fungal species such as Cryptococcus neoformans, Aspergillus. 
fumigatus, as well as for C. albicans (McCarthy and Walsh, 2018, Jastrzębowska and Gabriel, 
2015). For example, in C. neoformans disruptions of the catabolic proline pathway was 
observed to decrease virulence through reducing the organism’s ability to respond to 
oxidative and nitrosative stress (Lee et al., 2013). In A. fumigatus it has also been proposed 
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that due to this dependence on amino acids during aspergillosis. As the disruption of carbon 
metabolism linked to amino acid metabolism such as methycitrate cycle can attenuate 




We hypothesised that using targeted/untargeted metabolomics that we could identify 
metabolomic differences between C. albicans phenotypically distinct isolates defined as high 
and low biofilm formers. Additionally, we hypothesised that we could identify metabolic 
changes that occur during the phenotypic shifting of C. albicans in the presence of serum. This 
chapter aims to interrogate the differentially modulated pathways under the biofilm inducing 
condition of serum supplementation. 
 
We additionally aimed to identify any metabolic response or reprogramming in C. albicans 
low, or biofilm deficient, clinical isolates compared to high or biofilm capable isolates. 
 
Specifically, this chapter aims to identify: 
- Differences in the metabolomic footprint of key metabolites using targeted LC-MS 
metabolomics.  
- Difference in the targeted metabolomic footprint which was unique to the low or high 
biofilm forming clinical isolates 
- Pathways that were reprogrammed or underwent changes in the response to serum 
using untargeted metabolomics  
- Pathway activity which was unique or specific to the either the low or high biofilm 
clinical isolates.  
 
This work has been presented at the following conferences: 
- Eurobiofilms, Amsterdam 2017 - Integration of Metabolomics and Transcriptomics in 
Biofilm Research (Poster, Recipient of a travel grant to attend from the organisers) 
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- ECCMID, Madrid 2018- De novo transcriptome assembly and annotation for analysis 
of the emerging pathogen Candida auris (Poster) 
- OMIG, Gregynog 2018- Omics approaches to studying microbial biofilms in oral 
health (Talk, Recipient of a travel grant to attend from the organisers) 
- IADR, London 2018- Omics and bioinformatics approaches to studying oral biofilms 
(Poster) 
- Eurobiofilms, Glasgow 2019 - Transcriptomic and multi-omics data integration 
approaches to interrogate mono and interkingdom species Candida biofilms (Talk) 
- Invited talk, Newcastle 2020 - OMIC modelling of Candida albicans interkingdom 
biofilm interactions (Seminar) 
 
4.3  Methods 
 
4.3.1 Biofilm Preparation  
HBF (n=3) and LBF (n=3) isolates were grown as biofilms for 4 and 24h in RPMI ± FCS, as 
described previously, in triplicate for a total of 9 biofilms per sample group.  All isolates used 
in this component of the thesis are summarised in Table 3.1 (found in section 3.3.3). 
 
Biofilms were grown as previously stated in polystyrene plates at 30ºC. 5μL of the spent media 
was added to 200μL of an ice cold solvent solution containing chloroform:methanol:water in 
a (1:3:1:v:v:v) ratio. This solution was then vortexed at maximum speed for 15sec and stored 
at -80ºC. The mixture solution was separated using Hydrophilic interaction liquid 
chromatography on SeQuant® ZIC® -pHILIC columns (Merck KGaA, Darmstadt, Germany), 
before LC-MS analysis performed on the Thermo Scientific Exactive Orbitrap system (Thermo 
Scientific, Hemel Hempstead, UK). Fresh media harvested at both 4h and 24h was used as a 
control and solvent solution was used as a blank. Thermo Xcalibur™ (version 2.2.42) was used 
for instrument control and data acquisition.  
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4.3.2 Data Acquisition and Processing 
Mass spectrometry raw data files were filtered and converted to mzXML file format using the 
msconvert component of the ProteoWizard software package (Chambers et al., 2012). 
mzXML files were submitted to the Polyomics integrated Metabolomics Pipeline (PiMP) 
(http://polyomics.mvls.gla.ac.uk/) (Gloaguen et al., 2017). In summary the integrated pipeline 
utilises the program XCMS for peak picking and MZmatch for peak matching, noise filtering 
and annotation of related peaks. Principal metabolites were identified against a panel of 
authentic pure standards (Sigma-Aldrich), that are maintained in the University of Glasgow 
Polyomics standard compound library, using accurate mass and RT (error 5%) and were 
defined as Identified based upon the Metabolite Standards Initiative. Putatively assigned 
compounds using the accurate mass and to give a predicted compound.  
 
4.3.3 Statistical Analysis 
Once peaks are identified their intensities was logged by base 2 and pairwise analysis was 
performed on group-to-group comparisons. PiMP is a web-based interface which allows for 
the uploading, hosting, processing, and analysis of metabolomics datasets. It includes 
pairwise and functional analysis parameters processed data was exported as abundance 
tables for further analysis. 
 
Tables were exported with peak Ids and the corresponding KEGG and compound identifiers, 
in addition to the identification status against the standard compounds. A total of 612 peaks 
were present within the data, of these, 49 corresponded to the known standards and the rest 
were identified putatively against the KEGG database compounds. Principal Component 
Analysis was performed on total sum scaled and log transformed peak relative abundance 
data to visualise overall variance within the data. The relative abundance for each sample was 
normalised to the relevant media controls before principal component analysis (PCA) to 
visualise variance after normalisation to the control media. Analysis of variance (ANOVA) was 
performed on the identified compounds followed by Benjamini-Hochberg false detection rate 
FDR of the p-values to account for the numerous ANOVA tests performed. Those metabolites 
which were still deemed to be significant following FDR of p-values were selected for further 
analysis and the post hoc Tukey test was performed. Tukey tests determined the significance 
between RPMI and Serum for each of the metabolites. 
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With many mass peaks being putatively assigned compounds accurate detection of all 
compounds in untargeted metabolomics is not possible. Therefore, compounds were 
analysed according to their contribution to metabolic pathways. Activity scores of the KEGG 
functional groups were calculated for each of the samples using the R package Pathway 
Activity Profiling algorithm (PAPi)(v1.12.0) (Aggio et al., 2010). ANOVA followed by Tukey post 
hoc test were performed to determine significantly changing pathways between our sample 
groups within base R. Partial Least Squares Discriminant Analysis was performed on all 
identified peaks for biomarker analysis. PLS-DA. PLS-DA is a multivariate supervised analysis 
useful in class discrimination. It is a classification approach which is also able to determine 
discriminatory markers between our groups. Important features are discernible through their 
variable importance in the projection (VIP) scores. PLS-DA was performed within the 
MetaboAnalyst (V4.0) software utility following the data being exported sample and peak 
relative abundance tables (Chong et al., 2018a). Biofilm processing data acquisition and 
analysis is summarised in Figure 4.1. 
 
 
Figure 4.1 Schematic depicting our workflow. This diagram illustrates from the wet lab stage of 
biofilm growth of biofilms and collection of supernatants to mass spectrometry and the pre-
processing by the Glasgow Polyomics in house analysis server and then final data analysis and 
interpretation through R statistical programming analysis and online analysis databases. 
 
 





4.4.1 Comparisons between media controls 
Volcano plots, scatter plot of log2 fold change (log2FC) against the negative log10 adjusted p-
value, were created for the comparison of media ± FCS after 4h and 24h incubation. A positive 
fold change indicates that the peak was observed at a higher relative abundance in the media 
± FCS. 16 different peaks were observed at the 24h time point and 20 peaks at the 4h time 
point (Figure 4.2). 8 of these metabolites were Identified within the standards and were 
higher in the media ± FCS. In RPMI + FCS compared to RPMI the identified metabolites in order 
of the significant abundance were Creatinine (p=3.8e-09), L-Glutamine (p=1.2e-07), Ornithine 
(p=0.00023), Hypoxanthine (p=1.1e-05), L-Malic acid (p=0.0022), Pantothenate (p= 0.013), 
Choline (p=0.016) and O-Acylcarnitine (p= 0.0051). 
 
 
Figure 4.2 Volcano plots depicting differentially represented metabolites in our media controls. 
Metabolite abundance was compared between the media controls RPMI and RPMI supplemented 
with FCS by LCMS. This was processed within PiMP to derive significance and log2 fold change between 
the two medias. Media that had been incubated for 4h and 24h was compared. The volcano plots 
depict the features changing between RPMI and RPMI supplemented with FCS. Comparison is 
between the media controls at 4h (A) and 24h (B). 
 
The most significantly changing metabolites after FDR are displayed with a log2 FC >2 are 
shown in Table 4.1. Most of these metabolites were involved in amino acid metabolism 





Adj. P-value > 0.05 Adj. P-value < 0.05
24/03/2021 PiMP
polyomics.mvls.gla.ac.uk/accounts/project/242/analysis/647/ 1/1
Adj. P-value > 0.05 Adj. P-value < 0.05




Table 4.1 Fold changes of FCS metabolites compared to RPMI. Metabolite abundance was compared 
between the media controls RPMI and RPMI supplemented with FCS by LCMS. This was processed 
within PiMP to derive significance and log2 fold change between the two medias. This table depicts 
those metabolites that were different between RPMI and RPMI supplemented with serum after 4 and 
24h. with a fold change greater than 1.5 indicated by light shading and dark shading of red (+ve) and 




RPMI media is comprised of sugars (glucose and glutathione), pH indicator (phenol red), 
inorganic salts (sodium chloride, sodium bicarbonate, disodium phosphate, potassium 
chloride, magnesium sulfate, and calcium nitrate), vitamins i-inositol; choline chloride; para-
aminobenzoic acid, folic acid, nicotinamide, pyridoxine hydrochloride, and thiamine 
hydrochloride; calcium pantothenate; biotin and riboflavin) and amino acids (glutamine; 
arginine; asparagine, cystine, leucine, and isoleucine; lysine hydrochloride; serine;  aspartic 
acid, glutamic acid, hydroxyproline, proline, threonine, tyrosine, and valine; each histidine, 
methionine, and phenylalanine; glycine; tryptophan; and reduced glutathione). RPMI is a 
well-defined media typically produced for cell culture and has been commonly utilised for 
Metabolite Formula logFC 4hFCS/4hRPMI logFC 24hFCS/24hRPMI Identification
Creatinine C4H7N3O 8.71 8.88 I
3-(N-Nitrosomethylamino)propionitrile C4H7N3O 8.71 8.88 A
Creatine C4H9N3O2 8.23 5.4 A
3-Guanidinopropanoate C4H9N3O2 8.23 5.4 A
L-Glutamine C5H10N2O3 5.26 5.07 I
Alanylglycine C5H10N2O3 5.26 5.07 A
3-Ureidoisobutyrate C5H10N2O3 5.26 5.07 A
D-Glutamine C5H10N2O3 5.26 5.07 A
Glutamine C5H10N2O3 5.26 5.07 A
Isoglutamine C5H10N2O3 5.26 5.07 A
Mannitol C6H14O6 4.01 1.7 A
Galactitol C6H14O6 4.01 1.7 A
D-Sorbitol C6H14O6 4.01 1.7 A
L-Iditol C6H14O6 4.01 1.7 A
L-Glucitol C6H14O6 4.01 1.7 A
D-Iditol C6H14O6 4.01 1.7 A
L-Ornithine C5H12N2O2 2.2 1.85 I
D-Ornithine C5H12N2O2 2.2 1.85 A
2,5-Diaminopentanoic acid C5H12N2O2 2.2 1.85 A
(2R,4S)-2,4-Diaminopentanoate C5H12N2O2 2.2 1.85 A
Hypoxanthine C5H4N4O 1.79 2 I
Allopurinol C5H4N4O 1.79 2 A
N-Acetylhistidine C8H11N3O3 1.72 2.01 A
HC Red No. 3 C8H11N3O3 1.72 2.01 A
N-Acetyl-L-histidine C8H11N3O3 1.72 2.01 A
(R)-Piperazine-2-carboxamide C5H11N3O -3.22 -0.06 A
(S)-Piperazine-2-carboxamide C5H11N3O -3.22 -0.06 A
4-Guanidinobutanal C5H11N3O -3.22 -0.06 A
Dimethyl sulfoxide C2H6OS -2.35 -1.45 A
Mercaptoethanol C2H6OS -2.35 -1.45 A
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culturing C. albicans. Serum or FCS however is undefined media with uncontrolled levels of 
constituents. However, it is a mixture of sugars such as glucose, hormones such as insulin, 
testosterone and progesterone, creatinine, bilirubin, proteins, salts, vitamins A/B and 
prostaglandins.  
 
4.4.2 Metabolomic profiling of Low and High Biofilm Forming Isolates 
The initial comparison exists between the low and high biofilm formers in RPMI with 
comparisons to changes that exist in those that are grown in Serum. We have previously 
identified transcriptomic changes between high and low biofilm formers. Between LBF and 
HBF grown for 24h in RPMI we identified significant changes (adjusted p-value less than 0.05) 
of 10 identified compounds and 19 annotated compounds. We identified 2 annotated 
compounds significantly changing in between HBF and LBF. Comparatively we identified 7 
identified compounds and 12 annotated peaks significantly changing at 24h between HBF and 
LBF in serum. This was much less at 4h in serum with 2 identified compounds significantly 
changing and 7 annotated peaks meeting the significance criteria. Volcano plots depicting 
these changes at each time point and media are shown in Figure 4.3. Blue dots indicate peaks 




Figure 4.3 Volcano plots showing differences between LBF and HBF at each respective timepoint in both RPMI and RPMI+FCS. Metabolite abundance was 
compared between high (HBF) and low (LBF) biofilm forming strains at 4h and 24h in both RPMI and Serum. This was processed within PiMP to derive 
significance and log2 fold change between the two strains. Significantly different metabolites between HBF and LBF are indicated with black dots. Significance 



















LBF24hRPMI / HBF24hRPMI volcano plot
Click and drag in the plot area to zoom in
Adj. P-value > 0.05 Adj. P-value < 0.05

























































































Between the LBF and HBF in RPMI, the most significantly changing metabolites in higher 
relative abundance in the low biofilm forming supernatants were L-Aspartate, L-
phenylalanine, L-glutamate, L-glutamine, L-tyrosine and Hydroxyproline 
trans-4-Hydroxy-L-proline according to the adjusted p-value <0.05. The most significant 
differences in serum according between the low and high biofilm formers were Betaine, sn-
glycero-3-Phosphocholin which were in higher relative abundance in the high biofilm forming 
strains media. L-glutamate, L-Aspartate and L-Arginine and O-Acetyl carnitine were in higher 
abundance in the media of the LBF (Figure 4.4).  
 
 
Figure 4.4 Bar chart of significantly changing identified compounds between HBF and LBF. From the 
analysis within the PiMP platform univariate comparisons between HBF and LBF was performed in for 
both Serum and RPMI independently. The log2 fold change and their significance (p<0.05) was then 
exported. Metabolite fold change between HBF and LBF grown for 24h in RPMI are coloured red and 
those grown in serum are coloured blue. Significant p-value of less than 0.05 than within each of the 
pairwise conditions HBF/LBF in their respective mediums is indicated by (*). A +ve log2 fold change 
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Through Pathway Activity Level Scoring within PiMP, it was also noted that in order the top 
five pathways significantly changing were the bacterial chemotaxis, Lysine biosynthesis, beta-
Alanine and metabolism, the Glutamatergic synapse and Nitrogen metabolism where the 
most enriched KEGG pathways in RPMI at 24h between HBF and LBF. In serum at 24h the top 
five significantly changing where, in order, sulphur metabolism, glutamatergic synapse, FoxO 
signalling pathway, bacterial chemotaxis and nitrogen metabolism. 
 
The FoxO pathway is associated the identified or annotated compounds D-glucose and L-
glutamate and was significant in serum between LBF and HBF due to the higher levels of 
glutamate in the HBF media. The FoxO pathway is a mammalian signalling pathway not 
typically found in microorganisms.  
 
Bacterial chemotaxis is a KEGG pathway which is not specific to C. albicans but is enriched by 
the identified L-aspartate. This is due to a limitation within the PiMP software and it being 
unable to filter the KEGG pathway assignment based upon species. The glutamatergic synapse 
was enriched between LBF and HBF due to the high peak abundance of L-glutamate followed 
by L-glutamine. Both were in higher abundance in the HBF strains media after 24h. Sulphur 
metabolism was enriched due to the significantly higher levels of the p-value 0.05 of O-Acetyl-
L-Serine in the LBF media and the significantly higher levels of Succinate in the HBF strains 
media. Nitrogen metabolism is similarly enriched by the L-glutamate and L-glutamine 
compounds. Many of the pathways within the pathway analysis included in the PiMP 
processing pipeline are unlikely to be representative of C. albicans. Currently the pathway 
profiling within the PiMP platform relies upon the larger, more general, KEGG database rather 
than species specific ones. As such many of the pathways are not specific to the organism 
being studied. In addition, because of the small differences in metabolite abundance between 
HBF and LBF the pathways that are overrepresented based upon small numbers of 
metabolites.  
 
PLS-DA shows the top discriminatory compounds between HBF isolate and LBF (Figure 4.5A). 
This comparison shows the direct changes of metabolome directly related to the two different 
strain types. L-phenylalanine, L-glutamate and L-tryptophan distinguish between the low and 
high biofilm formers according to the variables importance in the projection (VIP) (Figure 
Chapter 4: Metabolomic profiling of phenotypically distinct Candida albicans clinical isolates 
137 
 
4.5B, C). Additional peaks also distinguish between the two isolate types however they show 
decreasing importance in the projection and due to being putatively identified these 
compounds could be a number of different metabolites. The top discriminatory variables 






Figure 4.5 Partial Least Squares of LBF and HBF C. albicans isolates at 24h. The metabolite abundance 
values identified by the PiMP software were submitted to MetaboAnalyst for partial least squares 
analysis (PLS). PLS was performed for Identification of the most discriminatory metabolites between 
HBF and LBF. HBF (red) are distinguished here from the LBF (green) (A). Variable importance in the 
projection (VIP) scores of the top discriminatory compound peaks (B). These scores indicate how 
impactful they are at discriminating the two conditions in order of importance. There compound peaks 
were then compared to their compound or metabolite name if they could be identified. Identification 
status and Name or compound of the VIP peaks are described in a table (C). 





4313026 Annotated C6H9N3O2 /C4H6N2O2
4313227 Annotated C10H20O3
4313119 Annotated C2H4O2S
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4.4.3 Multivariate analysis of C. albicans HBF and LBF  
Principal component analysis (PCA) displayed good separation of the different groups 
between our two medias and time points (Figure 4.6A). However, little separation was 
observable between our two different strain phenotypes (i.e., HBF and LBF). Samples also 
clustered together in groups of media and time. We have previously shown that there are 
strong phenotypic differences and previously identified metabolomic profile within the 
transcriptome (Rajendran et al., 2016a). Within our study design of samples strain to strain 
variation did not account for much of the total variation observed as shown with the PCA. For 
example, the samples grown for 24h in RPMI formed a distinct cluster. Data was normalised 
to media controls, by dividing the metabolite abundance by of the sample by the metabolite 
abundance within the media only controls, the values became log relative compared to the 
media control. This alleviated the high skew within the data and removed some of the 
heteroscedastic within the data (Figure 4.6B). It also improves the interpretability when 
comparing the footprint of the organisms between two different medias. As some values will 
be positive, indicating that they are added or secreted to the media by the cells, or the values 
would become negative indicating that they had been taken away from the media or spent. 
PCA projection of the normalised data again showed separation of the data by time and by 
media. Similarly, to the non-media normalised data our samples seemed to group and cluster 
according to their incubation times and media. One outlier was also removed from the data 
according to a cut of 50% or more missing features for further analysis. Other failures prior to 
processing within PiMP, due to failures during mass spectrometry and/or data acquisition 
meant that only two sample groups had a total of 9 replicates. However, the lowest number 
of replicates per sample was 6 during PiMP processing and this was deemed adequate. 
Samples also showed clear reproducibility within their metabolomic profiles (Figure 4.6). All 






Figure 4.6 Principal component analysis (PCA) of metabolomics secretome/metabolic footprint analysis of C. albicans high and low biofilms in the presence 
or absence of serum at 4h or 24h. All untargeted metabolites were included in the principal component for all samples (A). The highest variability within the 
sample set is shown on PC1 (60.03%) with the second highest shown on PC2 (18%) (A). PCA of the same metabolomics data normalised to the growth media 
controls with the largest variation between the media corrected samples PC1 (29.39%) and the second largest variation on component 2 (21.49%) (B). 















4.4.4 Profiling of targeted metabolites in isolates grown in serum vs RPMI 
Within the different samples a total 49 compounds matched to a known standard from the 
Polyomics standards collection. Many metabolites within the standard compound library 
were not observed. These may be due to metabolites being below the detection limit of the 
machinery. More plausibly it could be due to the limitations of doing metabolic foot printing 
or extracellular metabolomics. Many intermediate metabolites within the metabolic 
networks of C. albicans may not have been externalised during growth and biofilm formation. 
However, this limitation is consistent throughout our testing and therefore comparison of the 
metabolic footprint left between our different sample groups still allows comparison and 
inference of the metabolic pathways being differentially regulated between our samples. Of 
the 49 metabolites that were identified, 38 were found to be in significantly different 
abundance between our groups. Of these, 21 had a difference in abundance between the 
sample groups according to ANOVA following correction for multiple tests with an FDR p-
value. Identified metabolites were grouped into super pathways according to their KEGG 
designation for visualisation. Although, many of the metabolites appear in several different 
KEGG database pathways. The 49 compounds relative fold change compared the media is 
summarised in Figure 4.7. Additionally, their super pathway grouping is also shown. Due to 
the data being a log2 fold change relative to the media control an increase or positive fold 
change indicates an increase in the media (the metabolite is secreted or released) and the 
larger the negative value indicates that the metabolite is spent relative to the negative 
control. ANOVA was performed for each of the metabolites, and they were considered 
significant after these values were corrected if the FDR p-value ≤ 0.05. Significant differences 
between RPMI and FCS grown strains was determined using the Tukey’s honestly significant 












Figure 4.7 Grid or heat plot of the relative abundance compared to the media control of the targeted 
or identified metabolites. Positive log2 values infer secretion of metabolites to the media and 
negative values infer that metabolites have been spent from the media. Values are log2 metabolites 
relative abundance which have been divided by the control values. The values have also been grouped 
into their super-pathway metabolic groups according to their KEGG classification. These values are 












Sample Name (Biofilm Condi:on)
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4.4.5 Identified amino acid metabolism 
Many of the identified metabolites are amino acids (24 identified metabolites), and of these 
11 were found to be in significantly greater abundance between RPMI and RPMI+FCS as 
determined by Tukey HSD <0.05 (Figures 4.8-4.9). Betaine is a metabolite in C. albicans that 
is found in the threonine, serine and cysteine metabolic pathways. Betaine was observed to 
be spent in FCS compared to RPMI in our LBF strain at 24h (p <0.0001). A difference in 
abundance is observable between FCS and RPMI in the HBF strain at 24h, with the FCS media 
showing less betaine secreted. However, this was not found to be significant. L-glutamine is 
a metabolite found in C. albicans in the arginine, purine and pyrimidine metabolism, as well 
as several other different metabolic pathways. It was observed to be excreted at a lower level 
in the 4h time points for both LBF and HBF in FCS and spent in comparison to excreted at 24h. 




Figure 4.8 Identified metabolites between RPMI and 
Serum in C. albicans isolates. Bar charts depicting the 
significantly different amino acid related metabolites 
selected by Analysis of Variance (ANOVA) followed by 
adjusting the p-value using Benjamini-Hochberg FDR. 
Identification of significant changes was performed 
using the Tukey HSD. Values are log2 peak area 
compared to media control with positive values 
indicating secretion and negative values indicating that 
the metabolite was spent compared to media control. 
For each plot significance is indicated according by the 
Tukey derived p-value where there is a significant 
difference between the log2 relative area in RPMI vs 
Serum in either HBF or LBF and at either 4 or 24h. 
Significance is indicated between the four comparisons 
as ns, p<0.05*,p<0.01**,p<0.001*** or p<0.0001****. 
Amino Acid






Figure 4.9 Identified 
metabolites between RPMI 
and Serum in C. albicans 
isolates. Bar charts depicting 
the significantly different 
amino acid and nucleotide 
related metabolites selected 
by Analysis of Variance 
(ANOVA) followed by adjusting 
the p-value using Benjamini-
Hochberg FDR. Identification 
of significant changes was 
performed using the Tukey 
HSD. Values are log2 peak area 
compared to media control 
with positive values indicating 
secretion and negative values 
indicating that the metabolite 
was spent compared to media 
control. For each plot 
significance is indicated 
according by the Tukey 
derived p-value where there is 
a significant difference 
between the log2 relative area 
in RPMI vs Serum in either HBF 
or LBF and at either 4 or 24h. 
Significance is indicated 
between the four comparisons 
as ns, p<0.05*, p<0.01**, 




L-isoleucine was found to be spent to a higher degree in FCS at all time points and in both 
strains. It was found to be significant between serum and RPMI at 4h in LBF(p=2.87e-07), 24h 
LBF (p=3.33e-05), 4h HBF (p=9.62e-05) and 24h HBF (p=0.000211). 
 
This same pattern was also observed in the L-leucine metabolite. L-leucine and L-isoleucine 
are metabolites involved in the valine, leucine and isoleucine degradation pathways, as well 
as the aminoacyl-tRNA biosynthesis pathway amongst others. 
 
L-tryptophan was spent to a higher degree in the FCS compared to RPMI at 24h in both strains, 
however, this was found to be significant in the HBF strain only (p=3.07e-05). Creatinine was 
spent in the RPMI media at 4h and was secreted in the FCS media in both strains and found 
to be significant in both strains at 4h (LBF p=3.60e-09, HBF p=1.08e-10). Tryptophan is found 
in the tryptophan metabolic pathway and in the phenylamine, tyrosine and tryptophan 
metabolic pathways in C. albicans. It is also found in the amino-acyl-tRNA biosynthesis 
pathway in addition to many other pathways. Amino acid data is shown as a bar chart with 
significance shown in Figure 4.8. Creatinine is additionally found as an intermediate of the 
arginine and proline metabolic pathways in C. albicans. L-arginine was found to be spent in 
all sample cultures however this was more so in the case of FCS at 24h. L-arginine was 
significantly more spent or utilised in the FCS media compared to the RPMI at 24h (LBF p= 
0.000956, HBF p=4.24e-08). Both L-alanine (LBF p=1.88e-08, HBF p=7.21e-09) and beta-
alanine were found to be more highly secreted in the media at 4h in the FCS media however 
there was found to be no significant differences at 24h. A similar pattern was observed in 5-
oxyproline with significantly higher level of metabolite being found to be secreted in the FCS 
media at 4h (LBF p=4.37e-13, HBF p=4.37e-13) and 24h (LBF p=4.37e-13, HBF p=4.37e-13) 
compared to RPMI. L-arginine is involved in the arginine and proline metabolic pathway as 
well as the aminoacyl-tRNA biosynthesis pathway. L-alanine and beta alanine found in the 
alanine, aspartate and glutamate metabolic pathways in addition to many others including 
amino-acyl-tRNA biosynthesis and cysteine and methionine metabolism. O-acetyl-carnitine 
was absent in the media controls for RPMI and was not present in any of the RPMI samples. 
It was found to be secreted to a small degree at 4h in FCS in both strains and then spent to a 
significant level at 24h (LBF p=4.13e-05, HBF p=2.90e-07). It is involved in the degradation of 
fatty acids and fatty acid metabolism, and specifically facilitates the movement of acetyl-CoA.  
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Other amino acid metabolism is shown as bar charts with significance between RPMI and 
Serum indicated in Figure 4.9. 
 
4.4.6 Identified Nucleotide metabolism  
Of the metabolites identified under the super pathway of nucleotide metabolism changes in 
level of metabolite were observed compared to the media control in the FCS media however 
no secretion or uptake was observed in the RPMI only (Figure 4.9). Hypoxanthine, a 
component of purine metabolism in C. albicans, was found to be significantly spent in the FCS 
media at 24h (LBF p=8.05e-10, HBF p=3.05e-06), whereas there was no change in level 
compared to media control in the RPMI in either strain or time point. This metabolite was 
also found to be completely absent in the RPMI media but was found in the FCS media control. 
Cytidine was similarly absent in the RPMI controls whereas it was present in the FCS media 
control. Cytidine a component of pyrimidine metabolism was secreted to a significant level 
compared to media control and compared to RPMI at both 4h and 24h and in both strains 
(p=4.37e-13). The same trend and level of significance was found of alantoin in FCS compared 
to RPMI. Allantoin was also found to be completely absent in the media control. Allantoin is 
a by-product of nucleic acid and ureic acid decomposition involved in the KEGG purine 
metabolism pathway.  
 
4.4.7 Carbohydrates 
Only 2 compounds classified as part of the carbohydrate super pathway designation within 
the KEGG database were found to be significant these were citrate and cis-aconitate when 
comparing supernatant of C. albicans grown in FCS to RPMI (Figure 4.10). Citrate was highly 
secreted in the 4h FCS media by C. albicans whereas it was spent in the RPMI. However, the 
relative concentrations of citrate in the media controls were relatively low to begin with. This 
difference was found to be significant in both strains (LBF p=0.00242, HBF p=4.38e-05) 
However, there were no differences found between media at 24h. cis-aconitate was also 
found to be much more excreted by C. albicans at 4h in the FCS compared to the RPMI (LBF 
p=5.12e-10, HBF p=6.50e-09) this was true for both strains however this was not found to be 
true at 24h.  
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4.4.8 Identified lipid and fatty acids 
Of the identified metabolites, 1 fatty acid and 3 lipid super-pathway related metabolites were 
found to be differentially excreted or spent within our media between our two strains and 
our two growth medias at 4 or 24h (Figure 4.10). L-carnitine a facilitator of fatty acid 
metabolism and specifically the transport of acyl-CoA following β-oxidation. Its level of 
regulation in FCS being almost identical to O-acylcarnitine. It was found to be significantly 
different than RPMI in both strains at 24h (LBF p=0.00375, HBF p=6.88e-05) with it being 
spent in the FCS compared to the RPMI. It was however secreted to a low level in the FCS and 
in the RPMI at both time points. There was no change from the media control in the HBF 
grown in the RPMI media. Taurine is found within the taurine and hypo taurine metabolic 
pathways in C. albicans. It was found to be excreted significantly more in FCS (p=4.37e-13) 
compared to RPMI where it was absent. The level of expression was visibly greater at 4h than 
24h (Figure 4.10). sn-glycero-3-phosphocholine a metabolite of the glycerophospholipid 
metabolic pathway was found to be significant when comparing FCS to RPMI at all time points 
and in both strains. It is excreted significantly more after 4h (LBF p=0.000189, HBF p=0.00981) 
of incubation in RPMI and was spent to significant degree at 24h (LBF p=0.0139, HBF 
p=0.0115) in contrast to secreted in FCS. Choline is a precursor in phospholipid biosynthesis 
in C. albicans. Choline was found to be spent in the media by C. albicans in all sample groups 
compared to the media control, however, this was to a significantly greater degree in the 




Figure 4.10 Identified metabolites between 
RPMI and Serum in C. albicans isolates. Bar 
charts depicting the significantly different 
carbohydrate, fatty acid and lipid related 
metabolites selected by Analysis of Variance 
(ANOVA) followed by adjusting the p-value using 
Benjamini-Hochberg FDR. Identification of 
significant changes was performed using the 
Tukey HSD. Values are log2 peak area compared 
to media control with positive values indicating 
secretion and negative values indicating that the 
metabolite was spent compared to media 
control. For each plot significance is indicated 
according by the Tukey derived p-value where 
there is a significant difference between the log2 
relative area in RPMI vs Serum in either HBF or 
LBF and at either 4 or 24h. Significance is 
indicated between the four comparisons as ns, 






4.4.9 Pathway activity profiling of C. albicans metabolic footprint 
Pathway activity profiling was applied to our datasets. The activity of C. albicans pathways 
was predicted from their extracellular abundance data. This data comprised all peaks, both 
annotated and identified from our targeted/untargeted metabolomics analysis. Pathway 
activity profiling is dependent upon KEGG identifiers due to the database being used was 
constructed from KEGG API. Pathways were filtered to include only those in the C. albicans 
KEGG database. This avoids misleading results caused by identification of enriched pathways 
that are not likely or implausible. Peak IDs were matched to KEGG identifiers and a matrix of 
samples/IDS against log2 media normalised peak abundances was utilised for PAPi analysis. 
Using the values relative to media is recommended for metabolic footprint or extracellular 
metabolomics by the authors of this methodology. It improves interpretability especially 
considering that our comparisons are between the metabolomic profiles of two separate 
medias. It allows for activity to be identified as either secretion or utilisation (spent) of 
metabolites within a pathway. 
 
An activity score with a positive value would indicate that this pathway activity is due to 
secreted metabolites to the media, and a negative score corresponds to a pathway activity 
relating to uptake of metabolites from the media or spent metabolites. Pathways that were 
different between any of sample groups are shown in as a grid plot (Figure 4.11). These 
pathways were filtered on a database of known pathways that can possibly occur in C. 
albicans KEGG specific pathways. This was a custom filter added to the analysis to further 
improve interpretability. As shown with the PiMP based enrichment metabolites are assigned 
to all possible KEGG pathways as opposed to those that are possible for that organism. 
Pathways that are theoretically possible from the KEGG database were further screened to 
identify those that were specifically different in FCS compared to RPMI. ANOVA was 
performed to identify significantly activate pathways within our entire sample group. 
Significantly changing pathways with a corrected p-value of ≤0.05 according to ANOVA are 
shown Figure 4.11. These pathways were then further filtered to identify those that 
specifically changed between RPMI and Serum. Pathways were found to both be significantly 
different between our sample groups and significantly different between our two media 
groups. This was ascertained with the Tukey’s HSD ≤0.05 (Figure 4.12-4.13).  
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Bar plots were drawn to illustrate the differences in pathway activation and their significance 
for the top 16 significantly changing pathways that were significant between FCS and RPMI in 
either HBF or LBF (Figure 4.12-4.13). The analysis methodology for first identifying significant 
terms by ANOVA and then identifying specifically those that differ between FCS and RPMI by 
Tukey HSD was similar to the identification of significantly changing targeted metabolites as 
outlined earlier in section 4.4.4. 
 
Figure 4.11 . Grid plot of the level of pathway activation according to Pathway Activity Profiling 
(PAPi).  Summary of activity by relative square root transformed activity score. The grid plot contains 
pathways found to be significant between any of our sample groups by ANOVA followed by Benjamini-
Hochberg FDR. Positive values indicate that the pathways activated where through secretion of 
metabolites and negative values indicate that pathways were activated through acquisition or 
utilisation of metabolites. The grid plot gives a summary overview of the differentially activated 




Figure 4.12 Top 8 activated 
pathways according to PAPi. Bar 
charts depicting the first 8 top 
significantly activated pathways 
according to PAPi followed 
selected by Analysis of Variance 
(ANOVA) followed by adjusting 
the p-value using Benjamini-
Hochberg FDR. Identification of 
significant changes was 
performed using the Tukey HSD. 
Values are the activity score 
assigned by PAPi metabolomic 
pathway analysis algorithm 
against the KEGG database. 
Activity scores are either +ve 
indicating metabolites within 
that pathway were secreted to 
the extracellular media or -ve 
indicating they were spent from 
the extracellular media. For each 
plot significance is indicated 
according by the Tukey derived p-
value where there is a significant 
difference between the activity 
score in RPMI vs Serum in either 
HBF or LBF and at either 4 or 24h. 
Significance is indicated between 
the four comparisons as ns, 
p<0.05*, p<0.01**, p<0.001*** 
or p<0.0001****. 
 





Figure 4.13 Second top 4 activated pathways according to PAPi. Bar charts depicting the second top 4 significantly activated pathways according to PAPi 
followed selected by Analysis of Variance (ANOVA) followed by adjusting the p-value using Benjamini-Hochberg FDR. Identification of significant changes was 
performed using the Tukey HSD. Values are the activity score assigned by PAPi metabolomic pathway analysis algorithm against the KEGG database. Activity 
scores are either +ve indicating metabolites within that pathway were secreted to the extracellular media or -ve indicating they were spent from the 
extracellular media. For each plot significance is indicated according by the Tukey derived p-value where there is a significant difference between the activity 
score in RPMI vs Serum in either HBF or LBF and at either 4 or 24h. Significance is indicated between the four comparisons as ns, p<0.05*, p<0.01**, 





Arachidonic metabolism was the most significantly regulated pathway due to a high 
abundance of metabolite secreted to the media by our isolates grown in the presence of FCS, 
and no activity of the metabolites related to this pathway in our isolates grown in the 
presence of RPMI only. It was found to be significant at both time points in both strains 
(p=4.37e-13). There is a visibly high activity at 4h with a reduction in activity at 24h in FCS 
compared to RPMI (Figure 4.12). This would seem to indicate a production and then utilisation 
of the metabolite involved in this pathway. However, arachidonic acid is not produced by C. 
albicans so is likely cleaving arachidonic acid from phospholipids found within the FCS. This 
may explain the lack of arachidonic in the RPMI controls. This is confirmed by looking at the 
relative peak abundance data for the arachidonic acid identified peak. There is a high 
abundance of this metabolite in our FCS supplemented C. albicans strain media, but no 
abundance in our RPMI only media C. albicans strain media.  
 
Biosynthesis of unsaturated fatty acids had a much higher positive activity score in both of 
our isolates grown in FCS which was significant at both 4 and 24h time points (p=4.37e-13). 
More pathway intermediates were present in the media than in the RPMI. This was true for 
both time points with slightly more activation of this pathway at 4h in the FCS. This difference 
was significant at both 4 and 24h and in both strains between RPMI and FCS. Biotin 
metabolism was shown to have a similar trend in all conditions with the metabolites secreted 
at 4h (LBF p=4.37e-13, HBF p=4.37e-13) and then either less secreted in FCS or spent in the 
case of RPMI at 24h (LBF p=3.97e-06, HBF p=1.11e-08). The difference was significant at all 
time points and both strains between FCS. Fatty acid biosynthesis is an integral process 
involved in the process of producing fatty acids for energy storage, constituents of the cell 
and protein modification. Biotin is required in C. albicans for growth and fatty acid 
metabolism.  
 
Glycerolipid metabolism had a higher positive activity score in all FCS samples compared to 
RPMI which was deemed to be significant at all time points (p=4.37e-13). A positive activity 
score (AS) is indicative of metabolites from this pathway being secreted into the media by C. 
albicans. The same trend was apparent in the pyruvate metabolism, which was shown to have 
a higher AS, and therefore higher abundance of pathway metabolites in the extracellular 
media in FCS compared to RPMI. This was found to be true in both strains and in both time 
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points. However, this difference was less pronounced at 24h with the AS being higher in RPMI 
at 24h compared to 4h. Pyruvate metabolism is pivotal metabolic pathway in yeast. Pyruvate 
is a ketone that is a junction in metabolism produced from glycolysis and can be converted to 
carbohydrates or utilised in the production of fatty acids. Glycerophospholipid was shown to 
have a difference in uptake activity in both our strains in RPMI compared to FCS in both strains 
at 4h (LBF p=0.000973, HBF p=0.00302) and 24h (LBF p=4.37e-13, HBF p=4.37e-13). 
Propanoate pathway activity showed a similar pattern in both strains at all time points 
however was significantly different between FCS and RPMI. 
 
Atrazine degradation pathway activity was significantly more positive in the FCS media at 4h 
(LBF p=4.39e-13, HBF p=4.37-13) and 24h (LBF p=3.44e-06, HBF p=4.28e-07) in both strains. 
This is indicative of a higher level of pathway metabolite intermediates present in the media 
point. This difference was found to be significant in both strains in FCS compared to RPMI. A 
very similar pattern of activity and significance was observed for pyruvate at 4h and 24h with 
p=4.37e-13. 
 
Glycerine serine and threonine metabolism showed fluctuation in activity between our 
groups. With it being significantly more excreted at 4h (LBF p=9.76e-06, HBF p=2.88e-06) and 
significantly less spent at 24h (LBF p=9.07e-11, HBF p=5.51e-10) in the FCS media. 
 
Lysine degradation was significantly activated at 4h (LBF p=0.656, HBF p=0.00162) in HBF but 
not LBF. Both medias showed positive activity however this was more positive in the HBF in 
FCS. At 24h the pathway was found to be negatively activated with the pathway metabolites 
being spent except for in the case of HBF grown in FCS which had a positive activity score. The 
level of activity was significantly different between RPMI and FCS in both strains at 24h (LBF 
p=0.00363, HBF p=4.30-08).  
 
In general, as indicated by our PCA analysis the level of pathway activity and metabolite 
regulation was found to be consistent between our two strains. Some differences were 
observed such as alanine, aspartate and glutamate metabolism specifically between the 
strains grown in FCS and lysine biosynthesis. Fluctuations in many important metabolic 
pathways were observed to be distinguished in the C. albicans in the FCS supplemented media 
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compared to RPMI alone. The most significant feature was the arachidonic acid, but this may 
be due to identification of high levels of metabolite in the FCS and complete absence in the 
RPMI despite its low representation of metabolites. However relatively high levels of 
arachidonic acid were observed in the peak abundance data in the samples grown in FCS 
(Figure 4.13).  Arachidonic acid pathway enrichment is however only enriched by arachidonic 
acid. As noted earlier arachidonic acid is not produced by Candida but could be cleaved from 
phospholipids by phospholipases. Candida utilises host derived phospholipids, which may be 
present in serum, to derive arachidonic acid. This in turn can be used as a carbon source and 
production of eicanosoids (Mishra et al., 2014, Ells et al., 2008).  
 
Figure 4.14 Bar chart comparing the relative abundance of arachidonic acid. Relative abundance of 
Arachidonic acid as discerned by the PiMP processing pipeline. Metabolites are representative of 
levels detected in the spent media of high and low biofilm C. albicans isolates in the grown in presence 
or absence of FCS and at 4h and 24h incubation times. Relative abundance with standard deviation is 
plotted for each sample group noted as isolate type, followed by the time the biofilm was grown for 





























































































This research aimed to apply the widely targeted/untargeted pHILIC/LCMS to interrogate the 
metabolomic footprint of C. albicans clinical isolates in the presence and absence of foetal 
calf/bovine serum (FCS). The clinical strains were categorised as either HBF or LBF, as 
previously described in Scottish Candidemia studies performed by Rajendran et al (2012) at 
the Glasgow Dental Hospital (Rajendran et al., 2016d). We aimed to compare the metabolic 
footprint of these high and low biofilm forming isolates in response to serum which is a known 
agitator of hyphal switching and morphogenesis in C. albicans (Villa et al., 2020). Hyphal 
morphogenesis is a feature of C. albicans heavily associated with biofilm phenotype. 
Additionally, we wished to contrast the difference in the impact of FCS on the LBF compared 
to HBF. From in vitro observations, highlighted previously in chapter 3, the biofilm inducing 
effects are more pronounced in the biofilm deficient or low biofilm forming strains. 
 
We use the term metabolic footprinting to distinguish it from metabolic fingerprinting, which 
is the measure of intracellular metabolite levels. Metabolic footprinting within  the research 
performed here is the measure of levels in the supernatant or spent media of the organism 
(Kell et al., 2005). Fluxes in the metabolic activity of the cell is reflected within the spent media 
through extracellular changes in secreted and spent metabolites. Metabolomic footprinting 
was chosen due to the nature of the work looking at the metabolism of components of the 
two medias. The initial aimed wished to look at the specific components of the serum media 
which were utilised by the C. albicans biofilms. Metabolic footprinting offers a simple 
procedure for extraction of metabolites and inference of the phenotype of microorganisms. 
However, it is less informative in comparison to some other metabolomics methodologies. 
Metabolomic footprinting provides a proxy for interpretation of intracellular activity, 
however, it is only a proximally, and the method could be improved with the integration of 
the intracellular metabolome or the fingerprint and even further improved with the use of 
metabolic flux by stable isotope labelling (Han et al., 2019b). Intracellular metabolomics is 
more commonplace and in combination with footprinting may have served to fill in gaps. This 
combined intracellular/extracellular profiling approach has been performed previously in 
2016 by Weidt et al in Candida biofilms (Weidt et al., 2016). Analytes that are not externalised 
during growth would not be detectable, and therefore a combination approach would offer 
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greater insight and may explain incompleteness of metabolic pathways. Metabolic flux 
analysis would also offer improved resolution through characterisation of reaction rates of 
enzymes within the biofilms (Sauer, 2006). Commonly 13C labelled carbon atoms are utilised 
to detect rates and fluxes of networks through tracking the abundance of these carbons 
through the metabolic pathways. This method would allow you to track rates of metabolic 
networks between the two strains or between two growth medias. Metabolic flux such as 
that using 13C labelled carbon has been demonstrated within C. albicans to identify metabolic 
activity specific to hyphal formation (Han et al., 2019b). 
 
The footprint often referred to as the exometabolomic does provide a high level of 
information of microbial activities specifically under different culture conditions in 
comparison to other more limited fluorometric assays. Within our research it has proven 
sufficient to distinguish differences in the metabolome under two specific culture conditions 
(Sue et al., 2011). We used 3 different high and 3 different LBF strains and 3 technical 
replicates which showed a great deal of overlap and reproducibility in their metabolic profiles. 
This was confirmed by our PCA analysis which showed that our metabolic footprints were 
reproducible for our 3 strains. Interestingly there was also the two phenotypically different 
strains were similar in their metabolic profiles. The samples were distinguishable by their time 
point of collection and by the media they were grown in. Initial observations would seem to 
imply that exposure to serum alters the metabolome of C. albicans, however, this is consistent 
from strain to strain. Despite failure of a few technical replicates within the mass 
spectrometry run we retained enough samples adequate for drawing conclusions from our 
data. Fragmentation data would have likely improved the interpretability of our untargeted 
analysis. Fragmentation data or ms/ms spectrum data would have allowed resolution of some 
of analytes which are ambiguous within our untargeted data (Pitt, 2009). 
 
When comparing LBF to HBF in comparison with the previous studies, we have performed 
within the group. L-phenylalanine, L-glutamate, L-trptophan were identified as key 
differentiators of HBF compared to LBF. We previously identified that AAT1 was at the centre 
of network of genes linked to amino acid metabolism (Rajendran et al., 2016a). Specifically, 
phenylamine, tyrosine and tryptophan metabolism and alanine, aspartate, and glutamate 
metabolism.  It is known that amino acid uptake such as l-phenylamine has a functional role 
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in germ tube formation (Kaur and Mishra, 1991). With uptake of L-phenylamine being much 
greater in full hyphae compared to non-hyphal cells in these early studies. Amino acid uptake 
is related to the pH regulation in C. albicans, pH in turn is a regulator of dimorphism in C. 
albicans. L-glutamate is a preferred nitrogen source for yeast followed by less preferable 
amino acids such as L-tryptophan, however both were found to be distinguishing features 
between LBF and HBF (Kraidlova et al., 2016).  These amino acids were in higher concentration 
in the LBF indicating that they are not being utilised to the same degree as HBF. 
 
This data perhaps helps to inform and confirm our earlier observations in 2016 that amino 
acid metabolic processes are important in biofilm formation (Rajendran et al., 2016a). 
Additionally, these processes are seemingly activated in HBF to a greater extent than LBF. PLS 
was able to identify these key differentiators between the high and low biofilm formers with 
many of the differentiating features between HBF and LBF being involved in amino acid and 
carbon metabolism. Identification of changes between HBF and LBF was based upon targeted 
metabolomics which could influence the analysis towards amino acid metabolism due to the 
standards used. From the metabolic footprint data, it was possible to determine that there 
are differences in the metabolism between HBF and LBF. However, it is difficult to draw 
conclusions about how these metabolites are being utilised by the cells. Fingerprinting and/or 
confirmatory experimentation would be needed to discern a greater understanding of amino 
acid metabolism in these phenotypically different isolates. 
 
Targeted analysis based upon known standard with accurate mass and retention time 
successfully identified 49 compounds within our samples.  Additionally, we identified 691 
putatively assigned metabolites using only mass and no standards which were then annotated 
with corresponding KEGG IDs. We performed a direct statistical comparison between our 
groups on the identified metabolites, this was possible due to our increased confidence in the 
identity of these metabolites. Annotated metabolites due to their more spurious nature were 
considered and visualised as contributors to entire metabolic pathways in enrichment type 
analysis. PAPI analysis was employed as this methodology is well suited to metabolic foot 
printing due of its ability to visualise both secreted and spent pathways activities. Pathway 
analysis software’s such as PAPi are dependent upon a priori knowledge maintained in 
databases such as the KEGG databases. R packages such as PAPi and other GUI based software 
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can access these databases through their APIs. By subtracting the observed analyte values 
from the media before undertaking PAPi allowing for activity scores to be calculated as 
positive or negative relative to the media. This allows not only for a determination of activity 
relevant to other samples but also to see the overall direction of the activity, whether that be 
an increase in secretion or uptake of metabolites. This feature of PAPi for metabolic 
footprinting added an extra layer of interpretability to the pathway findings. 
 
Our targeted analysis using the identified metabolites revealed numerous changes within our 
list of standard compounds between the FCS supplemented C. albicans. Significant changes 
in amino acids were observed, with the majority of significant metabolites belonging to this 
family, which in part is due to the larger representation of amino acids within the standards 
used. Those spent over time by C. albicans in FCS included betaine, L-glutamine, L-asparagine, 
L-isoleucine and L-leucine. Those spent more in the FCS un-supplemented included L-
tryptophan and creatinine. 
 
Amino acid sensing and uptake in C. albicans is a known inducer of hyphal morphogenesis. 
The amino acid sensor ssy1p (csy1p) is nutritional response sensor that activates the amino 
acid permease AAP genes (Klasson et al., 1999). AAP genes are responsible for transcription 
of amino acid permease, a superfamily of proteins responsible for transport of amino across 
the plasma membrane (Martínez and Ljungdahl, 2005). The regulation of these genes has 
been previously demonstrated to be dependent upon sensing through the ssy1p. The SPS 
plasma membrane sensor, comprised of the subunits Ssy1, Pr32 and Ssy5, activated in fungi 
upon sensing of extracellular amino acids results in proteolytic cleavage of the transcription 
Stp2 inducing genes responsible for amino acid metabolism (Böttcher et al., 2020). This 
mechanism in C. albicans is associated with virulence, triggering of yeast to hyphae 
morphogenesis and biofilm formation (Miramón and Lorenz, 2016, Ramachandra et al., 
2014). Several amino acids were differentially changing in FCS in both our low and high biofilm 
formers including l-arginine, l-alanine, beta-alanine, s-oxyproline and l-carnitine. These amino 
acids are related to several KEGG pathways within C. albicans. Amino acids are thought to 
trigger signalling pathways in C. albicans either directly or in directly such as Arginine in the 
activation of SPS plasma sensor and or indirectly through their biosynthesis leading to 
alkalinisation (Garbe and Vylkova, 2019). Amino acid pathways including cyanamino acid 
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metabolism, glycine, serine and threonine, and others are activated differentially between 
FCS compared to RPMI. 
 
From the identified metabolites related to nucleotide metabolism many failed to be identified 
in any of the RPMI samples. Serum contained higher levels of hypoxyxanthine, which were 
spent at 24h. Citidine was found to be excreted in the FCS media. Hypoxyxanthine is a purine 
base related compound, transported by C. albicans by the Fcy21p adenine-guanine-
hypoxanthine-cytosine permease (Pantazopoulou and Diallinas, 2007). C. albicans can utilise 
purines as a nitrogen source. The Fcy21p expression is thought to be linked to nitrogen 
starvation as demonstrated by Goudela et al (Goudela and Tsilivi, 2006). Citrate from the 
super pathway of carbohydrate was secreted more by the C. albicans grown in serum at 4h 
at which point the C. albicans strains in RPMI had spent this metabolite. Higher levels of the 
metabolites citrate and aconitate indicate higher level of TCA at the 4h time point in C. 
albicans. However, citrate to cis-aconitate is a reversible reaction so directionality is not 
deducible from these identified metabolites. The TCA cycle was shown to be more active at 
the earlier biofilm time points in the FCS than RPMI from the PAPi analysis. Mature biofilm 
formation is linked to the essential activation of both the amino acid and TCA metabolic 
pathways (Tao et al., 2017). Pyruvate was activated to a higher degree in C. albicans 
metabolism through the putative analyte secretion lactate and malate. 
 
Biosynthesis of unsaturated fatty acids and the related propanoate metabolic pathway were 
highly activated in FCS compared to RPMI putatively assigned compounds arachidonic acid, 
docosahexadonic acid, oleic acid and steraic acid. Arachidonic acid and oleic acid play an 
important role in the synthesis of prostaglandins. Arachidonic acid is a precursor for the 
production of Prostaglandin E2 (PGE2) (Mishra et al., 2014). Production of prostaglandins by 
C. albicans has been shown to modulate hyphal formation and control the host inflammatory 
response (Noverr and Huffnagle, 2004). Arachidonic acid was visualised noted as it was found 
to be a very serum specific metabolite, having no activity within the RPMI only or serum 
deficient cultures. Future work will need to consider in vitro experimentation to determine 
the quantity and related enzymatic activity within a larger population of strains to determine 
the relationship between biofilm formation and hyphal morphogenesis in C. albicans. 
Arachidonic acid was noted as it was found to be a very serum specific metabolite having no 
Chapter 4: Metabolomic profiling of phenotypically distinct Candida albicans clinical isolates 
161 
 
activity within the RPMI only or serum deficient cultures. Arachidonic is typically reported as 
being an exogenous metabolite utilised by fungal species in the production of prostaglandins 
(Mishra et al., 2014, Liu et al., 2016). As we have indicated C. albicans does not produce 
arachidonic acid and is likely deriving this from phospholipids within the FCS. These 
phospholipid biproducts could be the nutritional and biosynthesis requirements for LBF 
biofilm development. This is interesting as these are host derived metabolites. 
 
Glycerolipid intermediates were secreted in the FCS and the glycerophospholipids were more 
spent in the RPMI. These pathways were putatively annotated by their intermediate’s 
glycerol, Glycerone, D-glycerate and D-glyceraldehyde. Glycerophospholipids are synthesised 
from products of fatty acid synthesis for production membrane glycerophospholipids in yeast 
(Klug and Daum, 2014). 
 
Within this chapter we have identified key metabolites that differentiated between HBF and 
LBF which confers some of the findings of our previous work. We have also identified 
interesting links in amino acid, fatty acid metabolic and prostaglandin producing pathways. 
Many of which are previously linked to hyphal and biofilm formation within the literature. 
Again, it is interesting to note that our LBF strains mirror the HBF strains in their metabolism 
under the influence of FCS. Many similarities exist between the two strains in response to 
serum, however, there are instances in which LBF vary in their metabolic profile in comparison 
to HBF.  
 
In conclusion, metabolic foot printing identified several pathways and identified metabolites 
changing in serum and RPMI. This goes to show the metabolic flexibility and plasticity 
undertaken by C. albicans in response to nutrient and environmental stress. More focused 
approaches to see the activation of specific pathways as discussed using metabolic flux 
analysis and removal of ambiguity of ms/ms would improve this study design. Within the 
current study putatively assigned metabolites are responsible for the enrichment of 
numerous pathways. However unlike in transcriptome-based studies, which also use 
enrichment, these metabolites are also identified from the same peaks as other metabolites. 
Pathway analysis, however, serves our interpretation well as we can hypothesis pathways 
that are being reprogrammed in FCS by our strains. What we observed from our 
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transcriptome data in chapter 4 was that there were numerous differences in up and 
downregulated differences in pathways in ± FCS. From our multivariate analysis, individual 
analysis of identified metabolites and through analysis of differentially activated pathways 
we observed that there were fewer differences between HBF and LBF in response to serum 
in the metabolomics data. This may be due to the methodology of metabolic footprinting as 
we have discussed in that we do not see what is happening within the organism. Therefore, 
it would be interesting to integrate the pathways and metabolic and transcriptomic profiles. 
A few methodologies have been developed to approach this topic as touched upon within 




- Identification of amino acid metabolism and related pathways in HBF compared LBF. 
- Distinct metabolomic profile of C. albicans isolates in FCS compared to RPMI. 
- Metabolic footprint is modified by activation of Amino acid, Lipid and Carbohydrate 
pathways. 
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5.1  Introduction  
 
Within the human host the switch from free floating planktonic cells to surface-attached and 
aggregated biofilm communities pose a particular clinical concern. Advantages offered to 
biofilms through this phenotype include increased tolerance to antimicrobial therapies and 
difficulties in clinical management. Like many bacterial pathogens it has been observed that 
the biofilm phenotype is observed within fungal species like C. albicans. We have shown 
through the literature that virulence and resistance has been a key feature underpinning the 
direction of C. albicans biofilm research, with a growing interest in interkingdom interactions. 
Work has been undertaken to test this phenotype in vitro and to interrogate the underlying 
mechanisms driving biofilm formation. As with many areas of academia, as research 
progresses in one area then this opens avenues of investigation in others. Indeed, it has been 
observed within microbial populations, including C. albicans, that not all strains and 
populations behave the same. We have observed within clinical cohorts that biological 
heterogeneity with respect to biofilm formation and resistance is a prominent feature in 
patients (Rajendran et al., 2016d, Rajendran et al., 2016a). These higher levels of antifungal 
resilience and biofilm forming ability is associated with increased mortality through clinical 
observations (Rajendran et al., 2016d). This thesis sought to explore this heterogeneity using 
a range of computational approaches to better understand the direction of research within 
the C. albicans biofilm community, which species it interacts with in biofilm infections, and 
the mechanisms underpinning biofilm formation.  
 
5.2 Understanding the biogeography of biofilms 
 
The field of microbiology continues to progress rapidly in no small part due to the rate of 
growth and cost effectiveness of omics technologies. Sequencing, mass spectrometry and 
NMR based technologies have propelled our hypothesis driving methodologies through 
providing holistic and high throughput profiling of molecular changes within microbial 
populations. NGS, most utilised in genomics, amplicon, shotgun sequencing transcriptomics 
within microbiology, has gone from being from expensive and niche to inexpensive and 
commonplace within the field. The availability of genome assemblies of bacterial and fungal 
pathogens has grown with the availability, and although many microbial genomes exist in 
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different stages of assembly, long read assembly methods through PacBio technologies and 
the Nanopore sequencers offer possibilities of increasing these assemblies further. 1000s of 
prokaryote genomes have been sequenced, and this number had grown to around 28,000 in 
2014, around 70,000 in 2017, and as of 2020 this number has grown closer to 200,000, with 
nearly 20,000 of these being considered complete genomes (Tatusova et al., 2014, Parks et 
al., 2017). The rise in genome databases has become an invaluable tool for amplicon-based 
and shotgun sequencing microbiome studies, and has allowed for taxonomic identification 
against the vast database of genomes (Balvočiūtė and Huson, 2017). Fungal amplicon or 
mycobiome studies, utilising the hypervariable ITS region, are starting to appear more readily 
in the literature (O'Connell et al., 2020, Richardson et al., 2019). These are more limited than 
bacterial 16S microbiome studies, though comparable in nature, due to our lesser knowledge 
base in fungi and the maturity of bioinformatic methods to analyse them (McTaggart et al., 
2019). 16S amplicon studies have benefited from the field developing over time and improved 
analytics (McTaggart et al., 2019). The number of genome assemblies for fungal species in 
comparison is only 348, within the refseq database, at the time of writing, with only 15 of 
these described as complete (O'Leary et al., 2016, 2020). Initiatives such as the 1000 fungal 
genomes project have been progressing this and aim to address the under representation of 
fungal genomes (http://1000.fungalgenomes.org).  
 
It is clear that C. albicans does not exist in isolation, and that it often resides within a complex 
interkingdom biofilm in a number of sites within the human host (Nobile, 2013). Due to 
numerous advancements within microbiology, it has become apparent that diseases are 
influenced by communities of organisms. These discoveries have been aided in no small part 
through NGS and 16S amplicon sequencing. As we have observed anecdotally, and 
additionally through reviewing the literature within this thesis, interkingdom relationships are 
important in the context of C. albicans biofilms. Clearly, there are key synergistic and 
antagonistic relationships that influence community structure and the overall biogeography 
of mucosal surfaces. The use of high throughput technologies on these interkingdom biofilms 
has already been applied to dual-species models including S. gordonii, S. mutans and P. 
gingivalis (Sztukowska et al., 2018b, Dutton et al., 2016, He et al., 2017). However, in general 
these communities are more complex than these two species models. Future work would aim 
to build upon these models further, with the addition of multiple organisms simultaneously 
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drive greater complexity to the biofilm models. The possibility to do this with greater 
frequency as these technologies move from being specialist facilities and services to everyday 
benchtop equipment, thereby minimising bottlenecks for innovation and advancement. 
Understanding these interactions perhaps needs to begin with improved profiling of the 
important interactions within a given disease.  
  
As a part of this work, we identified relationships that exist between Candida spp. and 
bacterial species within oral sites within the host. There was an important limitation in that 
qPCR was used for total fungal load to compare to our amplicon data. A better indicator of 
interactions would have been profiling of the fungal mycobiome, though these experiments 
predated our current technological capacity for ITS sequencing. The mycobiome has perhaps 
been overlooked, microbiome studies and their supporting databases have increased 
dramatically whereas the same is not true of the mycobiome research with methodologies 
for microbiome being far more standardised (Proctor et al., 2019, Cullen et al., 2020, 
McTaggart et al., 2019, Tiew et al., 2020). Importantly, future whole community studies 
should also consider the mycobiome as part of their methodology. Fungal mycobiome studies 
do exist that highlight their importance in disease and health comparisons such as the 
differently abundant taxa observed in caries (O'Connell et al., 2020). Bacteriome and 
mycobiome joint studies also have been performed within the oral cavity, however wider 
adoption would enable the fungal mycobiome studies to improve and have a greater level of 
standardisation similar the bacterial microbiome (Li et al., 2019, Peters et al., 2017, Persoon 
et al., 2017b). Nevertheless, as with many fungal diseases there is a reluctance to accept the 
notion that fungi play a significant role. Despite this, my own ideas that have evolved from 
the evidence generated within this thesis is that C. albicans plays an important ‘active 
participant role’ opposed to an ‘innocent bystander’ in complex communities. This is 
supported by studies by the Krom group who suggests that C. albicans may serve as a 
‘keystone commensal’ in multispecies oral communities (Janus et al., 2016). It seems logical 
that incorporation of a fungal element provides physical support amongst other attributes to 
bacterial members of the community. However, to fully appreciate this we must first decipher 
how C. albicans biofilm formation is co-ordinated before we add complexity and start 
investigating interkingdom interactions at the molecular level. 
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5.3 Omics approaches to Candida albicans biofilms 
 
To support bioinformatics and the high throughput methods for interrogating molecular 
biology systems, many protein bioinformatic databases have been developed. Sequence 
databases, structural, chemistry, enzymatic and ontological to name a few have been 
developed (Chen et al., 2017). These databases have been developed to address more 
specialised and more specific bioinformatic databases. For example,  the Kyoto Encyclopaedia 
of Genes which contains a per species database of enzymes and related pathways (Kanehisa 
et al., 2015). Gene Ontology is a database that was developed to maintain a high-level 
consistent dictionary of terms (ontologies) to describe molecular functions within systems 
biology (2006). These terms are also maintained across species for the most part unless highly 
specific to the organism. Many of these databases, for example UniProtKB, PANTHER, pfam 
and TIGRFAMS and other family databases are utilised in homology-based methods, such as 
BLAST+ and HMM to annotate genome assemblies (Apweiler et al., 2004). Fungal specific 
databases include the Saccharomyces Genome Database (SGD) and the Candida Genome 
Database (CGD). The CGD is based upon the SGD and maintains a curated database of 
genomic and protein information for Candida spp. Additionally they maintain orthologous 
information and cross reference to other protein databases such as UniProt (Skrzypek et al., 
2016). These bioinformatic databases improve interpretability of sequencing-based 
experiments and provide biological interpretability of otherwise insurmountable datasets. 
These databases are integral to amplicon, RNA-Seq, metabolomics, proteomics, and other 
omics experiments. The more complete our knowledge base is then the more informed our 
interpretation of omics data can be. GSEA, ORA and other pathway analysis methods all 
depend upon this solid a priori knowledge. The growth of these resources also parallels the 
growth of omics techniques. Collectively, these tools have provided the possibility to 
interrogate large data sets with greater rigour and enabled us to start integrating data. 
 
These databases can be utilised to perform ORA and GSEA, and this API is utilised by many 
software’s that implement either ORA of GSEA that includes metexplore, PiMP and 
PaintOmics3. It is through these knowledge bases that many of the functional, pathway and 
network-based models are possible. Human and mice studies have led the way, such as the 
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large functional databases held by the GO consortium. Both tools and databases for larger 
variety of species are becoming available and these are being advanced all the time. 
 
The R package clusterProfiler additionally uses KEGG, which is a wrapper that provides both 
ORA and GSEA through the R function fgsea. GSEA has been performed on the upregulated 
genes in serum in both LBF and HBF Candida isolates. From this we have ascertained 
overlapping pathways upregulated in both HBF and LBF (Figure 5.1). What we observe is that 
over representation analysis shows difference between HBF and LBF and the overlap between 
the two. LBF genes are significantly enriched in more pathways than HBF with more pathways 
having an adjusted p-value of less 0.05. It is possible to observe that genes involved in a 
number of pathways that we observed to have differential activity from our metabolomics 
footprint. Notably, biosynthesis of unsaturated fatty acids and propanoate and fatty acid 
metabolism. Many of the pathways that we see overrepresented in the LBF grown in serum 
compared to RPMI did not appear in our PAPi analysis. The top 10 pathways are illustrated 
for HBF, LBF and the overlap despite many not being significant in HBF. An explanation for 
this may be that the LBF is regulated or reprogramming its metabolism to a greater extent 
than the HBF. Interestingly we also observed upregulation of the MAPK signalling pathway in 




Single omic experiments are almost “commonplace” in the year 2020 within life sciences and 
microbiology. However, progress and breakthrough in technology creates hypothesis and 
further avenues within research. This is common to all of life sciences including microbiology 
and more specifically biofilm research. Integration within the field of microbial bioinformatics 
is one of the current challenges. There is interest in integrating omics of every description 
including the integration of transcriptomic and metabolomic datasets. Transcriptomics and 
metabolomics have a complicated, not necessarily direct, relationship which makes 
integration challenging and interpretation convoluted (Cavill et al., 2015).  
 




Methodologies for integrating transcriptomics and metabolomics can be categorised as 
conceptual, multivariate and pathway. In the coming sections we aim to discuss these 
methodologies in detail regarding C. albicans biofilm research. Using metabolomics and 
transcriptomics data derived from research in previous chapters we will identify strengths 
and potentials of these methodologies at interrogating biofilms. Some limitations exist within 
the data which is important to note. A repeat study methodology was used to derive the 
samples for the transcriptomics and metabolomics. This introduces a batch effect which due 
to the nature of the two data types formed is not possible to correct for the inherent batch 
effects introduced. As the biofilms were grown on separate days from separate medias there 
are variables that are technical and variability that are unique to the analysis performed in 
each batch. Some variability can be typically removed within individual technologies, such as 
gene expression data with which you can normalise data to the same features across batches. 
Figure 5.1 Comparative analysis of the enriched KEGG terms serum in both low and high biofilm 
forming C. albicans isolates. Differentially expressed genes that were upregulated in C. albicans 
isolates that were grown in serum compared to RPMI are compared. Those genes that were unique 
to HBF, LBF or overlapped between the two were submitted to over enrichment analysis against the 
known KEGG pathways for C. albicans. The top ten terms for each analysis are shown although they 
are not considered significant unless adjusted p-value <0.05. Significance was determined by 
hypergeometric testing. Dotplots indicate the level of significance of the FDR adjusted p-value 
(p.adjust) and the size of the dot indicate the number of over enriched genes within the pathway 
within each analysis. 
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The batch effect is between two different methodologies therefore it is not possible to 
normalise the metabolomic data in one batch to the gene expression in another batch as they 
do not share features. This is an important consideration and ultimately limits the power of 
the data. However, we still wished to utilise the data to assess the current approaches to 
integrate data sets. The metabolomics data was also derived from a larger sample set, so in 
certain instances such as multivariate analysis it was considered necessary to reduce the 
sample set to make it comparable with the transcriptomics. This also introduced a further 
limitation as we had an incomplete dataset for both the transcriptomic and metabolomic 
datasets which will be outlined. 
 
5.4.1 Conceptual integration 
Conceptual integration is perhaps the simplest method of data integration. In the case of 
transcriptomics and metabolomics it involves the direct comparison of separately analysed 
data sets. A recent example investigating the metabolomic reprogramming of C. albicans in 
response to hypoxic stress utilised both metabolomics and transcriptomics (Burgain et al., 
2020). The authors identified metabolomic pathways that underwent perturbations in 
response to hypoxia. Subsequently they visualised differentially expressed metabolites to 
observe whether these perturbations were also observed in the transcriptome of C. albicans. 
The research does not make any strong claims regarding the effectiveness of this method. 
However, they highlight transcriptional signatures that overlap with the metabolomic 
findings. The use of ontologies in the form of metabolomic pathways allows for at least 
related genes to be integrated. Similarly, a study identifying changes in metabolism of S. 
mutans cultured with C. albicans utilises both the transcriptome and metabolome (He et al., 
2017). In this instance transcriptomics drives the hypothesis of changes regarding sugar 
metabolism in S. mutans. The usefulness of metabolomics is in its ability to test the 
extracellular concentrations of metabolites to observe this sugar utilisation. Whether or not 
this is strictly regarded as integration, it nevertheless has an additive usefulness to utilise both 
technologies to improve the completeness of the interpretation. 
 
We performed conceptual integration of our metabolomic and transcriptomic data. We did 
this based upon key pathways that had been identified through PAPi in our metabolomics 
analysis. A list of pathways with differential activity scores was compiled from analysis in 
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chapter 4. From our list of metabolic pathways, we then identified transcripts which were 
differentially changing between RPMI and serum at 4h or 24h and in HBF or LBF. The 
transcripts which were differentially expressed were filtered and considered significantly 
changing according to original cut-off of ≥ 1.5 log2 fold change and adjusted p-value ≤0.05. A 
custom script within R was used to filter by differential expression and then by whether those 
transcripts were present in our significantly changing pathways from our PAPi analysis as 
determined by FDR ANOVA p<0.05. Of our 51 pathways that were significantly changing in 
serum compared to RPMI in either of our strains, 46 of those pathways that contained genes 
that were significantly changing within those pathways. The core metabolic pathways and 
their corresponding transcriptional changes are visualised in Figure 6.2. Gene expression is 
displayed in heatmaps with upregulation (i.e., higher in FCS shown in red) and downregulation 
(i.e., higher in RPMI shown in blue) for each of our two strains at time points 4h and 24h. 
 
From the transcriptional activity it is possible to see corresponding changes that align with 
our metabolomics data (Figure 5.2). Notably biosynthesis of unsaturated fatty acids displayed 
increased gene expression in our LBF at 24h in FCS. This same pattern is not observed in the 
HBF strain. Many of these distinguishing genes in LBF were also observed in the propanoate 
metabolic pathway. Fatty acid metabolism has been previously shown to modulate 
morphogenesis in C. albicans (Noverr and Huffnagle, 2004). Our observations here would 
indicate that the observed phenotypic switching or increased morphogenesis that we observe 
in our LBF is through the utilisation of these pathways. From our overlayed transcriptional 
expression in Figure 5.2, we can see LBF are alternating to beta-oxidation of fatty acids. The 
genes within the Glycine, serine and threonine pathway SER33, GCV2, GCV1 are upregulated 
in in FCS to a greater degree than HBF at 4 hours additionally IFG3 and SHM2 are also 
upregulated in FCS in HBF but to a lesser extent. Pyruvate metabolism genes show a similar 
pattern at 4h in both strains apart from LYS22 which encodes homocitrate synthase activity. 
ALD5 is upregulated in LBF FCS at 24h and not HBF as is the putative gene C7_02010C. ALD5 
is aldehyde dehydrogenase and C7_02010C shares homology with aldehyde dehydrogenase 
according to the CGD, which are involved in the biosynthesis of acetate. Both are also 
identified in the pantothenate and CoA biosynthesis pathways, as well as the lysine 
degradation pathways. Glycerolipid and glycerophospholipid showed differential activity in 
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the metabolomics data glycerolipid metabolites showed high (secreted activity) in FCS and 
high (spent activity) in the RPMI. Visualised higher levels of gene expression are observed in 
some FCS with very high levels in certain genes in the HBF. Through overlaying our transcripts 
on our metabolic pathways, it is possible to discern that there are corresponding features 
within the transcriptomics as shown in Figure 5.2. And some patterns such as the gene 
expression in biosynthesis of unsaturated fatty acids are easier to discern than others. 
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Figure 5.2 Differential expression of genes associated with key metabolic pathways. Differential expression of C. albicans transcripts in FCS 
vs Serum was performed between LBF and HBF at 4h and 24h. Those differentially expressed genes that were differentially expressed and that 
also belonged to a pathway that was determined to be significant by PAPi analysis based upon differences in activity score between our sample 
groups according to FDR corrected ANOVA. Pathways filtered first on significance within the PAPi analysis then pathways with significantly DE 
genes from at least one condition are displayed. Leaving genes involved in pathways that. Log2 fold change RPMI compared to Serum for each 
strain at both 4 and 24h are represented within the heatmaps within each pathway shown. 
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5.4.2 Pathway models 
Pathway driven models are based on a priori knowledge on biological databases that are 
maintained either generically or for individual species. These databases include, but are not 
limited to, the KEGG, Reactome, wikiPathways, MSigDb and Gene Ontology databases 
(Kanehisa et al., 2015, Jassal et al., 2020, Slenter et al., 2018). Methods of functional scoring 
or enrichment have become prominent, especially with classification of genes within 
transcriptome studies, in which pathways are scored or enriched dependent upon how 
represented they are. Gene set enrichment analysis and over representation-based analysis 
have become popular methods to identify the most represented functional classes from these 
databases. The hypergeometric distribution of identifying overrepresented classes utilises a 
list of genes of interest typically those that are differentially expressed. The hypergeometric 
distribution is utilised to assess whether that set of genes are significantly associated with a 
specific pathway or classifier. In contrast, the GSEA methodology utilises the entire list of 
features without any prior filtering or selection. GSEA uses the aggregates of per gene or 
features within the set-in order to address the limitation of ORA in which identification of 
small but coordinated changes are missed (Subramanian et al., 2005). By this method 
pathways that have small but consistent changes across the entire gene set are detected. This 
method also requires the gene rank in contrast to ORA. The gene rank based upon the 
expression score commonly the log fold change of a gene within gene list. These techniques 
are no longer limited to gene expression and ORA and metabolite set enrichment analysis 
(MSEA) are utilised within the field of metabolomics. ORA for metabolomics is available 
through numerous bioinformatic tools including IMPaLA, MBRole, MetaboAnalyst, 
MetExplore and PiMP. MSEA is also available through a number of these tools including the 
widely used MetaboAnalyst (Gloaguen et al., 2017, Cottret et al., 2018, Chong et al., 2018a, 
Kamburov et al., 2011). 
 
The pathway approach to many single omic studies has been preferrable way to approach 
omics data with a large number of features that can be difficult to interrogate and interpret 
an individual level. Pathway and functional classification of gene, protein, metabolite and 
other molecular level features considered in regard to their overall function within a cell or 
organism have been chosen by many researchers to interpret the phenotypic changes that 
they observe (Cruickshank-Quinn et al., 2018). Pathway analysis methods have been 
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expanded to the integration of more than metabolomics. Many of the software tools noted 
including IMPaLA, MetaboAnalyst, Metexplore have either been created or expanded to 
incorporate the integration of transcriptomic data (Chong et al., 2018a, Cottret et al., 2018, 
Kamburov et al., 2011). The specifically address IMPaLA for example was first utilised in 2011 
to integrate transcriptome and metabolism in consensus pathway-based approach. The 
approach is essentially an extension of the ORA using Fishers method to consider pathway 
overrepresentation based upon the joint probabilities from both the transcriptome and 
metabolome feature lists (Kamburov et al., 2011). It was noted that due to the necessity of 
robustly annotated databases of pathways for both genes and metabolomics there exists a 
limitation that this technique cannot identify any novel functions. It could also be added that 
this study was a human biological study in which the technique was tested and there are other 
considerations when applying integration to other organisms. Specific microbes suffer in 
comparison to human and mouse studies in that they are less well studied. This means that 
limitation that exist in pathway-based approaches are amplified for other organisms and 
microorganisms. 
 
This approach has gained popularity and is included within other popular and visualisation 
packages. These include PaintOmics 3 which has a specific focus on integration of data from 
multiple omics sources including proteomics and utilises the KEGG database for feature 
classification. MetaboAnalyst which is widely popular and has become a “one stop shop” for 
metabolomics analysis incorporates many of the popular tools for single omics and now the 
ability to incorporate transcriptomic data. Joint pathway enrichment/over representation 
methods are utilised by both tools in this specific application, and both offer a number of 
methods for visualising the data. Limitations exist for individual species across many of the 
integration and single omics tools in OR. It is possible to map identifiers to the model yeast S. 
cerevisiae for analysis of C. albicans and other yeasts. Availability of different species 
databases within these tools is increasing and this will inevitably continue to grow as omics 
and analysis tools become more utilised within microbial research. 
 
An important consideration is that when utilising RNA-Sequencing you measure the total 
mRNA and therefore all features are represented. Metabolomics data depending on the 
instrument and method utilised can influence the metabolites that are represented 
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(Bhinderwala et al., 2018). Metabolites are more likely or easier to find dependant on whether 
NMR, GC-MS or LC-MS is used in acquiring metabolomic data. 
 
Figure 5.3 Integrated pathway enrichment from C. albicans transcripts and metabolomes. 
Upregulated genes in FCS compared to RPMI media after growth of biofilms in for 24h were mapping 
of IDs to S. cerevisiae orthologs, before being submitted for joint pathway analysis through 
MetaboAnalyst. Metabolites that were also in differential abundance between C. albicans isolates 
grown in FCS media compared RPMI at 24h were also submitted for joint pathway over representation 
analysis. From this the joint inverse p-value (-Log10pval) and pathway impact from central and highly 
important pathways. This was performed for both LBF (A) and HBF (B) isolates comparing pathways 
impacted in FCS grown cells in a joint metabolome-transcriptome analysis. The pathway impact is 
plotted on the x with the inverse joint log10 p value plotted on the y. The node size increases with 
pathway impact.   
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The method utilised here was the method of pathway enrichment utilised by the widely used 
MetaboAnalyst software package. This software supports the overlapping of pathways from 
multiple organisms which currently does not support C. albicans, but it does support S. 
cerevisiae. S. cerevisae is a commonly used model organism from which a lot of the homology 
information of C. albicans is drawn (Skrzypek et al., 2016). Candida gene IDs from the CGD 
were first mapped to their corresponding Saccharomyces corresponding systematic name. 
Upregulated genes from HBF at 24 in FCS and LBF at 24h in FCS relative to RPMI were selected 
based upon our previous cut-offs. Like ORA performed on individual datasets this list of 
“important” features is what are submitted. A corresponding list of metabolites assigned to 
their KEGG identifiers, from our metabolomics analysis were also submitted for pathway 
enrichment analysis. In total two enrichment analysis were performed one for LBF and one 
for HBF both at 24h (Figure 5.3). Metabolites and genes are then integrated either by 
combining queries. Combining queries pools both metabolites and transcripts. Or by 
performing two separate over representation analysis and combining p-values. Pathway-level 
p-value joining was chosen for our data. Pathway level weights the gene and metabolite data 
based on how many genes or metabolites are in the corresponding pathways. Pathway level 
also allows for pathways to be enriched even if there are only features available from one 
data set (either genes or metabolites). We observed that amino-acyl-tRNA biosynthesis was 
the most significantly upregulated according to false detection rate (FDR) adjusted p-value in 
both LBF and HBF. It is important to note that aminoacyl tRNA synthesis has only one enzyme 
within this pathway and therefore it is significantly overrepresented within our data but has 
a lower bar for enrichment due to the few features. However, this is indicated by the low 
pathway impact score received by this pathway despite its significance value. KEGG and other 
databases include aminoacyl tRNA synthesis within their pathways however it is perhaps 
should not be considered as such. Pathway analysis attempts to account for pathways with 
low smaller or larger numbers of features such as in the case of hypergeometric analysis.  
 
This significance was driven by mapped metabolites and not transcripts. Arginine and proline 
were over-enriched in both LBF and HBF as was arginine biosynthesis. In LBF beta-alanine was 
also enriched significantly but not in HBF. In HBF the Glycerolipid metabolism was enriched 
but not in LBF. Joint pathway scores and metabolite/gene numbers are available in Appendix 
IV. 
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5.4.3 Statistical and multivariate methods 
Multivariate based methods or dimensionality reduction-based approaches are widely used 
within bioinformatics. They are often applied to single omics data, such as the commonly used 
principal component analysis (PCA), to reduce the data and identify the largest variation 
which exists within the feature set (Marini and Binder, 2019). PCA seeks the directions that 
account for the largest variation and therefore can visualise natural separation in the data. 
Separation that is due to the overall variation in the data is determined by PCA and because 
of this is classified as an unsupervised dimensionality reduction technique (Stein-O'Brien et 
al., 2018). 
 
Several multivariate methods in recent years have been proposed for integrating omics 
datasets with a number of variations of these techniques appearing within the literature. 
Notably partial least squares (PLS) regression which aims to maximise the covariance between 
the datasets (e.g. Transcriptome and Metabolome (Wold, 1973). Also, Canonical Correlation 
Analysis (CCA) which aims to maximise correlation rather than covariance. Both have been 
utilised as methods of dimensionality reduction, classification and in variable discrimination 
(Wold, 1973, González et al., 2012). 
 
PLS and CCA in contrast to PCA can correlate the information from one matrix [x] to the 
information in another [y]. In omics x and y are our feature tables from two omics data 
experiments. PLS is perhaps the most widely used multivariate technique for data integration 
of omics data in particular integration of metabolomic-transcriptomic data (Worley and 
Powers, 2013). Due to its capabilities in handling data with high levels of collinearity and when 
trying to identify aspects of one dataset that predict features of another or covariance such 
as in the case of metabolomic and transcriptomic data (González et al., 2012). PLS is long 
standing multivariate tool which pre-dates omics technologies however was applied to omics 
data sets as early as 2004 (Griffin et al., 2004). Sparse PLS in transcriptomic-metabolomic 
integration is novel variation of the PLS method which arose specifically to address the 
selection of variables for biological interpretation through lasso penalization (KA et al., 2008). 
This method allows for the variable selection and classification allowing for the use of PLS 
which allows it to resolve the classification problems. PLS discriminant analysis has (PLS-DA) 
has also been shown to be another effective variation of PLS capable of performing 
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classification and discrimination on similar omics sets (Boccard and Rutledge, 2013). The 
sparse PLS-DA described by Lê Cao et al is able to identify discriminatory variables given and 
matrix of features and their classes (Cao et al., 2011). 
 
Similar to pathway analysis, a field of data integration by multivariate methods has arisen and 
now many of these methods are becoming available in software packages. Many of these are 
biostatical packages written in an implanted through the R programming language. These 
include integrOmics, MixOmics, OmicsPLS and 02PLS in the Siumca software package (Rohart 
et al., 2017, KA et al., 2009, Bouhaddani et al., 2018). MixOmics offers several multivariate 
methods both supervised and unsupervised for single, dual and multiple integration models 
(Rohart et al., 2017). 
 
We utilised MixOmics to assess multivariate integration upon multiple omics datasets. We 
utilised a supervised discriminatory analysis to identify features which discriminate between 
our classes. Our classes provided were the two time points and the two medias. We did not 
classify the samples in terms of their strain due to low replicate number and to primarily 
identify covariate features in the Serum vs RPMI. The MixOmics contains several analysis 
methods some which are common and others which are novel within the MixOmics package. 
Supervised classification of multiple omics data is provided by their block.plsda and sPLS-DA 
methods. The aim of which is to identify co-expressed variables within our dataset which 
explain our classes as described. A caveat to this approach with our dataset these integration 
methods are described as highly sensitive to differences in omics platforms even in the case 
of measurements on the same samples. Due to our repeat measures study design in which 
we prepared to different batches of samples, one for metabolomics and one for 
transcriptomics. This batch effect is something that we are unable to control for across 
different omics technologies and therefore we utilised multivariate integration as “fishing” or 
hypothesis driving tool and therefore do not intend to draw firm conclusions from them.  
 
For integrating samples, we use block.splsda function from within MixOmics we utilised log 
relative normalised transcripts from DESeq2 and the log media normalised metabolites. 
Metabolites were filtered to leave only identified metabolites within the data set and reduced 
the metabolomics data set so that only the matching LBF and HBF strain used in both assays 
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remained. After our matched datasets were created the block.splsda uses a multiblock 
method for data integration. Where the blocks are the data types organised by matching 
sample identifiers. sPLS-DA combines PLS-DA with Lasso penalisation for selecting the most 
discriminant variables. Samples were assigned as time and media and strain type was ignored. 
Our hypothesis was to maximise the discriminant variables between FCS and RPMI. sPLS-DA 
multiblock has the dual objective of maximising the co-variance within the blocks of omics 
(i.e., metabolomic and transcriptomic) whilst discriminating between our groups. The correct 
number of components was tuned based on the balanced error rate which was deemed to by 
2 components. Tuning parameters were used to determine the number of metabolites and 
transcripts needed for discrimination on each component this was 20,20 for transcripts and 
10,10 for metabolites. From our block plots shown in Figure 5.4A our first component 
discriminated between time and our second component by media with our most covariate 
variables Figure 5.4B. Discriminant features and their contributions to component 2 are 
shown in Figure 5.5A and the correlation between these variables are shown in the circus plot 
5.5B. We identified a subset of our identified metabolites that discriminant between C. 
albicans grown in FCS vs RPMI and secondly covariate genes that discriminate between these 
two biofilms. VPS28 is an important discriminatory feature in FCS involved in the proteolytic 
activation of Rim101, a pH alkaline response promoter if hyphal formation (Figure 5.4). DAD2 
also an identified discriminator is involved in microtubule binding subcomplex DASH required 
for proper chromosome segregation (Figure 5.4). STRING analysis which identifies protein-
protein interactions based on function, homology, publication history and many other 
identifiable relationships did not identify any common links between our subset of transcripts 
(Szklarczyk et al., 2019). 
 




Figure 5.4 Sparse partial least squares discriminant analysis (sPLS-DA) of C. albicans isolates in the 
presence and absence of serum. The log2 relative to the media control normalised metabolome 
matrix and the DESeq2 normalised transcript matrix were submitted to sPLS-DA in the mixOmics 
package. Data projection of the transcriptome data and the metabolome data based upon the most 
discriminant features are shown (A). Sample groups of timepoint and media that isolates are grown in 
are colorised. The correlation between the most discriminant metabolites and transcripts are shown 
(B). Metabolic and transcriptomic features are colourise.  
A
B




Figure 5.5 Important features and correlations between metabolites and transcripts. Loadings plot 
of discriminant features on component 2 (A). The loading weight for transcripts and metabolites which 
discriminate most highly on component two are displayed in a bar plot. Colour of the bar is dependent 
on the sample in which the feature (transcript or metabolite) is most abundant. Correlations of 
discriminant metabolites and transcripts (B). Circos plot displays the correlation between all our 
discriminatory variables on component 2. Component 2 shows the largest separation between 
samples grown in FCS compared to RPMI. Lines between metabolites and transcripts indicate 
correlation and coloured either red for +ve or blue for +ve correlation. 
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5.4.4 Data Integration Conclusions  
Through metabolomic and transcriptomic profiling we have identified several key pathways 
that are differentially changing between C. albicans in serum vs RPMI. Additionally, we have 
been able to identify metabolic networks which are being reprogrammed in otherwise biofilm 
deficient strains to induce them to form biofilms and undergo morphogenesis. Fatty acid 
biosynthesis seems to be key appearing in transcriptomic and metabolomic data alike as an 
important feature in the metabolomic adaptation in serum. 
 
By integrating the two data sets we have identified important features which were not 
apparent when considering each individual data set alone. To date integrated metabolomics 
and transcriptomics have rarely been performed on in vitro biofilm models. There are 
limitations that exist within the data which have been highlighted throughout. Using both 
knowledge based and multivariate methods however it is possible to apply these analytical 
techniques to in vitro to determine both underlying pathways and important “signatures” 
within the models. As our bioinformatic databases on non-model organisms continues to 
grow as with the growth of omics technologies and it is these continued advancements will 
continue to help us decipher biofilms in vitro.  
 
5.5 Final discussion and Conclusions 
 
C. albicans biofilms are increasingly being recognised as important contributors to clinical 
infections, where historically they had been dismissed. These biofilms compared to planktonic 
cells are more resilient and drug resistant. Understanding the mechanisms of biofilm 
formation have become a key focus in Candida research. Through reviewing the literature and 
careful experimentation, with two distinct phenotypes, in biofilm inducing conditions we have 
begun to decipher the pathways driving this phenomenon in clinical isolates. 
 
Within chapters 3, 4 and above, we have shown that within different clinical isolates of C. 
albicans, their phenotypic behaviour is distinct, which is governed by their transcriptomic and 
metabolomic profiles. Further to this even under the same stimulus, in our case serum, their 
metabolome and transcriptomic response is not completely parallel. These are observations 
that would not be made with traditional in vitro that focuses on type strains. Serum is just 
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one stimulus and C. albicans biofilm formation is differentially affected by number of known 
stimulus including pH, host factors, nutrients, and bacterial interactions. Biofilm formation is 
complex, and C. albicans is known to have a regulatory network of 6 genes that in turn 
regulate 1000 genes responsible, or linked to, hyphal formation (Nobile et al., 2012). We and 
others have also observed this to be heterogenous, especially within clinical strains. Another 
layer of complexity is the interactions of differentially “biofilm-ready” strains and their 
interactions with these promotors such as serum. As we have highlighted, the response of 
different C. albicans isolates to serum is not consistent and regulation of different metabolic 
networks to achieve hyphal and biofilm formation is strain dependant (Rajendran et al., 
2016a, Rajendran et al., 2016d). LBF do not respond to RPMI 1640, which typically triggers 
hyphal and biofilm formation due to the copious amounts of glucose (Kucharíková et al., 
2011), a response that is observed in well characterised type strains and many of our clinical 
isolates (Weerasekera et al., 2016, Rajendran et al., 2016d). Biofilm formation through 
glucose sensing in C. albicans is modulated through three key networks glucose repression, 
the sugar receptor repressor (SRR), and adenylate cyclase networks. Two of these cascades, 
the SRR and adenylate cyclase are implicated in cellular morphogenesis. LBF strains do not 
respond to this stimulus in the same way and remain unadhered and predominantly as yeast. 
However, as we have demonstrated they are not biofilm defective, and additional stimuli are 
able to induce alternative metabolic reprogramming to induce this phenotype. In serum the 
LBF can utilise the fatty acid metabolic pathway to induce this phenotype. LBF and HBF 
seemingly differed more in their transcriptional activity than in their metabolic. A limitation 
of our study design perhaps that we did not have the intracellular metabolic activity to 
interrogate alongside our extracellular data. As indicated previously within the thesis, 
improved metabolomics techniques such as ms/ms and metabolic flux would also perhaps 
demonstrate with greater resolution the activation of metabolic networks of our different 
strains under the different stressors. 
 
Throughout this work LBF and HBF isolates were compared against each other and were 
grown in either FCS or RPMI. RPMI was considered the baseline or control media with the 
supplementation of FCS to the media being our test condition. Similarly, HBF was our point of 
comparison with which we compared the LBF isolates. This was due to the larger and much 
more stark effect of FCS on LBF as shown in chapter 3. In which the non-biofilm formers 
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morphogenically switch to biofilm formers in FCS supplemented media. FCS is poorly defined 
and poorly controlled media, particularly when compared to synthetically made medias such 
as RPMI. This introduces lots of variability which cannot be controlled. Further 
experimentation would benefit from introduction of metabolites, metals and vitamins found 
in FCS in known quantities to provide more reproducible and better controlled 
experimentation. Such as the introduction of individual amino acids or metal ions such as zinc 
to minimal media. In this fashion we could identify the individual effects of metabolites and 
potential biofilm influencers without confounding factors and variability from poorly defined 
medias. These are avenues of research that could be taken forward from the work presented 
here. 
 
Within this body of work and throughout much of the work within Oral Sciences group we 
have opted to use clinical isolates in the place of laboratory type strains. Type strains, despite 
being well defined, are unrepresentative and do not model the heterogeneity that is seen in 
clinical samples. This heterogeneity amongst clinical isolates is well highlighted in the Scottish 
candidaemia study from which these isolates were received (Rajendran et al., 2016d). 
However, comparison to a type of strain control may have been beneficial when identifying 
shared and differing responses, due to the literature on biofilm formation strains such as 
SC5314 being much larger. Another limitation is that throughout many of our comparisons 
we only used a small number of isolates, such as those within the RNA-Seq work in chapter 3 
were we used 1 HBF and 1 LBF. We used these to represent our two phenotypes to compare 
the effects of FCS on Low vs High Biofilm formers. However, in the light of how much 
heterogeneity and biofilm forming variation there is between strains, as highlighted by the 
Candidemia study, other methodologies may have been more appropriate. For example, 
rather than a 1 vs 1 controlled experiment with technical replication, profiling of a larger 
cohort of isolates may have yielded further information. By comparing a larger number of 
isolates, we would have been able to observe trends and correlations in features from 
metabolomic, transcriptomic and proteomic with the observed phenotype. This study design 
would have been less biased towards select isolates that show extremes of the two isolates 
and discerned more suitable differences that are related to phenotype.  
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We have previously described metabolomics and transcriptomic experiments as hypothesis 
driving methodologies in contrast to hypothesis testing experiments. A limitation of the work 
presented in this thesis is the lack of confirmatory experimentation. For example, work using 
minimal media with metabolites incrementally added would have confirmed some of our 
findings. Addition of zinc to the media to confirm the downregulation of these genes for 
example. Further work to elucidate the presence of arachidonic acid such as confirmatory 
assays available in the form of enzyme-linked immunosorbent assays (ELISA). The lack of 
these assays are due to a time and lab access restriction but would be interesting avenues of 
research for the Oral Sciences research group. Similarly, we saw amino acid metabolism and 
fatty acid metabolism changes. Experimentation with different phenotypic isolates of Candida 
in the presence and absence of amino acids such as proline, arginine and serine could yield 
interesting results. Simple biofilm assays such as crystal violet could inform whether amino 
acid presence is able to induce biofilm formation in low or intermediate biofilm formers. 
Similarly, it is common to confirm RNA-Seq findings with qPCR of select genes of interest. The 
aim being to check that qPCR findings match with our high throughput observations. This is 
commonly performed using RNA that is retrieved from samples that have had all the same 
experimental steps as the RNA-Seq data. There has been arguments made that the 
information that this adds is low and that RNA-Seq is robust enough that this is no longer 
necessary (Coenye, 2021). Validating by qPCR has potentially been inherited from microarrays 
which had higher error and bias compared to RNA-Seq and RNA-Seq by comparison shows 
low concordant results with only around 1.8% of genes (Everaert et al., 2017). Additionally, 
the use of small number of genes to validate a much larger dataset may seem unintuitive. As 
is discussed in the review from 2021 the lack of correlation with a single gene through 
validation does not speak to the validity of the remainder of the dataset (Coenye, 2021). 
However, due to our collection of blood stream isolates being so large with >100 categorised 
isolates then qPCR could possibly add to our findings. Taking a larger and more varied 
selection of C. albicans isolates we could have profiled the expression of genes of interest, 
such as the SAPs which were upregulated in FCS, zinc transporters which were up in RPMI or 
the ATO gene family which were specific to the LBF in FCS, in a much larger selection of 
isolates. This would have allowed us to see if the differential expression of these genes was 
consistent across phenotypically similar strains. This adds to the previous point that a simpler 
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RNA-Seq study design on a much larger selection of biologically varying C. albicans isolates 
would similarly add more power to the study design.  
 
Throughout this thesis we have discussed multi-omics and focused on transcriptomic and 
metabolomic analysis. There are many other omics, including lipidomic and genomics. There 
are also many variations of some of the techniques used as we highlighted in the 
metabolomics section. Notably missing from this work is the inclusion of genomic data. A 
genomic profile of all the isolates from the Scottish candidaemia study would be the logical 
progression. Whole genome sequencing by Illumina or similar platforms followed by assembly 
of genomes and identification of variants, either copy number of single nucleotide variants 
(SNV). This is future work that will be of great importance, through using NGS to genotypically 
understand any phenotypic and clinical variation within these strains. This work would answer 
questions both about variation that determines our observed phenotypes in vitro and 
variation related to our epidemiological findings (Rajendran et al., 2016d). These isolates were 
highly curated with both clinical data and antifungal resistance and sensitivity data. Links to 
the genomic data could also provide insights into the heterogeneity in antifungal 
susceptibility and resistance that was observed between these isolates. Functional genomics 
is an effective tool at linking the genome to phenotype and pathogenicity/virulence related 
functions in yeasts and fungi (Farrer and Fisher, 2017).  
 
Within the literature review we also highlighted the importance of transcriptional control on 
the much larger network of biofilm and hyphal genes. These were important findings that 
were first discovered by Nobile and colleagues in 2012 (Nobile et al., 2012). Transcription 
factor activity through these cascades could therefore have been profiled using 
phosphoproteomics. Phosphoproteomics identifies active pathways through mass 
spectrometry phosphoprotein analysis (Dudley and Bond, 2014). This methodology has 
previously been shown to be effective in tracking the phosphorylation of proteins involved in 
pathogenesis in C. albicans and was applied to identify the activity of protein kinases during 
hyphal elongation (Ghorai et al., 2018). It would be interesting therefore to see if there were 
any changes in the dynamics of these hyphal regulating kinase cascades between high and 
low forming isolates. To our knowledge this would be the first study looking at the differences 
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in protein kinase and kinase interaction with phosphoproteins between clinically relevant 
isolates.  
 
Considering omics approaches as hypothesis drivers and not hypothesis testers, however, this 
body of work opens several avenues of investigation. Further work would hope to expand on 
the inducibility of biofilm formation from other known inducers. It is also assumed that HBF 
are more tolerant to antimicrobials, and to date little is known about whether this resistance 
is shared by LBF that have been induced. Because hyphal formation and biofilm formation is 
inducible it is perhaps also possible to hypothesis that these conditions exist within the host. 
Novel antifungal regimens that consider alternative metabolic pathways may also yield 
improved antifungal sensitivity in vivo. As discussed, we have only discussed one stimulus out 
of the many that are known to induce heterogeneity. Anecdotally, work not presented in this 
thesis show that certain bacteria are able to induce this biofilm phenotype. This indicates that 
biofilm heterogeneity is more complex, and perhaps these LBF strains are more adapted to 
co-exist mutually or synergistically with bacterial species. It has been shown that the 
relationship with bacteria is a growing trend and within the oral cavity we additionally 
demonstrated that fungi do impact the microbial community. Candida’s role within multi-
species biofilms is still needed to be understand fully and how both Candida and bacteria 
interact with each other. This is particularly true in the oral cavity as we have identified from 
the literature over the last 20 years and our own microbiome studies. The studies outlined 
here lead the way for further omics profiling of increasingly complex interkingdom 
communities. It is our belief that these studies need to be performed and the thought of what 
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